<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2026"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2026"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:pfsa="http://profusa.com/20260630"
  xmlns:srt="http://fasb.org/srt/2026"
  xmlns:us-gaap="http://fasb.org/us-gaap/2026"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="pfsa-20260630.xsd" xlink:type="simple"/>
    <context id="cref_496962156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1340915823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:AscentPartnersFundLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-08-19</startDate>
            <endDate>2026-08-19</endDate>
        </period>
    </context>
    <context id="cref_754644200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:AscentPartnersFundLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-19</instant>
        </period>
    </context>
    <context id="cref_180299970">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-08-18</startDate>
            <endDate>2026-08-18</endDate>
        </period>
    </context>
    <context id="cref_417250911">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-08-18</startDate>
            <endDate>2026-08-18</endDate>
        </period>
    </context>
    <context id="cref_119935471">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">pfsa:EmployeeBonusesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-08-18</startDate>
            <endDate>2026-08-18</endDate>
        </period>
    </context>
    <context id="cref_1465053354">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">pfsa:AdvisorsAndVendorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-08-18</startDate>
            <endDate>2026-08-18</endDate>
        </period>
    </context>
    <context id="cref_1406285210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-08-18</startDate>
            <endDate>2026-08-18</endDate>
        </period>
    </context>
    <context id="cref_346576114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">pfsa:SeriesANonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-08-18</startDate>
            <endDate>2026-08-18</endDate>
        </period>
    </context>
    <context id="cref_65396335">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-13</instant>
        </period>
    </context>
    <context id="cref_2046281447">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-08-12</startDate>
            <endDate>2026-08-12</endDate>
        </period>
    </context>
    <context id="cref_2017145347">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-12</instant>
        </period>
    </context>
    <context id="cref_200603577">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-08-12</endDate>
        </period>
    </context>
    <context id="cref_988890546">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1760202102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-07-31</instant>
        </period>
    </context>
    <context id="cref_1765404405">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-07-31</instant>
        </period>
    </context>
    <context id="cref_769800211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-31</startDate>
            <endDate>2026-07-31</endDate>
        </period>
    </context>
    <context id="cref_508631920">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">pfsa:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-31</startDate>
            <endDate>2026-07-31</endDate>
        </period>
    </context>
    <context id="cref_1903852325">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">pfsa:SeriesANonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-31</startDate>
            <endDate>2026-07-31</endDate>
        </period>
    </context>
    <context id="cref_445490913">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">pfsa:OptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-31</startDate>
            <endDate>2026-07-31</endDate>
        </period>
    </context>
    <context id="cref_1583072532">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">pfsa:OptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-31</startDate>
            <endDate>2026-07-31</endDate>
        </period>
    </context>
    <context id="cref_80705224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pfsa:MedScreenLaboratoriesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-07-31</instant>
        </period>
    </context>
    <context id="cref_295563055">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <instant>2026-07-27</instant>
        </period>
    </context>
    <context id="cref_1579910082">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-27</startDate>
            <endDate>2026-07-27</endDate>
        </period>
    </context>
    <context id="cref_1774277253">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">pfsa:ELOCPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-31</startDate>
            <endDate>2026-07-31</endDate>
        </period>
    </context>
    <context id="cref_1606834516">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-31</startDate>
            <endDate>2026-07-31</endDate>
        </period>
    </context>
    <context id="cref_1291181401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-07</startDate>
            <endDate>2026-07-07</endDate>
        </period>
    </context>
    <context id="cref_853412475">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1613454691">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_8656465">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_433015125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_778583285">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_126326278">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">pfsa:EarnoutSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_1247065944">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:AscentPIPENotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1621573025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:AscentPIPENotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_24398820">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">pfsa:TaslyConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_330754979">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_1053028611">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">pfsa:EarnoutSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_893477863">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">pfsa:OptionsToPurchaseCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_525068321">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">pfsa:OptionsToPurchaseCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_631897872">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1103434203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">pfsa:LoansPayableHeldAtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_705606665">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">pfsa:RelatedPartyConvertibleNotesPayableAtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_445501554">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">pfsa:RelatedPartyConvertibleNotesPayableAtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_487009401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_521100978">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_1771939082">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_283228345">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pfsa:StatementOfIncomeLocationAxis">pfsa:AdministrativeServiceFeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_841424808">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pfsa:StatementOfIncomeLocationAxis">pfsa:AdministrativeServiceFeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_2144262498">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_1339240323">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_4447815">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_552726845">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_166583866">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">pfsa:NVACSponsorILLCOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_2043099235">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">pfsa:NVACSponsorILLCOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1476517352">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">pfsa:TheFoundersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_1135426697">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">pfsa:TheFoundersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1685443802">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">pfsa:NVACSponsorILLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_116765221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">pfsa:NVACSponsorILLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_2100081469">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">pfsa:TaslyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_967183272">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">pfsa:TaslyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1542769222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pfsa:ResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_1189771306">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pfsa:ResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1825677182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pfsa:ResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_1265100041">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pfsa:ResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_2071186968">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pfsa:GeneralAndAdministrativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_1674465270">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pfsa:GeneralAndAdministrativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1670057360">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pfsa:GeneralAndAdministrativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_516476530">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pfsa:GeneralAndAdministrativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_279465061">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_683057423">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_592262246">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_483527547">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pfsa:ThousandTwentyFiveIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_405697873">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <startDate>2026-05-07</startDate>
            <endDate>2026-05-07</endDate>
        </period>
    </context>
    <context id="cref_1976886926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pfsa:TwoThousandTenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_911624918">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:HCWWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1653801061">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:HCWWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_63415997">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:RepresentativesWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_15407559">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:RepresentativesWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_1500117593">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_2101963542">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_1060540123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1030451730">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_211542808">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:PublicWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_175147910">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_221860134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <startDate>2026-04-29</startDate>
            <endDate>2026-04-29</endDate>
        </period>
    </context>
    <context id="cref_181692182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-20</startDate>
            <endDate>2026-04-20</endDate>
        </period>
    </context>
    <context id="cref_113966588">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-20</startDate>
            <endDate>2026-04-20</endDate>
        </period>
    </context>
    <context id="cref_1779854870">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:AscentWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1203138532">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:AscentWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_552763750">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1052881828">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_966753452">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:AscentWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1072514866">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:AscentWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1810070407">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:HCWWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_288278288">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:HCWWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_679378796">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:RepresentativesWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1745349373">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:RepresentativesWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_554893378">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1521110747">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1515966903">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_310701023">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_871387629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:PublicWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_2011423406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1950113667">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">pfsa:IssuanceOfEarnoutSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_354173338">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">pfsa:IssuanceOfEarnoutSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_492419163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">pfsa:OutstandingCommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_72780092">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">pfsa:OutstandingCommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_2088078009">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">pfsa:IssuanceOfOptionsUnderTheTwoThousandTenPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1273526037">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">pfsa:IssuanceOfOptionsUnderTheTwoThousandTenPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_2136082356">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">pfsa:OutstandingOptionsUnderTwoThousandTenPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1443777198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">pfsa:OutstandingOptionsUnderTwoThousandTenPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1007243374">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <startDate>2026-02-01</startDate>
            <endDate>2026-02-28</endDate>
        </period>
    </context>
    <context id="cref_477349365">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_710033096">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">pfsa:BenchmarkCompanyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1841423955">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">pfsa:OperatingLeaseObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_2042217600">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">pfsa:OperatingLeaseObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_11121223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <startDate>2026-01-27</startDate>
            <endDate>2026-01-27</endDate>
        </period>
    </context>
    <context id="cref_1398474254">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">pfsa:NewLeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-27</startDate>
            <endDate>2026-01-27</endDate>
        </period>
    </context>
    <context id="cref_1727000301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:BorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1703656236">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:PromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:BorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1457165476">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:SeniorNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:BorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_516374104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:PPPLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:BorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_990767968">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:BorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1620108994">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:TaslyConvertibleDebtRelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:BorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_857227374">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">pfsa:PPPLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1158212978">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">pfsa:SeniorNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_707439183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">pfsa:SeniorNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_2038731489">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1286433117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_448710947">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">pfsa:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_1011423167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">pfsa:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1101054349">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_276287916">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_985413407">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_1232237483">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_1949920802">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="cref_1493331618">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="cref_370897421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">pfsa:SeniorNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1333971396">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_201115319">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_1943710765">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_2003996832">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_6246743">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">pfsa:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1239202785">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">pfsa:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1627526449">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <startDate>2026-06-23</startDate>
            <endDate>2026-06-23</endDate>
        </period>
    </context>
    <context id="cref_1025699883">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <startDate>2026-04-24</startDate>
            <endDate>2026-04-24</endDate>
        </period>
    </context>
    <context id="cref_267912151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <startDate>2026-04-06</startDate>
            <endDate>2026-04-06</endDate>
        </period>
    </context>
    <context id="cref_1458494491">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1163422627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">pfsa:TaslyConvertibleDebtRelatedPartyAtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_2063090379">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">pfsa:TaslyConvertibleDebtRelatedPartyAtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1093374776">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:TaslyConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_919073489">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:TaslyConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_4641836">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_137095580">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">pfsa:TaslyConvertibleDebtRelatedPartyAtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="cref_1142370945">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1337257417">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_299885455">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1803770222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:AscentPIPENotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_35443710">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-20</instant>
        </period>
    </context>
    <context id="cref_1416218782">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-20</instant>
        </period>
    </context>
    <context id="cref_465977170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-20</instant>
        </period>
    </context>
    <context id="cref_2007779218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2027-04-20</instant>
        </period>
    </context>
    <context id="cref_280602754">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:AscentPIPENotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-20</instant>
        </period>
    </context>
    <context id="cref_125224100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-02</startDate>
            <endDate>2026-04-02</endDate>
        </period>
    </context>
    <context id="cref_64592548">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-02</instant>
        </period>
    </context>
    <context id="cref_2067957749">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-02</instant>
        </period>
    </context>
    <context id="cref_836594507">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2027-04-02</startDate>
            <endDate>2027-04-02</endDate>
        </period>
    </context>
    <context id="cref_2066662965">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2027-04-02</instant>
        </period>
    </context>
    <context id="cref_742915857">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:AscentPIPENotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-02</instant>
        </period>
    </context>
    <context id="cref_1504193733">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">pfsa:RelatedPledgeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-02</instant>
        </period>
    </context>
    <context id="cref_2052371366">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">pfsa:PIPESubscriptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-02</instant>
        </period>
    </context>
    <context id="cref_699838351">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1854029298">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1174028695">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">pfsa:AprilTwentyTwentySixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:AscentPIPENotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1391318560">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_326829935">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:PPPLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="cref_1509580890">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="cref_774196741">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:SeniorNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="cref_1750623848">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:TaslyConvertibleDebtRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="cref_564467413">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:JuniorConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="cref_1858504101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:SeniorNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_986438284">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:JuniorConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_687569782">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:PPPLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_1506143925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_1896784723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:TaslyConvertibleDebtRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_1224068254">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:PPPLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="cref_839579100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="cref_1550908874">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:SeniorNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="cref_1663177274">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:TaslyConvertibleDebtRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="cref_1708146614">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:JuniorConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="cref_1887753489">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:SeniorNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="cref_795156743">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:JuniorConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="cref_124060944">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:PPPLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="cref_1132075286">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="cref_1960383429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:TaslyConvertibleDebtRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="cref_2068785483">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:PPPLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="cref_567134068">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="cref_1275188923">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:SeniorNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="cref_128811614">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:TaslyConvertibleDebtRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="cref_1953581452">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:JuniorConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="cref_1998870429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:DOInsuranceFinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1828519998">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:SeniorNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_920647719">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:ConvertiblePromissoryNoteRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_482928940">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:TaslyConvertibleDebtRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_782487662">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:SeniorNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_900716984">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:SeniorNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1479801101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:ConvertiblePromissoryNoteRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1105431510">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:ConvertiblePromissoryNoteRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_143335751">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:LoansPayablesInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_249402601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:DOInsuranceFinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1350234277">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:PPPLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_725364953">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1184042403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1103899081">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:SeniorNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_239084172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:SeniorNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1727949712">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:TaslyConvertibleDebtRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1685313687">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:LoansPayablesInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1225942580">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:LoansPayablesInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_150233668">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:PPPLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1395954209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1512439617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_616795955">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:SeniorNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1145002775">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:ConvertiblePromissoryNoteRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1001554303">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:LoansPayablesInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_795889418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_879442911">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:SeniorNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1767342225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:LoansPayablesInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1732842588">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:ConvertiblePromissoryNoteRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1720775043">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:TaslyConvertibleDebtRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1314037718">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:DOInsuranceFinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1703614914">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:DOInsuranceFinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_909296507">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_231997891">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:SeniorNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_1867653040">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:ConvertiblePromissoryNoteRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_1726074040">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:TaslyConvertibleDebtRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_1838377757">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:LoansPayablesInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_575229552">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:PPPLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_233839587">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1858606938">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:SeniorNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1956424655">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:LoansPayablesInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_469666132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:TaslyConvertibleDebtRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_632922629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:DOInsuranceFinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1691449733">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:DOInsuranceFinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1530643582">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:PPPLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_938099005">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_964975286">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:SeniorNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1486589709">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:ConvertiblePromissoryNoteRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_558633562">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:TaslyConvertibleDebtRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1659609866">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:LoansPayablesInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1770842783">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_652785231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_181399372">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_1312882388">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1806077489">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1122969955">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pfsa:LoansPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">pfsa:FairValueOfCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_894978972">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pfsa:LoansPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">pfsa:FairValueOfCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1221446360">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pfsa:LoansPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1264764146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pfsa:LoansPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_279329609">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pfsa:LoansPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1249148369">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pfsa:LoansPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1960713392">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pfsa:LoansPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1875503243">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pfsa:LoansPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1934275296">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pfsa:TaslyConvertibleNoteRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="cref_284285301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pfsa:TaslyConvertibleNoteRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_1287881122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pfsa:TaslyConvertibleNoteRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="cref_1907849123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pfsa:TaslyConvertibleNoteRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="cref_1199347720">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pfsa:TaslyConvertibleNoteRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="cref_113009238">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pfsa:TotalLevel3RelatedPartyConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_370576236">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pfsa:RelatedPartyConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_213427050">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pfsa:TaslyConvertibleNoteRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1643901266">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pfsa:TotalLevel3RelatedPartyConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_2054901614">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pfsa:RelatedPartyConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1494627373">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pfsa:TaslyConvertibleNoteRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1138967112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pfsa:TotalLevel3RelatedPartyConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_1576903624">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pfsa:RelatedPartyConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_2082299376">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pfsa:TaslyConvertibleNoteRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_1220106736">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pfsa:TotalLevel3RelatedPartyConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_2082906046">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pfsa:TaslyConvertibleNoteRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1162265563">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pfsa:TotalLevel3RelatedPartyConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1865825429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pfsa:RelatedPartyConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_867040326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pfsa:TaslyConvertibleNoteRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_2039798321">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">pfsa:FairValueOfCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_474503820">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputOptionVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1848064682">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1444226790">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">pfsa:MeasurementInputDebtRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1440330822">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:WarrantsLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1353231876">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_679743220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:WarrantsLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1559462887">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:AscentWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_880231378">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:RepresentativesWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1216300098">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_2034627019">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:WarrantsLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_1131121924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:RepresentativesWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_1265355780">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_385375310">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:WarrantsLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_2119320024">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:RepresentativesWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_439831922">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1499422870">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:WarrantsLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_144596688">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:RepresentativesWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1983616198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_603114473">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_2137903473">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pfsa:WarrantLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">pfsa:FairValueOfCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1263350621">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pfsa:WarrantLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">pfsa:FairValueOfCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_260734898">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pfsa:WarrantLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1918530263">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pfsa:WarrantLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_373797147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pfsa:WarrantLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1953658540">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pfsa:WarrantLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_644213327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pfsa:WarrantLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1840681411">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pfsa:WarrantLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1814801564">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pfsa:WarrantLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_39081096">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pfsa:WarrantLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_2104304165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1641325391">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:RepresentativesWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1649060390">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_339012237">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_962984040">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1846470091">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1377884820">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <instant>2026-04-02</instant>
        </period>
    </context>
    <context id="cref_1894852061">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:ELOCWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-20</instant>
        </period>
    </context>
    <context id="cref_1877472753">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:ELOCWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_720646264">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:ELOCWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1232708550">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">pfsa:ELOCPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_190850052">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">pfsa:ELOCPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1636204611">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">pfsa:ELOCPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1474767452">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <instant>2025-07-28</instant>
        </period>
    </context>
    <context id="cref_725547165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-09</instant>
        </period>
    </context>
    <context id="cref_1087692109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">pfsa:FebruaryReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-09</startDate>
            <endDate>2026-02-09</endDate>
        </period>
    </context>
    <context id="cref_573187633">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-17</instant>
        </period>
    </context>
    <context id="cref_549261231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-08-17</startDate>
            <endDate>2026-08-17</endDate>
        </period>
    </context>
    <context id="cref_553273376">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">pfsa:ELOCPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-27</startDate>
            <endDate>2025-10-27</endDate>
        </period>
    </context>
    <context id="cref_1065796396">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">pfsa:ELOCPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_326112696">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">pfsa:ELOCPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1499574654">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_2049122364">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1188634825">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-28</startDate>
            <endDate>2025-07-28</endDate>
        </period>
    </context>
    <context id="cref_862313956">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:PIPEConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_762878902">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">pfsa:AscentConvertibleNoteAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-12</instant>
        </period>
    </context>
    <context id="cref_1877772804">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="cref_1366156791">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:PIPEConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="cref_301838592">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="cref_1905232369">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="cref_258284346">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="cref_295168145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="cref_115014141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="cref_146453500">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="cref_2059095953">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="cref_717000525">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="cref_824579099">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_504299761">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_1146081111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="cref_1099721133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="cref_85640999">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="cref_991988056">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="cref_1750132856">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="cref_76604954">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="cref_630668889">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="cref_1697009852">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="cref_1400161968">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="cref_435315273">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="cref_1911586431">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="cref_1758065113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="cref_2143223074">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="cref_1586520882">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="cref_1804831361">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="cref_1958988437">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="cref_437148813">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_373520702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1651086280">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1320053688">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1842852390">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_387292067">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_1154050613">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_1940574821">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1983744206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1917067130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_27050776">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_773036080">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1162692304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_810086022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
        </entity>
        <period>
            <instant>2026-08-18</instant>
        </period>
    </context>
    <context id="cref_869081602">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1252091504">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_389976961">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_519169877">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1652036292">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_877452344">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1963797799">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:AscentWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_763554049">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:AscentWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_19150775">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_713651180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1580858154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1343485248">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_627275894">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_14449110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">pfsa:LoansPayableHeldAtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_661308655">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_219262666">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">pfsa:EarnoutSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_1014181908">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1499031780">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_331585081">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:PPPLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_1487040249">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:PPPLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1123562661">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pfsa:ConvertiblePromissoryNoteRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_739950774">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="cref_678289354">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="cref_2136062883">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="cref_1522950734">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="cref_511051940">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:RepresentativesWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_161393837">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_946089074">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1853496641">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:RepresentativesWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_912067788">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:RepresentativesWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_2092241241">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:RepresentativesWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_41616020">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_647000154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_377660832">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1938583770">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:RepresentativesWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1379488162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">pfsa:RepresentativesWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_414653761">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_212327296">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_302057777">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_1145146570">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_900299053">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1539459543">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_61195065">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1719798891">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_1709034871">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_2016811345">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_1394063579">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001859807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pfsa:RelatedPartyConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <unit id="uref_1340915823">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="uref_138178116">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="uref_2062431040">
        <measure>shares</measure>
    </unit>
    <unit id="uref_527123470">
        <measure>pure</measure>
    </unit>
    <us-gaap:CommonStockValue
      contextRef="cref_988890546"
      id="fc_216170721"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="cref_592262246"
      id="fc_638346461"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_869081602"
      id="fc_869081602"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_1252091504"
      id="fc_1252091504"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_389976961"
      id="fc_389976961"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_1162692304"
      id="fc_2145116626"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_519169877"
      id="fc_519169877"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_1652036292"
      id="fc_1652036292"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_877452344"
      id="fc_877452344"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_1917067130"
      id="fc_918207218"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_1940574821"
      id="fc_895476671"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="cref_519169877"
      id="fc_1993385131"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="cref_1652036292"
      id="fc_1163289462"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="cref_1963797799"
      id="fc_1963797799"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="cref_763554049"
      id="fc_763554049"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="cref_1963797799"
      id="fc_248509124"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="cref_1963797799"
      id="fc_1781900980"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:WarrantIssued
      contextRef="cref_1216300098"
      id="fc_1434415381"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:WarrantIssued
      contextRef="cref_880231378"
      id="fc_332852027"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:ReclassificationOfWarrantLiabilityToAdditionalPaidinCapital
      contextRef="cref_1216300098"
      id="fc_1366381371"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:ReclassificationOfWarrantLiabilityToAdditionalPaidinCapital
      contextRef="cref_880231378"
      id="fc_1600085982"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_19150775"
      id="fc_19150775"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_713651180"
      id="fc_713651180"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_1580858154"
      id="fc_1580858154"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_1337257417"
      id="fc_1102547853"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_1651086280"
      id="fc_1920042966"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="cref_19150775"
      id="fc_1478229101"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="cref_713651180"
      id="fc_1015116339"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="cref_1580858154"
      id="fc_170871922"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="cref_1337257417"
      id="fc_159011725"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="cref_1651086280"
      id="fc_841256360"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="cref_19150775"
      id="fc_267491696"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="cref_713651180"
      id="fc_501393289"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="cref_1580858154"
      id="fc_320861840"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="cref_1337257417"
      id="fc_912202512"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="cref_1651086280"
      id="fc_1762507943"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:AdjustmentsToAdditionalPaidInCapitalExciseTaxPayableAttributableToRedemptionOfCommonStock
      contextRef="cref_19150775"
      id="fc_1199666906"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:AdjustmentsToAdditionalPaidInCapitalExciseTaxPayableAttributableToRedemptionOfCommonStock
      contextRef="cref_713651180"
      id="fc_1660024941"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:AdjustmentsToAdditionalPaidInCapitalExciseTaxPayableAttributableToRedemptionOfCommonStock
      contextRef="cref_1580858154"
      id="fc_293186003"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:AdjustmentsToAdditionalPaidInCapitalExciseTaxPayableAttributableToRedemptionOfCommonStock
      contextRef="cref_1337257417"
      id="fc_1913703047"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:AdjustmentsToAdditionalPaidInCapitalExciseTaxPayableAttributableToRedemptionOfCommonStock
      contextRef="cref_1651086280"
      id="fc_1776669523"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="cref_19150775"
      id="fc_609326797"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="cref_713651180"
      id="fc_1754729935"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="cref_1343485248"
      id="fc_1343485248"
      unitRef="uref_2062431040"
      xsi:nil="true"/>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="cref_627275894"
      id="fc_627275894"
      unitRef="uref_2062431040"
      xsi:nil="true"/>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="cref_14449110"
      id="fc_14449110"
      unitRef="uref_2062431040"
      xsi:nil="true"/>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="cref_661308655"
      id="fc_661308655"
      unitRef="uref_2062431040"
      xsi:nil="true"/>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="cref_219262666"
      id="fc_219262666"
      unitRef="uref_2062431040"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="cref_988890546"
      id="fc_1796558968"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="cref_592262246"
      id="fc_1618009940"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:CryptoAssetFairValueCurrent
      contextRef="cref_988890546"
      id="fc_2097858115"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:ConversionOfDebtToEquity
      contextRef="cref_330754979"
      id="fc_379073753"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="cref_330754979"
      id="fc_317487766"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:UnpaidDeferredOfferingCosts
      contextRef="cref_853412475"
      id="fc_1549462061"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="cref_1014181908"
      id="fc_1014181908"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="cref_1499031780"
      id="fc_1499031780"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:ContractualTerm contextRef="cref_477349365" id="fc_333186512">P0Y</pfsa:ContractualTerm>
    <pfsa:ReclassificationOfWarrantLiabilityToAdditionalPaidinCapital
      contextRef="cref_330754979"
      id="fc_975962476"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentFairValue
      contextRef="cref_331585081"
      id="fc_331585081"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="cref_1145002775"
      id="fc_616849018"
      unitRef="uref_527123470"
      xsi:nil="true"/>
    <pfsa:DebtConversionPricesPerShare
      contextRef="cref_1395954209"
      id="fc_706740288"
      xsi:nil="true"/>
    <pfsa:DebtConversionPricesPerShare
      contextRef="cref_150233668"
      id="fc_1759056592"
      xsi:nil="true"/>
    <pfsa:DebtConversionPricesPerShare
      contextRef="cref_1998870429"
      id="fc_986038095"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="cref_150233668"
      id="fc_823388662"
      xsi:nil="true"/>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="cref_124060944"
      id="fc_1605500249"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="cref_496962156"
      id="fc_32881946"
      unitRef="uref_2062431040"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="cref_496962156"
      id="fc_1382895685"
      unitRef="uref_138178116"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="cref_879442911"
      id="fc_1912374246"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="cref_795889418"
      id="fc_1429651243"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="cref_1487040249"
      id="fc_1487040249"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="cref_1314037718"
      id="fc_1152359340"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:DebtForgiveness
      contextRef="cref_1767342225"
      id="fc_633164231"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:DebtForgiveness
      contextRef="cref_1720775043"
      id="fc_1652242228"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:DebtForgiveness
      contextRef="cref_1732842588"
      id="fc_89252809"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:DebtForgiveness
      contextRef="cref_879442911"
      id="fc_675468233"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:DebtForgiveness
      contextRef="cref_795889418"
      id="fc_1322252669"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:DebtForgiveness
      contextRef="cref_1487040249"
      id="fc_104208705"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:DebtForgiveness
      contextRef="cref_1314037718"
      id="fc_516545939"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:AccruedStatedInterest
      contextRef="cref_1767342225"
      id="fc_1158532364"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:AccruedStatedInterest
      contextRef="cref_1720775043"
      id="fc_1740708361"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:AccruedStatedInterest
      contextRef="cref_1732842588"
      id="fc_205627344"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:AccruedStatedInterest
      contextRef="cref_1487040249"
      id="fc_960828265"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:AccruedStatedInterest
      contextRef="cref_1314037718"
      id="fc_1065622223"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentFairValue
      contextRef="cref_1350234277"
      id="fc_2084895650"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentFairValue
      contextRef="cref_249402601"
      id="fc_1608739325"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:StatedInterest
      contextRef="cref_1960383429"
      id="fc_914156588"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="cref_1960383429"
      id="fc_703909118"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="cref_1132075286"
      id="fc_1045442393"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="cref_853412475"
      id="fc_1909185797"
      unitRef="uref_2062431040"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="cref_795156743"
      id="fc_733099946"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="cref_1960383429"
      id="fc_1681646948"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="cref_1132075286"
      id="fc_621654645"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="cref_124060944"
      id="fc_1335500869"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:ConversionOfDebtToEquity
      contextRef="cref_795156743"
      id="fc_1445692272"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:ConversionOfDebtToEquity
      contextRef="cref_1887753489"
      id="fc_498699758"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:ConversionOfDebtToEquity
      contextRef="cref_1132075286"
      id="fc_1502939321"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:ConversionOfDebtToEquity
      contextRef="cref_124060944"
      id="fc_657741355"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="cref_986438284"
      id="fc_1920364349"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="cref_1896784723"
      id="fc_974205172"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="cref_1506143925"
      id="fc_438897670"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="cref_687569782"
      id="fc_2134421991"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:ConversionOfDebtToEquity
      contextRef="cref_879442911"
      id="fc_635689269"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:ConversionOfDebtToEquity
      contextRef="cref_795889418"
      id="fc_1187634311"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:ConversionOfDebtToEquity
      contextRef="cref_1487040249"
      id="fc_268324749"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:ConversionOfDebtToEquity
      contextRef="cref_1314037718"
      id="fc_554662285"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:ConversionOfDebtToEquity
      contextRef="cref_986438284"
      id="fc_978537416"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:ConversionOfDebtToEquity
      contextRef="cref_1858504101"
      id="fc_1875831696"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:ConversionOfDebtToEquity
      contextRef="cref_1506143925"
      id="fc_1371145217"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:ConversionOfDebtToEquity
      contextRef="cref_687569782"
      id="fc_1330609207"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="cref_1896784723"
      id="fc_280326152"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="cref_1506143925"
      id="fc_1920628771"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="cref_687569782"
      id="fc_751310220"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="cref_1720775043"
      id="fc_1433235312"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="cref_1732842588"
      id="fc_1297511385"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="cref_879442911"
      id="fc_1765185523"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="cref_795889418"
      id="fc_1291574257"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="cref_1487040249"
      id="fc_1432709797"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="cref_1314037718"
      id="fc_374712761"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:DebtRepayments
      contextRef="cref_1720775043"
      id="fc_1231569308"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:DebtRepayments
      contextRef="cref_1732842588"
      id="fc_590782202"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:DebtRepayments
      contextRef="cref_879442911"
      id="fc_1425216027"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:DebtRepayments
      contextRef="cref_795889418"
      id="fc_1431677020"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:DebtRepayments
      contextRef="cref_1487040249"
      id="fc_1314215860"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="cref_1720775043"
      id="fc_154967678"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="cref_1732842588"
      id="fc_1320907053"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="cref_1620108994"
      id="fc_1505952347"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="cref_990767968"
      id="fc_1588240824"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="cref_516374104"
      id="fc_964200383"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="cref_1457165476"
      id="fc_991599179"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="cref_1703656236"
      id="fc_1495778935"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:DebtRepayments
      contextRef="cref_469666132"
      id="fc_741686741"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:DebtRepayments
      contextRef="cref_1123562661"
      id="fc_1123562661"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:DebtRepayments
      contextRef="cref_1858606938"
      id="fc_411448295"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:DebtRepayments
      contextRef="cref_575229552"
      id="fc_1422744864"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:ConversionOfDebtToEquity
      contextRef="cref_1123562661"
      id="fc_815338591"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:ConversionOfDebtToEquity
      contextRef="cref_1858606938"
      id="fc_1120041276"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:ConversionOfDebtToEquity
      contextRef="cref_233839587"
      id="fc_355055345"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:ConversionOfDebtToEquity
      contextRef="cref_575229552"
      id="fc_740072080"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:ConversionOfDebtToEquity
      contextRef="cref_632922629"
      id="fc_817662186"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="cref_469666132"
      id="fc_625290624"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="cref_1123562661"
      id="fc_1732463026"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="cref_1858606938"
      id="fc_1095239976"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="cref_233839587"
      id="fc_1703443675"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="cref_575229552"
      id="fc_1777932412"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="cref_632922629"
      id="fc_1370697288"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:DebtForgiveness
      contextRef="cref_1956424655"
      id="fc_1591706187"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:DebtForgiveness
      contextRef="cref_469666132"
      id="fc_1575221502"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:DebtForgiveness
      contextRef="cref_1123562661"
      id="fc_2049795016"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:DebtForgiveness
      contextRef="cref_1858606938"
      id="fc_26389377"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:DebtForgiveness
      contextRef="cref_233839587"
      id="fc_1196344204"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:AccruedStatedInterest
      contextRef="cref_1956424655"
      id="fc_548664657"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:AccruedStatedInterest
      contextRef="cref_469666132"
      id="fc_162603099"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:AccruedStatedInterest
      contextRef="cref_1123562661"
      id="fc_1342787577"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:AccruedStatedInterest
      contextRef="cref_632922629"
      id="fc_1947972587"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:FinancingInterestExpense
      contextRef="cref_1613454691"
      id="fc_918964688"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="cref_1613454691"
      id="fc_144128159"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration contextRef="cref_853412475" id="fc_1196192841">http://fasb.org/srt/2026#ChiefExecutiveOfficerMember</us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="cref_330754979"
      id="fc_798745542"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:LossOnChangeInFairValueOfDigitalAssets
      contextRef="cref_330754979"
      id="fc_180967354"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:GainsLossesOnExtinguishmentOfPaycheckProtectionProgramDebt
      contextRef="cref_330754979"
      id="fc_1478140331"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:FinancingInterestExpense
      contextRef="cref_330754979"
      id="fc_1800285936"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="cref_330754979"
      id="fc_964353402"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="cref_1771939082"
      id="fc_1788198754"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:LossOnChangeInFairValueOfDigitalAssets
      contextRef="cref_496962156"
      id="fc_853132953"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:LossOnChangeInFairValueOfDigitalAssets
      contextRef="cref_1771939082"
      id="fc_1505227101"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:GainsLossesOnExtinguishmentOfPaycheckProtectionProgramDebt
      contextRef="cref_496962156"
      id="fc_1488226025"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:GainsLossesOnExtinguishmentOfPaycheckProtectionProgramDebt
      contextRef="cref_1771939082"
      id="fc_491714939"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:FinancingInterestExpense
      contextRef="cref_1771939082"
      id="fc_476033518"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:TransactionCosts
      contextRef="cref_433015125"
      id="fc_715458886"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="cref_433015125"
      id="fc_1170691057"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="cref_778583285"
      id="fc_871433468"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="cref_433015125"
      id="fc_1370590824"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="cref_778583285"
      id="fc_2050868357"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="cref_433015125"
      id="fc_308529073"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:FinancingInterestExpense
      contextRef="cref_433015125"
      id="fc_1073004091"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <dei:EntityCentralIndexKey contextRef="cref_853412475" id="ixv-9689">0001859807</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="cref_853412475" id="ixv-9690">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="cref_853412475" id="ixv-9691">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:CurrentFiscalYearEndDate contextRef="cref_853412475" id="ixv-9692">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:DividendsCommonStockCash
      contextRef="cref_853412475"
      id="fc_328233919"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:TransactionCosts
      contextRef="cref_1613454691"
      id="fc_1204118409"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="cref_1613454691"
      id="fc_1211449122"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="cref_1613454691"
      id="fc_173593206"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="cref_1613454691"
      id="fc_1213716140"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="cref_739950774"
      id="fc_739950774"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="cref_678289354"
      id="fc_678289354"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="cref_2136062883"
      id="fc_2136062883"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="cref_1522950734"
      id="fc_1522950734"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="cref_1400161968"
      id="fc_827229142"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_739950774"
      id="fc_858168440"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_678289354"
      id="fc_1259757638"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_2136062883"
      id="fc_1198245592"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1522950734"
      id="fc_419970107"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_435315273"
      id="fc_496513322"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_991988056"
      id="fc_1840325586"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="cref_330754979"
      id="fc_868892601"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="cref_330754979"
      id="fc_605887038"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:LossOnChangeInFairValueOfDigitalAssets
      contextRef="cref_330754979"
      id="fc_1014366813"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromDisposalCryptoAsset
      contextRef="cref_330754979"
      id="fc_392406433"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="cref_330754979"
      id="fc_896621210"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="cref_330754979"
      id="fc_2085217331"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="cref_330754979"
      id="fc_1470618685"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="cref_330754979"
      id="fc_2018285595"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="cref_853412475"
      id="fc_2096635608"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="cref_853412475"
      id="fc_1366762589"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:OtherLoansPayableCurrent
      contextRef="cref_988890546"
      id="fc_1635779624"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:LoansPayableRelatedPartyAtFairValue
      contextRef="cref_988890546"
      id="fc_1063352601"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="cref_988890546"
      id="fc_1782236903"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="cref_592262246"
      id="fc_1885513208"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="cref_511051940"
      id="fc_511051940"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:Depreciation
      contextRef="cref_330754979"
      id="fc_1821835447"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:NoncashWarrantIssuanceExpense
      contextRef="cref_330754979"
      id="fc_1711862476"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:LossOnSettlementOfForwardShareIssuanceContract
      contextRef="cref_330754979"
      id="fc_1545386715"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="cref_330754979"
      id="fc_1260861281"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:ReversalOfExciseTaxPayableAttributableToRedemptionOfCommonStock
      contextRef="cref_330754979"
      id="fc_1423949884"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="cref_1014181908"
      id="fc_1194482741"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="cref_1499031780"
      id="fc_896289894"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:WarrantLiabilities
      contextRef="cref_161393837"
      id="fc_161393837"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:WarrantLiabilities
      contextRef="cref_946089074"
      id="fc_946089074"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:WarrantLiabilities
      contextRef="cref_1853496641"
      id="fc_1853496641"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:WarrantLiabilities
      contextRef="cref_912067788"
      id="fc_912067788"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:WarrantLiabilities
      contextRef="cref_2092241241"
      id="fc_2092241241"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:WarrantLiabilities
      contextRef="cref_679378796"
      id="fc_229538959"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="cref_1014181908"
      id="fc_1290442340"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="cref_1499031780"
      id="fc_1150907625"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:CryptoAssetFairValueCurrent
      contextRef="cref_41616020"
      id="fc_41616020"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:CryptoAssetFairValueCurrent
      contextRef="cref_2104304165"
      id="fc_2061553027"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="cref_339012237"
      id="fc_149630768"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="cref_41616020"
      id="fc_560326791"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="cref_339012237"
      id="fc_1380963926"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="cref_41616020"
      id="fc_1111838196"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:WarrantLiabilities
      contextRef="cref_647000154"
      id="fc_647000154"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:WarrantLiabilities
      contextRef="cref_377660832"
      id="fc_377660832"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:WarrantLiabilities
      contextRef="cref_1938583770"
      id="fc_1938583770"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <pfsa:WarrantLiabilities
      contextRef="cref_1379488162"
      id="fc_1379488162"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="cref_339012237"
      id="fc_614302253"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="cref_41616020"
      id="fc_1710058319"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="cref_869081602"
      id="fc_540091636"
      unitRef="uref_2062431040"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="cref_1252091504"
      id="fc_1073160078"
      unitRef="uref_2062431040"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="cref_389976961"
      id="fc_1527585686"
      unitRef="uref_2062431040"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="cref_414653761"
      id="fc_414653761"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="cref_212327296"
      id="fc_212327296"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="cref_302057777"
      id="fc_302057777"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="cref_1145146570"
      id="fc_1145146570"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="cref_824579099"
      id="fc_1340491827"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_414653761"
      id="fc_761763015"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_212327296"
      id="fc_1722080580"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_302057777"
      id="fc_632678721"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1145146570"
      id="fc_1044644676"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_504299761"
      id="fc_1774329305"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_115014141"
      id="fc_750237761"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:DeferredCosts
      contextRef="cref_592262246"
      id="fc_1063246583"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="cref_1580858154"
      id="fc_1604961138"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="cref_1337257417"
      id="fc_1391770387"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="cref_1651086280"
      id="fc_1598197908"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_19150775"
      id="fc_866272510"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_713651180"
      id="fc_361609427"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1580858154"
      id="fc_1353082058"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1337257417"
      id="fc_705602286"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1320053688"
      id="fc_672260822"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_900299053"
      id="fc_900299053"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_1539459543"
      id="fc_1539459543"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_61195065"
      id="fc_61195065"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_299885455"
      id="fc_1836975778"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="cref_900299053"
      id="fc_2139785155"
      unitRef="uref_2062431040"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="cref_1539459543"
      id="fc_1975185324"
      unitRef="uref_2062431040"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="cref_61195065"
      id="fc_954068294"
      unitRef="uref_2062431040"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="cref_877452344"
      id="fc_303133793"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="cref_1917067130"
      id="fc_1150905897"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="cref_1940574821"
      id="fc_494958825"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="cref_519169877"
      id="fc_959060029"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="cref_1652036292"
      id="fc_1016260472"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="cref_877452344"
      id="fc_617354897"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="cref_1917067130"
      id="fc_1976095475"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="cref_1940574821"
      id="fc_725414581"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_519169877"
      id="fc_1875528767"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1652036292"
      id="fc_645381121"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_877452344"
      id="fc_991755234"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1917067130"
      id="fc_497145049"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1983744206"
      id="fc_1608202460"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="cref_1719798891"
      id="fc_1719798891"
      unitRef="uref_2062431040"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_1719798891"
      id="fc_99713303"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="cref_1709034871"
      id="fc_1709034871"
      unitRef="uref_2062431040"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_1709034871"
      id="fc_2101993611"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="cref_2016811345"
      id="fc_2016811345"
      unitRef="uref_2062431040"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_2016811345"
      id="fc_1480617586"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_1154050613"
      id="fc_1870421649"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_2143223074"
      id="fc_1233233027"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="cref_1394063579"
      id="fc_1394063579"
      unitRef="uref_1340915823"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="cref_853412475" id="ixv-13119">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="cref_853412475" id="ixv-13120">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="cref_853412475" id="ixv-13121">2026-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus contextRef="cref_853412475" id="ixv-13122">2026</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="cref_853412475" id="ixv-13123">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="cref_853412475" id="ixv-13124">001-41177</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="cref_853412475" id="ixv-13125">PROFUSA, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="cref_853412475" id="ixv-13126">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="cref_853412475" id="ixv-13127">86-3437271</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="cref_853412475" id="ixv-13128">626         Bancroft Way</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="cref_853412475" id="ixv-13129">Suite A</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="cref_853412475" id="ixv-13130">Berkeley</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry contextRef="cref_853412475" id="ixv-13131">CA</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode contextRef="cref_853412475" id="ixv-13132">94710</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="cref_853412475" id="ixv-13133">(925)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="cref_853412475" id="ixv-13134">997-6925</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="cref_853412475" id="ixv-13135">Common         Stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="cref_853412475" id="ixv-13136">PFSA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="cref_853412475" id="ixv-13137">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="cref_853412475" id="ixv-13138">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="cref_853412475" id="ixv-13139">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="cref_853412475" id="ixv-13140">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="cref_853412475" id="ixv-13141">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="cref_853412475" id="ixv-13142">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="cref_853412475" id="ixv-13143">false</dei:EntityExTransitionPeriod>
    <dei:EntityShellCompany contextRef="cref_853412475" id="ixv-13144">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="cref_810086022"
      decimals="0"
      id="ixv-13145"
      unitRef="uref_2062431040">605647</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="cref_988890546"
      decimals="-3"
      id="ixv-13146"
      unitRef="uref_1340915823">719000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="cref_592262246"
      decimals="-3"
      id="ixv-13147"
      unitRef="uref_1340915823">1778000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="cref_988890546"
      decimals="-3"
      id="ixv-13148"
      unitRef="uref_1340915823">122000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="cref_592262246"
      decimals="-3"
      id="ixv-13149"
      unitRef="uref_1340915823">541000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:CryptoAssetFairValueCurrent
      contextRef="cref_592262246"
      decimals="-3"
      id="ixv-13150"
      unitRef="uref_1340915823">1445000</us-gaap:CryptoAssetFairValueCurrent>
    <us-gaap:AssetsCurrent
      contextRef="cref_988890546"
      decimals="-3"
      id="ixv-13151"
      unitRef="uref_1340915823">841000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="cref_592262246"
      decimals="-3"
      id="ixv-13152"
      unitRef="uref_1340915823">3764000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="cref_988890546"
      decimals="-3"
      id="ixv-13153"
      unitRef="uref_1340915823">84000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="cref_592262246"
      decimals="-3"
      id="ixv-13154"
      unitRef="uref_1340915823">8000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="cref_988890546"
      decimals="-3"
      id="ixv-13155"
      unitRef="uref_1340915823">47000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="cref_592262246"
      decimals="-3"
      id="ixv-13156"
      unitRef="uref_1340915823">3000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:DeferredCosts
      contextRef="cref_988890546"
      decimals="-3"
      id="ixv-13157"
      unitRef="uref_1340915823">70000</us-gaap:DeferredCosts>
    <us-gaap:Assets
      contextRef="cref_988890546"
      decimals="-3"
      id="ixv-13158"
      unitRef="uref_1340915823">1042000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="cref_592262246"
      decimals="-3"
      id="ixv-13159"
      unitRef="uref_1340915823">3775000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="cref_988890546"
      decimals="-3"
      id="ixv-13160"
      unitRef="uref_1340915823">7855000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="cref_592262246"
      decimals="-3"
      id="ixv-13161"
      unitRef="uref_1340915823">7345000</us-gaap:AccountsPayableCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent
      contextRef="cref_988890546"
      decimals="-3"
      id="ixv-13162"
      unitRef="uref_1340915823">44000</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent
      contextRef="cref_592262246"
      decimals="-3"
      id="ixv-13163"
      unitRef="uref_1340915823">1953000</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="cref_988890546"
      decimals="-3"
      id="ixv-13164"
      unitRef="uref_1340915823">6223000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="cref_592262246"
      decimals="-3"
      id="ixv-13165"
      unitRef="uref_1340915823">5981000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="cref_1286433117"
      decimals="-3"
      id="ixv-13166"
      unitRef="uref_1340915823">41000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="cref_2038731489"
      decimals="-3"
      id="ixv-13167"
      unitRef="uref_1340915823">41000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="cref_988890546"
      decimals="-3"
      id="ixv-13168"
      unitRef="uref_1340915823">8207000</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="cref_592262246"
      decimals="-3"
      id="ixv-13169"
      unitRef="uref_1340915823">42000</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="cref_988890546"
      decimals="-3"
      id="ixv-13170"
      unitRef="uref_1340915823">644000</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="cref_592262246"
      decimals="-3"
      id="ixv-13171"
      unitRef="uref_1340915823">946000</us-gaap:NotesPayableCurrent>
    <pfsa:ConvertibleAndPromissoryNotesPayable
      contextRef="cref_988890546"
      decimals="-3"
      id="ixv-13172"
      unitRef="uref_1340915823">5153000</pfsa:ConvertibleAndPromissoryNotesPayable>
    <pfsa:ConvertibleAndPromissoryNotesPayable
      contextRef="cref_592262246"
      decimals="-3"
      id="ixv-13173"
      unitRef="uref_1340915823">4560000</pfsa:ConvertibleAndPromissoryNotesPayable>
    <us-gaap:OtherLoansPayableCurrent
      contextRef="cref_592262246"
      decimals="-3"
      id="ixv-13174"
      unitRef="uref_1340915823">1390000</us-gaap:OtherLoansPayableCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="cref_988890546"
      decimals="-3"
      id="ixv-13175"
      unitRef="uref_1340915823">28167000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="cref_592262246"
      decimals="-3"
      id="ixv-13176"
      unitRef="uref_1340915823">22258000</us-gaap:LiabilitiesCurrent>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="cref_988890546"
      decimals="-3"
      id="ixv-13177"
      unitRef="uref_1340915823">2000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="cref_592262246"
      decimals="-3"
      id="ixv-13178"
      unitRef="uref_1340915823">298000</us-gaap:WarrantsAndRightsOutstanding>
    <pfsa:LoansPayableRelatedPartyAtFairValue
      contextRef="cref_592262246"
      decimals="-3"
      id="ixv-13179"
      unitRef="uref_1340915823">7877000</pfsa:LoansPayableRelatedPartyAtFairValue>
    <us-gaap:Liabilities
      contextRef="cref_988890546"
      decimals="-3"
      id="ixv-13180"
      unitRef="uref_1340915823">28169000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="cref_592262246"
      decimals="-3"
      id="ixv-13181"
      unitRef="uref_1340915823">30433000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="cref_988890546"
      decimals="4"
      id="ixv-13182"
      unitRef="uref_138178116">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="cref_592262246"
      decimals="4"
      id="ixv-13183"
      unitRef="uref_138178116">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="cref_988890546"
      decimals="0"
      id="ixv-13184"
      unitRef="uref_2062431040">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="cref_592262246"
      decimals="0"
      id="ixv-13185"
      unitRef="uref_2062431040">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="cref_988890546"
      decimals="0"
      id="ixv-13186"
      unitRef="uref_2062431040">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="cref_592262246"
      decimals="0"
      id="ixv-13187"
      unitRef="uref_2062431040">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="cref_988890546"
      decimals="0"
      id="ixv-13188"
      unitRef="uref_2062431040">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="cref_592262246"
      decimals="0"
      id="ixv-13189"
      unitRef="uref_2062431040">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_988890546"
      decimals="4"
      id="ixv-13190"
      unitRef="uref_138178116">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_592262246"
      decimals="4"
      id="ixv-13191"
      unitRef="uref_138178116">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="cref_988890546"
      decimals="0"
      id="ixv-13192"
      unitRef="uref_2062431040">600000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="cref_592262246"
      decimals="0"
      id="ixv-13193"
      unitRef="uref_2062431040">600000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_988890546"
      decimals="0"
      id="ixv-13194"
      unitRef="uref_2062431040">132308</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_988890546"
      decimals="0"
      id="ixv-13195"
      unitRef="uref_2062431040">132308</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_592262246"
      decimals="0"
      id="ixv-13196"
      unitRef="uref_2062431040">12320</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_592262246"
      decimals="0"
      id="ixv-13197"
      unitRef="uref_2062431040">12320</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:AdditionalPaidInCapital
      contextRef="cref_988890546"
      decimals="-3"
      id="ixv-13198"
      unitRef="uref_1340915823">145865000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="cref_592262246"
      decimals="-3"
      id="ixv-13199"
      unitRef="uref_1340915823">134123000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="cref_988890546"
      decimals="-3"
      id="ixv-13200"
      unitRef="uref_1340915823">-172992000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="cref_592262246"
      decimals="-3"
      id="ixv-13201"
      unitRef="uref_1340915823">-160781000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="cref_988890546"
      decimals="-3"
      id="ixv-13202"
      unitRef="uref_1340915823">-27127000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_592262246"
      decimals="-3"
      id="ixv-13203"
      unitRef="uref_1340915823">-26658000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="cref_988890546"
      decimals="-3"
      id="ixv-13204"
      unitRef="uref_1340915823">1042000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="cref_592262246"
      decimals="-3"
      id="ixv-13205"
      unitRef="uref_1340915823">3775000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="cref_496962156"
      decimals="-3"
      id="ixv-13206"
      unitRef="uref_1340915823">823000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="cref_1771939082"
      decimals="-3"
      id="ixv-13207"
      unitRef="uref_1340915823">393000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="cref_853412475"
      decimals="-3"
      id="ixv-13208"
      unitRef="uref_1340915823">1969000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="cref_330754979"
      decimals="-3"
      id="ixv-13209"
      unitRef="uref_1340915823">827000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="cref_496962156"
      decimals="-3"
      id="ixv-13210"
      unitRef="uref_1340915823">1722000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="cref_1771939082"
      decimals="-3"
      id="ixv-13211"
      unitRef="uref_1340915823">610000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="cref_853412475"
      decimals="-3"
      id="ixv-13212"
      unitRef="uref_1340915823">4582000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="cref_330754979"
      decimals="-3"
      id="ixv-13213"
      unitRef="uref_1340915823">1600000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="cref_496962156"
      decimals="-3"
      id="ixv-13214"
      unitRef="uref_1340915823">2545000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="cref_1771939082"
      decimals="-3"
      id="ixv-13215"
      unitRef="uref_1340915823">1003000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="cref_853412475"
      decimals="-3"
      id="ixv-13216"
      unitRef="uref_1340915823">6551000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="cref_330754979"
      decimals="-3"
      id="ixv-13217"
      unitRef="uref_1340915823">2427000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="cref_496962156"
      decimals="-3"
      id="ixv-13218"
      unitRef="uref_1340915823">-2545000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="cref_1771939082"
      decimals="-3"
      id="ixv-13219"
      unitRef="uref_1340915823">-1003000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="cref_853412475"
      decimals="-3"
      id="ixv-13220"
      unitRef="uref_1340915823">-6551000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="cref_330754979"
      decimals="-3"
      id="ixv-13221"
      unitRef="uref_1340915823">-2427000</us-gaap:OperatingIncomeLoss>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="cref_496962156"
      decimals="-3"
      id="ixv-13222"
      unitRef="uref_1340915823">-4251000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="cref_1771939082"
      decimals="-3"
      id="ixv-13223"
      unitRef="uref_1340915823">-153000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="cref_853412475"
      decimals="-3"
      id="ixv-13224"
      unitRef="uref_1340915823">-5048000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="cref_330754979"
      decimals="-3"
      id="ixv-13225"
      unitRef="uref_1340915823">-309000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="cref_496962156"
      decimals="-3"
      id="ixv-13226"
      unitRef="uref_1340915823">-418000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="cref_853412475"
      decimals="-3"
      id="ixv-13227"
      unitRef="uref_1340915823">-676000</us-gaap:FairValueAdjustmentOfWarrants>
    <pfsa:LossOnChangeInFairValueOfDigitalAssets
      contextRef="cref_853412475"
      decimals="-3"
      id="ixv-13228"
      unitRef="uref_1340915823">295000</pfsa:LossOnChangeInFairValueOfDigitalAssets>
    <us-gaap:InterestExpenseOther
      contextRef="cref_496962156"
      decimals="-3"
      id="ixv-13229"
      unitRef="uref_1340915823">5000</us-gaap:InterestExpenseOther>
    <us-gaap:InterestExpenseOther
      contextRef="cref_1771939082"
      decimals="-3"
      id="ixv-13230"
      unitRef="uref_1340915823">533000</us-gaap:InterestExpenseOther>
    <us-gaap:InterestExpenseOther
      contextRef="cref_853412475"
      decimals="-3"
      id="ixv-13231"
      unitRef="uref_1340915823">10000</us-gaap:InterestExpenseOther>
    <us-gaap:InterestExpenseOther
      contextRef="cref_330754979"
      decimals="-3"
      id="ixv-13232"
      unitRef="uref_1340915823">1142000</us-gaap:InterestExpenseOther>
    <us-gaap:InterestExpenseNonoperating
      contextRef="cref_496962156"
      decimals="-3"
      id="ixv-13233"
      unitRef="uref_1340915823">21000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating
      contextRef="cref_1771939082"
      decimals="-3"
      id="ixv-13234"
      unitRef="uref_1340915823">1193000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating
      contextRef="cref_853412475"
      decimals="-3"
      id="ixv-13235"
      unitRef="uref_1340915823">39000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating
      contextRef="cref_330754979"
      decimals="-3"
      id="ixv-13236"
      unitRef="uref_1340915823">2328000</us-gaap:InterestExpenseNonoperating>
    <pfsa:GainsLossesOnExtinguishmentOfPaycheckProtectionProgramDebt
      contextRef="cref_853412475"
      decimals="-3"
      id="ixv-13237"
      unitRef="uref_1340915823">1391000</pfsa:GainsLossesOnExtinguishmentOfPaycheckProtectionProgramDebt>
    <us-gaap:FinancingInterestExpense
      contextRef="cref_496962156"
      decimals="-3"
      id="ixv-13238"
      unitRef="uref_1340915823">2410000</us-gaap:FinancingInterestExpense>
    <us-gaap:FinancingInterestExpense
      contextRef="cref_853412475"
      decimals="-3"
      id="ixv-13239"
      unitRef="uref_1340915823">2470000</us-gaap:FinancingInterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="cref_496962156"
      decimals="-3"
      id="ixv-13240"
      unitRef="uref_1340915823">54000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="cref_1771939082"
      decimals="-3"
      id="ixv-13241"
      unitRef="uref_1340915823">1000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="cref_853412475"
      decimals="-3"
      id="ixv-13242"
      unitRef="uref_1340915823">125000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="cref_496962156"
      decimals="-3"
      id="ixv-13243"
      unitRef="uref_1340915823">-6210000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="cref_1771939082"
      decimals="-3"
      id="ixv-13244"
      unitRef="uref_1340915823">-1345000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="cref_853412475"
      decimals="-3"
      id="ixv-13245"
      unitRef="uref_1340915823">-5660000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="cref_330754979"
      decimals="-3"
      id="ixv-13246"
      unitRef="uref_1340915823">-2637000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="cref_496962156"
      decimals="-3"
      id="ixv-13247"
      unitRef="uref_1340915823">-8755000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1771939082"
      decimals="-3"
      id="ixv-13248"
      unitRef="uref_1340915823">-2348000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="cref_853412475"
      decimals="-3"
      id="ixv-13249"
      unitRef="uref_1340915823">-12211000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="cref_330754979"
      decimals="-3"
      id="ixv-13250"
      unitRef="uref_1340915823">-5064000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_496962156"
      decimals="2"
      id="ixv-13251"
      unitRef="uref_138178116">-151.8</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_496962156"
      decimals="2"
      id="ixv-13252"
      unitRef="uref_138178116">-151.8</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_1771939082"
      decimals="2"
      id="ixv-13253"
      unitRef="uref_138178116">-9100.78</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_1771939082"
      decimals="2"
      id="ixv-13254"
      unitRef="uref_138178116">-9100.78</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_853412475"
      decimals="2"
      id="ixv-13255"
      unitRef="uref_138178116">-326.74</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_853412475"
      decimals="2"
      id="ixv-13256"
      unitRef="uref_138178116">-326.74</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_330754979"
      decimals="2"
      id="ixv-13257"
      unitRef="uref_138178116">-19627.91</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_330754979"
      decimals="2"
      id="ixv-13258"
      unitRef="uref_138178116">-19627.91</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_496962156"
      decimals="0"
      id="ixv-13259"
      unitRef="uref_2062431040">57676</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_496962156"
      decimals="0"
      id="ixv-13260"
      unitRef="uref_2062431040">57676</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_1771939082"
      decimals="0"
      id="ixv-13261"
      unitRef="uref_2062431040">258</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_1771939082"
      decimals="0"
      id="ixv-13262"
      unitRef="uref_2062431040">258</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_853412475"
      decimals="0"
      id="ixv-13263"
      unitRef="uref_2062431040">37372</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_853412475"
      decimals="0"
      id="ixv-13264"
      unitRef="uref_2062431040">37372</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_330754979"
      decimals="0"
      id="ixv-13265"
      unitRef="uref_2062431040">258</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_330754979"
      decimals="0"
      id="ixv-13266"
      unitRef="uref_2062431040">258</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:SharesOutstanding
      contextRef="cref_1162692304"
      decimals="0"
      id="ixv-13267"
      unitRef="uref_2062431040">12320</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_773036080"
      decimals="-3"
      id="ixv-13268"
      unitRef="uref_1340915823">134123000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_27050776"
      decimals="-3"
      id="ixv-13269"
      unitRef="uref_1340915823">-160781000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_592262246"
      decimals="-3"
      id="ixv-13270"
      unitRef="uref_1340915823">-26658000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="cref_1917067130"
      decimals="0"
      id="ixv-13271"
      unitRef="uref_2062431040">3214</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_1983744206"
      decimals="-3"
      id="ixv-13272"
      unitRef="uref_1340915823">469000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_683057423"
      decimals="-3"
      id="ixv-13273"
      unitRef="uref_1340915823">469000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="cref_1917067130"
      decimals="0"
      id="ixv-13274"
      unitRef="uref_2062431040">8266</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="cref_1983744206"
      decimals="-3"
      id="ixv-13275"
      unitRef="uref_1340915823">1260000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="cref_683057423"
      decimals="-3"
      id="ixv-13276"
      unitRef="uref_1340915823">1260000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="cref_1983744206"
      decimals="-3"
      id="ixv-13277"
      unitRef="uref_1340915823">187000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="cref_683057423"
      decimals="-3"
      id="ixv-13278"
      unitRef="uref_1340915823">187000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1940574821"
      decimals="-3"
      id="ixv-13279"
      unitRef="uref_1340915823">-3456000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="cref_683057423"
      decimals="-3"
      id="ixv-13280"
      unitRef="uref_1340915823">-3456000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="cref_1154050613"
      decimals="0"
      id="ixv-13281"
      unitRef="uref_2062431040">23800</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_387292067"
      decimals="-3"
      id="ixv-13282"
      unitRef="uref_1340915823">136039000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_1842852390"
      decimals="-3"
      id="ixv-13283"
      unitRef="uref_1340915823">-164237000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_279465061"
      decimals="-3"
      id="ixv-13284"
      unitRef="uref_1340915823">-28198000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="cref_1337257417"
      decimals="0"
      id="ixv-13285"
      unitRef="uref_2062431040">89806</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_1320053688"
      decimals="-3"
      id="ixv-13286"
      unitRef="uref_1340915823">2471000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_496962156"
      decimals="-3"
      id="ixv-13287"
      unitRef="uref_1340915823">2471000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="cref_1337257417"
      decimals="0"
      id="ixv-13288"
      unitRef="uref_2062431040">18702</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="cref_1320053688"
      decimals="-3"
      id="ixv-13289"
      unitRef="uref_1340915823">3460000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="cref_496962156"
      decimals="-3"
      id="ixv-13290"
      unitRef="uref_1340915823">3460000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="cref_1320053688"
      decimals="-3"
      id="ixv-13291"
      unitRef="uref_1340915823">1798000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="cref_496962156"
      decimals="-3"
      id="ixv-13292"
      unitRef="uref_1340915823">1798000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <pfsa:AdjustmentsToAdditionalPaidInCapitalExciseTaxPayableAttributableToRedemptionOfCommonStock
      contextRef="cref_1320053688"
      decimals="-3"
      id="ixv-13293"
      unitRef="uref_1340915823">1909000</pfsa:AdjustmentsToAdditionalPaidInCapitalExciseTaxPayableAttributableToRedemptionOfCommonStock>
    <pfsa:AdjustmentsToAdditionalPaidInCapitalExciseTaxPayableAttributableToRedemptionOfCommonStock
      contextRef="cref_496962156"
      decimals="-3"
      id="ixv-13294"
      unitRef="uref_1340915823">1909000</pfsa:AdjustmentsToAdditionalPaidInCapitalExciseTaxPayableAttributableToRedemptionOfCommonStock>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="cref_1320053688"
      decimals="-3"
      id="ixv-13295"
      unitRef="uref_1340915823">188000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="cref_496962156"
      decimals="-3"
      id="ixv-13296"
      unitRef="uref_1340915823">188000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1651086280"
      decimals="-3"
      id="ixv-13297"
      unitRef="uref_1340915823">-8755000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="cref_496962156"
      decimals="-3"
      id="ixv-13298"
      unitRef="uref_1340915823">-8755000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="cref_299885455"
      decimals="0"
      id="ixv-13299"
      unitRef="uref_2062431040">132308</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_373520702"
      decimals="-3"
      id="ixv-13300"
      unitRef="uref_1340915823">145865000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_437148813"
      decimals="-3"
      id="ixv-13301"
      unitRef="uref_1340915823">-172992000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_988890546"
      decimals="-3"
      id="ixv-13302"
      unitRef="uref_1340915823">-27127000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="cref_1958988437"
      decimals="0"
      id="ixv-13303"
      unitRef="uref_2062431040">4350314</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_1958988437"
      decimals="-3"
      id="ixv-13304"
      unitRef="uref_1340915823">5231000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="cref_1804831361"
      decimals="0"
      id="ixv-13305"
      unitRef="uref_2062431040">5293175</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_1804831361"
      decimals="-3"
      id="ixv-13306"
      unitRef="uref_1340915823">13701000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="cref_1586520882"
      decimals="0"
      id="ixv-13307"
      unitRef="uref_2062431040">8220445</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_1586520882"
      decimals="-3"
      id="ixv-13308"
      unitRef="uref_1340915823">46217000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="cref_2143223074"
      decimals="0"
      id="ixv-13309"
      unitRef="uref_2062431040">258</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_1758065113"
      decimals="-3"
      id="ixv-13310"
      unitRef="uref_1340915823">5753000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_1911586431"
      decimals="-3"
      id="ixv-13311"
      unitRef="uref_1340915823">-124958000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_1905232369"
      decimals="-3"
      id="ixv-13312"
      unitRef="uref_1340915823">-119205000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="cref_435315273"
      decimals="-3"
      id="ixv-13313"
      unitRef="uref_1340915823">5000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="cref_1697009852"
      decimals="-3"
      id="ixv-13314"
      unitRef="uref_1340915823">5000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1400161968"
      decimals="-3"
      id="ixv-13315"
      unitRef="uref_1340915823">-2716000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1697009852"
      decimals="-3"
      id="ixv-13316"
      unitRef="uref_1340915823">-2716000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="cref_630668889"
      decimals="0"
      id="ixv-13317"
      unitRef="uref_2062431040">4350314</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_630668889"
      decimals="-3"
      id="ixv-13318"
      unitRef="uref_1340915823">5231000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="cref_76604954"
      decimals="0"
      id="ixv-13319"
      unitRef="uref_2062431040">5293175</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_76604954"
      decimals="-3"
      id="ixv-13320"
      unitRef="uref_1340915823">13701000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="cref_1750132856"
      decimals="0"
      id="ixv-13321"
      unitRef="uref_2062431040">8220445</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_1750132856"
      decimals="-3"
      id="ixv-13322"
      unitRef="uref_1340915823">46217000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="cref_991988056"
      decimals="0"
      id="ixv-13323"
      unitRef="uref_2062431040">258</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_85640999"
      decimals="-3"
      id="ixv-13324"
      unitRef="uref_1340915823">5758000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_1099721133"
      decimals="-3"
      id="ixv-13325"
      unitRef="uref_1340915823">-127674000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_1146081111"
      decimals="-3"
      id="ixv-13326"
      unitRef="uref_1340915823">-121916000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="cref_504299761"
      decimals="-3"
      id="ixv-13327"
      unitRef="uref_1340915823">82000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="cref_1771939082"
      decimals="-3"
      id="ixv-13328"
      unitRef="uref_1340915823">82000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="cref_824579099"
      decimals="-3"
      id="ixv-13329"
      unitRef="uref_1340915823">-2348000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1771939082"
      decimals="-3"
      id="ixv-13330"
      unitRef="uref_1340915823">-2348000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="cref_717000525"
      decimals="0"
      id="ixv-13331"
      unitRef="uref_2062431040">4350314</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_717000525"
      decimals="-3"
      id="ixv-13332"
      unitRef="uref_1340915823">5231000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="cref_2059095953"
      decimals="0"
      id="ixv-13333"
      unitRef="uref_2062431040">5293175</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_2059095953"
      decimals="-3"
      id="ixv-13334"
      unitRef="uref_1340915823">13701000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="cref_146453500"
      decimals="0"
      id="ixv-13335"
      unitRef="uref_2062431040">8220445</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_146453500"
      decimals="-3"
      id="ixv-13336"
      unitRef="uref_1340915823">46217000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="cref_115014141"
      decimals="0"
      id="ixv-13337"
      unitRef="uref_2062431040">258</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_295168145"
      decimals="-3"
      id="ixv-13338"
      unitRef="uref_1340915823">5840000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_258284346"
      decimals="-3"
      id="ixv-13339"
      unitRef="uref_1340915823">-130022000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_301838592"
      decimals="-3"
      id="ixv-13340"
      unitRef="uref_1340915823">-124182000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="cref_853412475"
      decimals="-3"
      id="ixv-13341"
      unitRef="uref_1340915823">-12211000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="cref_330754979"
      decimals="-3"
      id="ixv-13342"
      unitRef="uref_1340915823">-5064000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherNoncashExpense
      contextRef="cref_853412475"
      decimals="-3"
      id="ixv-13343"
      unitRef="uref_1340915823">33000</us-gaap:OtherNoncashExpense>
    <us-gaap:OtherNoncashExpense
      contextRef="cref_330754979"
      decimals="-3"
      id="ixv-13344"
      unitRef="uref_1340915823">2328000</us-gaap:OtherNoncashExpense>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="cref_853412475"
      decimals="-3"
      id="ixv-13345"
      unitRef="uref_1340915823">1391000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <pfsa:GainOnChangeInFairValueOfRelatedPartyConvertibleDebt
      contextRef="cref_853412475"
      decimals="-3"
      id="ixv-13346"
      unitRef="uref_1340915823">5048000</pfsa:GainOnChangeInFairValueOfRelatedPartyConvertibleDebt>
    <pfsa:GainOnChangeInFairValueOfRelatedPartyConvertibleDebt
      contextRef="cref_330754979"
      decimals="-3"
      id="ixv-13347"
      unitRef="uref_1340915823">309000</pfsa:GainOnChangeInFairValueOfRelatedPartyConvertibleDebt>
    <us-gaap:Depreciation
      contextRef="cref_853412475"
      decimals="-3"
      id="ixv-13348"
      unitRef="uref_1340915823">2000</us-gaap:Depreciation>
    <us-gaap:ShareBasedCompensation
      contextRef="cref_853412475"
      decimals="-3"
      id="ixv-13349"
      unitRef="uref_1340915823">375000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="cref_330754979"
      decimals="-3"
      id="ixv-13350"
      unitRef="uref_1340915823">82000</us-gaap:ShareBasedCompensation>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="cref_853412475"
      decimals="-3"
      id="ixv-13351"
      unitRef="uref_1340915823">-676000</us-gaap:FairValueAdjustmentOfWarrants>
    <pfsa:NoncashWarrantIssuanceExpense
      contextRef="cref_853412475"
      decimals="-3"
      id="fc_534044038"
      unitRef="uref_1340915823">-2178000</pfsa:NoncashWarrantIssuanceExpense>
    <pfsa:LossOnChangeInFairValueOfDigitalAssets
      contextRef="cref_853412475"
      decimals="-3"
      id="ixv-13353"
      unitRef="uref_1340915823">295000</pfsa:LossOnChangeInFairValueOfDigitalAssets>
    <pfsa:LossOnSettlementOfForwardShareIssuanceContract
      contextRef="cref_853412475"
      decimals="-3"
      id="ixv-13354"
      unitRef="uref_1340915823">82000</pfsa:LossOnSettlementOfForwardShareIssuanceContract>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="cref_853412475"
      decimals="-3"
      id="ixv-13355"
      unitRef="uref_1340915823">-419000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="cref_330754979"
      decimals="-3"
      id="ixv-13356"
      unitRef="uref_1340915823">140000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="cref_853412475"
      decimals="-3"
      id="ixv-13357"
      unitRef="uref_1340915823">50000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="cref_330754979"
      decimals="-3"
      id="ixv-13358"
      unitRef="uref_1340915823">-1000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="cref_853412475"
      decimals="-3"
      id="ixv-13359"
      unitRef="uref_1340915823">510000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="cref_330754979"
      decimals="-3"
      id="ixv-13360"
      unitRef="uref_1340915823">1027000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="cref_853412475"
      decimals="-3"
      id="ixv-13361"
      unitRef="uref_1340915823">178000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="cref_330754979"
      decimals="-3"
      id="ixv-13362"
      unitRef="uref_1340915823">331000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="cref_853412475"
      decimals="-3"
      id="ixv-13363"
      unitRef="uref_1340915823">-5208000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="cref_330754979"
      decimals="-3"
      id="ixv-13364"
      unitRef="uref_1340915823">-1126000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromDisposalCryptoAsset
      contextRef="cref_853412475"
      decimals="-3"
      id="ixv-13365"
      unitRef="uref_1340915823">1150000</us-gaap:ProceedsFromDisposalCryptoAsset>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="cref_853412475"
      decimals="-3"
      id="ixv-13366"
      unitRef="uref_1340915823">78000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="cref_853412475"
      decimals="-3"
      id="ixv-13367"
      unitRef="uref_1340915823">1072000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="cref_853412475"
      decimals="-3"
      id="ixv-13368"
      unitRef="uref_1340915823">1500000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="cref_853412475"
      decimals="-3"
      id="ixv-13369"
      unitRef="uref_1340915823">2858000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="cref_853412475"
      decimals="-3"
      id="ixv-13370"
      unitRef="uref_1340915823">1281000</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="cref_330754979"
      decimals="-3"
      id="ixv-13371"
      unitRef="uref_1340915823">1450000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="cref_330754979"
      decimals="-3"
      id="ixv-13372"
      unitRef="uref_1340915823">476000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="cref_853412475"
      decimals="-3"
      id="ixv-13373"
      unitRef="uref_1340915823">3077000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="cref_330754979"
      decimals="-3"
      id="ixv-13374"
      unitRef="uref_1340915823">974000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="cref_853412475"
      decimals="-3"
      id="ixv-13375"
      unitRef="uref_1340915823">-1059000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="cref_330754979"
      decimals="-3"
      id="ixv-13376"
      unitRef="uref_1340915823">-152000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="cref_592262246"
      decimals="-3"
      id="ixv-13377"
      unitRef="uref_1340915823">1778000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="cref_1905232369"
      decimals="-3"
      id="ixv-13378"
      unitRef="uref_1340915823">191000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="cref_988890546"
      decimals="-3"
      id="ixv-13379"
      unitRef="uref_1340915823">719000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="cref_301838592"
      decimals="-3"
      id="ixv-13380"
      unitRef="uref_1340915823">39000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <pfsa:ConversionOfDebtToEquity
      contextRef="cref_853412475"
      decimals="-3"
      id="ixv-13381"
      unitRef="uref_1340915823">4720000</pfsa:ConversionOfDebtToEquity>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="cref_853412475"
      decimals="-3"
      id="ixv-13382"
      unitRef="uref_1340915823">244000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <pfsa:ReversalOfExciseTaxPayableAttributableToRedemptionOfCommonStock
      contextRef="cref_853412475"
      decimals="-3"
      id="ixv-13383"
      unitRef="uref_1340915823">1909000</pfsa:ReversalOfExciseTaxPayableAttributableToRedemptionOfCommonStock>
    <pfsa:UnpaidDeferredOfferingCosts
      contextRef="cref_330754979"
      decimals="-3"
      id="ixv-13384"
      unitRef="uref_1340915823">904000</pfsa:UnpaidDeferredOfferingCosts>
    <pfsa:ReclassificationOfWarrantLiabilityToAdditionalPaidinCapital
      contextRef="cref_853412475"
      decimals="-3"
      id="ixv-13385"
      unitRef="uref_1340915823">1798000</pfsa:ReclassificationOfWarrantLiabilityToAdditionalPaidinCapital>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="cref_853412475" id="ixv-3756">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;1 &#x2014;&#160;Organization,
Description of Business, Going Concern and Significant Risks and Uncertainties&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;Description of Business&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; Profusa, Inc. (the &#x201c;Company&#x201d;), originally
incorporated in California on May
11, 2009, develops biointegrated sensors designed to provide continuous, clinical-grade monitoring of body chemistry for
personal and medical use. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company&#x2019;s first offering in the European
Union, the Lumee&#x2122; Oxygen Platform, monitors tissue oxygen levels and is intended for applications such as peripheral artery disease,
chronic wounds (including diabetic ulcers and pressure sores), and reconstructive surgery. The Company&#x2019;s research and development
efforts are primarily focused on the Lumee&#x2122; Glucose Platform, a continuous glucose monitor (&#x201c;CGM&#x201d;) consisting of a biocompatible
gel injected under the skin that monitors interstitial glucose levels for several months from a single injection, offering an alternative
to traditional finger-stick glucometers and short-term needle-type CGMs.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;On July 11, 2025 (the &#x201c;Closing Date&#x201d;),
NorthView Acquisition Corporation (&#x201c;Northview&#x201d;) consummated its business combination (the &#x201c;Business Combination&#x201d;)
with Profusa, Inc., a California corporation (&#x201c;Legacy Profusa&#x201d;), pursuant to the Merger Agreement and Plan of Reorganization,
dated November 7, 2022 (as amended, the &#x201c;Merger Agreement&#x201d;), among Northview, Legacy Profusa, and NV Profusa Merger Sub Inc.,
a wholly-owned Delaware subsidiary of Northview (&#x201c;Merger Sub&#x201d;). At closing, Merger Sub merged with and into Legacy Profusa
(the &#x201c;Merger&#x201d;), with Legacy Profusa surviving as a wholly-owned subsidiary of Northview. In connection with the closing, Northview
changed its name to &#x201c;Profusa, Inc.&#x201d;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Going Concern&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Company has incurred significant net operating
losses from operations. As of June&#160;30, 2026, the Company had a working capital deficit of approximately $27.3
million. For the six months ended June 30, 2026, the Company incurred a net loss of $12.2
million and used $5.2
million of cash in operating activities. Management expects to continue to incur additional substantial losses in the foreseeable future
as a result of research and development activities. The Company has been able to finance its operations primarily with the proceeds from
the issuance of equity and debt instruments. Additional funds may be necessary to maintain current operations and will be required for
successful product commercialization efforts. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; On February 11, 2025, Northview executed a Securities
Purchase Agreement (the &#x201c;PIPE Subscription Agreement&#x201d;) with Ascent Partners Fund LLC (&#x201c;Ascent&#x201d; or together with
any party who may become party to the PIPE Subscription Agreement, the &#x201c;PIPE Investors&#x201d;). As of April 2026, the Company has
remaining borrowing capacity under the PIPE Subscription Agreement of $12.2
million in principal, and issued $1.7
million of Ascent PIPE Notes. On August 12, 2026, the Company executed the 5th amendment to the Ascent Convertible Note Agreement for
which the Company received an additional tranche of $0.7
million on August 13, 2026. As of the issuance date of these condensed consolidated financial statements, the Company has $9.8
million of principal available for draw down under the PIPE Subscription Agreement subject to certain conditions, which the investor may
provide at its discretion. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; On July 28, 2025 (the &#x201c;effective date&#x201d;),
the Company entered into the Equity Line of Credit (&#x201c;ELOC&#x201d;) Securities Purchase Agreement (the &#x201c;ELOC Purchase Agreement&#x201d;)
and the ELOC Registration Rights Agreement (the &#x201c;ELOC Registration Rights Agreement&#x201d;) with Ascent (the &#x201c;Committed Equity
Facility&#x201d;). Upon the terms and subject to the satisfaction of the conditions contained in the PIPE Subscription Agreement, from
and after the effective date, the Company will have the right, in its sole discretion, to sell to Ascent up to $100.0
million of shares of the Company&#x2019;s common stock, subject to certain limitations set forth in the ELOC Purchase Agreement, from time
to time during the term of the ELOC Purchase Agreement. Sales of common stock under the ELOC Purchase Agreement, and the timing of any
such sales, are solely at the Company&#x2019;s option, and the Company is under no obligation to sell any securities to Ascent under the
ELOC Purchase Agreement. During the three and six months ended June 30, 2026, approximately $2.5
million and $2.9
million representing 89,806
and 93,020
shares, respectively, of the Company&#x2019;s common stock were sold pursuant to the ELOC Purchase Agreement. The Company has entered into
this strategic Committed Equity Facility in order to continue to fund its operating cash flows. As of the issuance date of these condensed
consolidated financial statements, the Company has $86.9
million of common stock available for issuance to Ascent under the Committed Equity Facility. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; 

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; Lumee Oxygen received regulatory approval in
Europe through the attainment of a CE mark, which subsequently lapsed in 2020. The Company is working to obtain a renewed CE Mark for
commercialization in Europe in order to generate revenues. In addition to management&#x2019;s focus on commercialization, additional financing
is available through the ELOC Purchase Agreement and executing remaining tranches of the PIPE Subscription Agreement which would provide
an aggregate of up to an additional $12.2&#160;million
in cash for operating expenses to further the product research and development. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; On September 11, 2025, Nasdaq notified the Company
that it is not in compliance with the Minimum Bid Price Requirement and the Market Value of Listed Securities (&#x201c;MVLS&#x201d;) Requirement
and provided the Company with an initial 180-day compliance period, or until March 10, 2026, to regain compliance. On October 27, 2025,
Nasdaq further notified the Company that its market value of publicly held shares had been below the Market Value Requirement for the
prior 30 consecutive
business days and provided the Company with an initial 180-day compliance period, or until April 27, 2026, to regain compliance with the
requirement. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;On March 11, 2026, Nasdaq notified the Company
that it had not regained compliance with the Minimum Bid Price Requirement or the MVLS Requirement by the March 10, 2026 deadline and
that the Company&#x2019;s securities were therefore subject to delisting from The Nasdaq Global Market on those bases. The Company appealed
that determination and appeared before the Nasdaq Hearings Panel on April 21, 2026. On April 28, 2026, Nasdaq also notified the Company
that it had not regained compliance with the Market Value of Publicly Held Shares (&#x201c;MVPHS&#x201d;) Requirement by the April 27, 2026
deadline, that this constituted an additional basis for delisting, and that the Nasdaq Hearings Panel would consider this deficiency in
connection with its decision. The Company submitted its response within the required timeframe.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;On May 6, 2026, Nasdaq notified the Company that
the Nasdaq Hearings Panel had granted the request for continued listing on Nasdaq subject to certain conditions. As a condition to the
exception, the Company was required to file an application to transfer its listing to The Nasdaq Capital Market by May 11, 2026, obtain
stockholder approval for a reverse stock split by June 23, 2026 and to demonstrate compliance with the minimum bid price requirement and
Nasdaq&#x2019;s stockholders&#x2019; equity requirement by July 20, 2026. On July 10, 2026, Nasdaq approved the Company&#x2019;s request
for an extension until July 31, 2026 to demonstrate compliance. The Company was also required to promptly notify the Panel of any significant
events during the exception period that could affect the Company&#x2019;s compliance, and the Panel reserved the right to reconsider the
terms of the exception if it determined continued listing was inadvisable or unwarranted. On May 13, 2026, the Company received Nasdaq&#x2019;s
notice confirming the Company&#x2019;s transfer to The Nasdaq Capital Market, effective on May 15, 2026. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; Pursuant to the execution of the Option Agreement
described in Note 13, the Company legally issued shares of common stock and Series A Non-Voting Convertible Preferred Stock on July 31,
2026 and there are no remaining conditions that would affect the recognition of the issued equity. Therefore, the Company believes that
as of July 31, 2026, it had at least $2.5
million of stockholders&#x2019; equity as required for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(1),
which represents an alternative continued listing standard to the $35.0
million market value of listed securities requirement under Nasdaq Listing Rule 5550(b)(2). As of the date these condensed consolidated
financial statements were issued, the Company was awaiting formal confirmation from Nasdaq that it had demonstrated compliance with the
applicable continued listing requirement. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;There can be no assurance that the Company will
timely satisfy the conditions of the exception, regain compliance with Nasdaq&#x2019;s continued listing standards, maintain compliance
with Nasdaq&#x2019;s continued listing standards thereafter, or otherwise maintain the listing of its securities on Nasdaq. If the Company
does not timely regain compliance with the applicable Nasdaq listing requirements, Nasdaq may commence delisting proceedings, suspend
trading in the Company&#x2019;s securities, or otherwise take action that could result in the removal of the Company&#x2019;s securities
from Nasdaq. Any such event could materially and adversely affect the liquidity and market price of the Company&#x2019;s securities, limit
the Company&#x2019;s ability to raise capital, and adversely affect the Company&#x2019;s business, financial condition, and results of operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; 

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company&#x2019;s condensed consolidated financial
statements have been prepared on a going-concern basis, which contemplates the realization of assets and the satisfaction of liabilities
in the normal course of business. The Company has reviewed the relevant conditions and events surrounding its ability to continue as a
going concern including among others: historical losses, projected future results, increased tariffs, cash requirements for the upcoming
year, funding capacity, net working capital deficit, and future access to capital.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;As of June&#160;30, 2026, there continue to be
factors which raise substantial doubt about the Company&#x2019;s ability to continue as a going concern within one year from the date the
condensed consolidated financial statements are issued. The condensed consolidated financial statements do not contain any adjustments
that might result from the outcome of this uncertainty.&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <dei:EntityIncorporationDateOfIncorporation contextRef="cref_853412475" id="ixv-13386">2009-05-11</dei:EntityIncorporationDateOfIncorporation>
    <pfsa:WorkingCapitalDeficit
      contextRef="cref_988890546"
      decimals="-5"
      id="ixv-13387"
      unitRef="uref_1340915823">27300000</pfsa:WorkingCapitalDeficit>
    <us-gaap:NetIncomeLoss
      contextRef="cref_853412475"
      decimals="-5"
      id="ixv-13388"
      unitRef="uref_1340915823">-12200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="cref_853412475"
      decimals="-5"
      id="ixv-13389"
      unitRef="uref_1340915823">-5200000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="cref_1366156791"
      decimals="-5"
      id="ixv-13390"
      unitRef="uref_1340915823">12200000</us-gaap:DebtInstrumentFaceAmount>
    <pfsa:PurchasePrice
      contextRef="cref_1877772804"
      decimals="-5"
      id="ixv-13391"
      unitRef="uref_1340915823">1700000</pfsa:PurchasePrice>
    <us-gaap:ConvertibleNotesPayable
      contextRef="cref_762878902"
      decimals="-5"
      id="ixv-13392"
      unitRef="uref_1340915823">700000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="cref_862313956"
      decimals="-5"
      id="ixv-13393"
      unitRef="uref_1340915823">9800000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="cref_1188634825"
      decimals="-5"
      id="ixv-13394"
      unitRef="uref_1340915823">100000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="cref_2049122364"
      decimals="-5"
      id="ixv-13395"
      unitRef="uref_1340915823">2500000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="cref_1499574654"
      decimals="-5"
      id="ixv-13396"
      unitRef="uref_1340915823">2900000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="cref_326112696"
      decimals="0"
      id="fc_326112696"
      unitRef="uref_2062431040">89806</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="cref_1065796396"
      decimals="0"
      id="fc_1065796396"
      unitRef="uref_2062431040">93020</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="cref_853412475"
      decimals="-5"
      id="ixv-13399"
      unitRef="uref_1340915823">86900000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:Cash
      contextRef="cref_988890546"
      decimals="-5"
      id="ixv-13400"
      unitRef="uref_1340915823">12200000</us-gaap:Cash>
    <pfsa:ConsecutiveBusinessDays contextRef="cref_553273376" id="ixv-13401">P30D</pfsa:ConsecutiveBusinessDays>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="cref_1903852325"
      decimals="-5"
      id="fc_131539919"
      unitRef="uref_1340915823">2500000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <pfsa:MarketValueOfListedSecurities
      contextRef="cref_853412475"
      decimals="-5"
      id="ixv-13403"
      unitRef="uref_1340915823">35000000</pfsa:MarketValueOfListedSecurities>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="cref_853412475" id="ixv-3812">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;2 &#x2014;&#160;Summary
of Significant Accounting Policies&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt; 

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;Basis of Presentation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company&#x2019;s condensed consolidated financial
statements include the accounts of Profusa and its wholly-owned subsidiary. The accompanying unaudited condensed consolidated financial
statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;)
for interim financial information and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. The condensed consolidated financial
statements include all adjustments (consisting only of normal recurring adjustments) that management believes are necessary for the fair
statement of the Company&#x2019;s financial information. These interim results are not necessarily indicative of results to be expected
for the full fiscal year or any future interim period. The condensed consolidated balance sheet as of June&#160;30, 2026 has been derived
from the audited financial statements at that date but does not include all of the information and footnotes required by GAAP for complete
financial statements. The interim condensed financial statements should be read in conjunction with the audited financial statements and
notes thereto contained in the Company&#x2019;s Form 10-K for the year ended December&#160;31, 2025, as filed with the Securities and Exchange
Commission.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt; 

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;Reverse Stock Splits&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; On August 17, 2026, the Company effected a 1-for-4
reverse stock split of its common stock (the &#x201c;August Reverse Stock Split&#x201d;). The August Reverse Stock Split did not change
the par value of the common stock, which remained $0.0001
per share, or the authorized number of shares of common stock. No fractional shares were issued in connection with the August Reverse
Stock Split. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; On July 7, 2026, the Company effected a 1-for-25
reverse stock split of its common stock (the &#x201c;July Reverse Stock Split&#x201d;). The July Reverse Stock Split did not change the
par value of the common stock, which remained $0.0001
per share, or the authorized number of shares of common stock. No fractional shares were issued in connection with the July Reverse Stock
Split. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;On February 9, 2026, the Company effected a 1-for-75
reverse stock split of its common stock (the &#x201c;February Reverse Stock Split&#x201d;). The February Reverse Stock Split did not change
the par value of the common stock, which remained $0.0001 per share, or the authorized number of shares of common stock. No fractional
shares were issued in connection with the February Reverse Stock Split.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The August Reverse Stock Split, the July Reverse
Stock Split, and the February Reverse Stock Split are collectively referred to herein as the &#x201c;Reverse Stock Splits.&#x201d; All share
and per share information has been retroactively adjusted to reflect the Reverse Stock Splits for all periods presented.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;  

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Use of Estimates&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The preparation of condensed consolidated financial
statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and
liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenue and expenses in the condensed consolidated
financial statements and accompanying notes. The Company regularly assesses these estimates, including those related to accrued liabilities,
valuation of the convertible notes and convertible loans payable at fair value, warrants, valuation allowance for deferred tax assets,
incremental borrowing rate, forward share issuance liabilities, and valuation of stock-based awards. Actual results could differ from
these estimates, and such differences could be material to the Company&#x2019;s financial position and results of operations.&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt; 

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;Segment Information&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;ASC 280, &#x201c;Segment Reporting&#x201d; (&#x201c;ASC
280&#x201d;), defines operating segments as components of an enterprise where discrete financial information is available that is evaluated
regularly by the chief operating decision-maker (&#x201c;CODM&#x201d;) in deciding how to allocate resources and in assessing performance.
The Company operates as a single operating segment. The Company&#x2019;s CODM is the chief executive officer, who has ultimate responsibility
for the operating performance of the Company and the allocation of resources. The CODM uses cash flows as the primary measure to manage
the business and does not segment the business for internal reporting or decision making.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; 

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Reclassification
of Prior Period Presentation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Certain prior period amounts have been reclassified
to conform to the current period presentation. The reclassification had no impact on loss from operations, net loss, net loss per share,
total assets, total liabilities, stockholders&#x2019; deficit, or cash flows.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;During the three and six months ended June 30,
2026, the Company reclassified amounts previously presented as interest expense related to the Company&#x2019;s convertible debt held at
fair value to loss on change in the fair value of convertible notes in the condensed consolidated statements of operations. The Company
also reclassified related party note payables from convertible senior notes and loans payable at fair value and promissory notes into
convertible and promissory notes payable to related parties on the condensed consolidated balance sheets. These reclassifications were
not material to the condensed consolidated financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; 

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Change in Accounting
Estimate&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; During the three months ended June 30, 2026,
the Company obtained additional information and completed a further evaluation of the applicability of certain Treasury regulations and
related tax guidance to the excise tax liability assumed in connection with the Business Combination. Based on this additional information,
management revised its estimate of the amount expected to be payable and concluded that the previously recorded excise tax liability was
no longer required, except for approximately $44
thousand of costs associated with seeking confirmation of the applicable tax treatment. The revision represented a change in accounting
estimate and was recognized prospectively in the period of change. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; As a result, during the three and six months
ended June 30, 2026, the Company reduced its excise tax payable by $1.9
million and increased additional paid-in capital by $1.9
million. The change in estimate decreased current and total liabilities and decreased total stockholders&#x2019; deficit by approximately
$1.9
million as of June 30, 2026. The change had no effect on the Company&#x2019;s net loss, net loss per share, or cash flows for the three
and six months ended June 30, 2026. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt;  

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;Leases&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company determines if an arrangement is or
contains a lease at inception by evaluating various factors, including if the contract conveys the right to control the use of an identified
asset for a period of time in exchange for consideration and other facts and circumstances. Lease classification is determined at the
lease commencement date. Lease liabilities and their corresponding right-of-use (&#x201c;ROU&#x201d;) assets are recognized at commencement
date and recorded based on the present value of lease payments over the expected lease term. The implicit rates within the Company&#x2019;s
operating leases are generally not determinable and therefore the Company estimates the incremental borrowing rate at the lease commencement
date to determine the present value of lease payments. The determination of the incremental borrowing rate requires judgment. The Company
determines the incremental borrowing rate for each lease using an estimated borrowing rate, adjusted for various factors including level
of collateralization and term to align with the terms of the lease. The ROU asset also might include lease prepayments, offset by lease
incentives. Certain leases include options to extend or terminate the lease. Lease terms include options to extend or terminate the lease
when it is reasonably certain we will exercise that option.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company has made accounting policy elections
to (i) not recognize ROU assets or lease liabilities for short-term leases (leases with lease terms of 12 months or less); and (ii) combine
lease and non-lease components. Variable lease payments are recognized in the condensed consolidated statements of operations when incurred
and include certain non-lease components, such as maintenance and other services provided by the lessor to the extent the charges are
variable. The cash flow impact from the change in operating lease right-of-use asset and the operating lease liability during the six
months ended June 30, 2026 is presented within the change in accrued expenses and other current liabilities on the condensed consolidated
statements of cash flows.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt; 

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;ELOC&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; On July 28, 2025, the Company entered into the
ELOC Purchase Agreement and a related registration rights agreement with Ascent. Subject to the terms and conditions of the ELOC Purchase
Agreement, the Company has the right, but not the obligation, to sell up to $100.0
million of shares of its common stock to Ascent from time to time at a discount to the lowest daily volume-weighted average price (&#x201c;VWAP&#x201d;)
of the Company&#x2019;s common stock, subject to specified caps and limitations. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The ELOC comprises a purchased put option and
a forward share issuance that do not qualify for equity classification. Accordingly, the ELOC is measured at fair value, with changes
between the put date and settlement date recognized in earnings. During the three and six months ended June 30, 2026, certain Advance
Notices provided that the purchase price would be funded upon delivery of shares to Ascent rather than upon Ascent&#x2019;s subsequent
resale of such shares, at a purchase price equal to 97%
of the lowest VWAP of the Company&#x2019;s common stock during the ten trading days prior to the applicable Advance Notice date, subject
to a true-up mechanism requiring the Company to issue additional shares if 97%
of the lowest VWAP during the adjustment period was lower than the price used at closing. During the three and six months ended June 30,
2026, the Company issued 16,030
shares of common stock under an Advance Notice consisting of 13,712
shares initially delivered and 2,318
true-up shares, as adjusted for the Reverse Stock Splits, resulting in the Company&#x2019;s receipt of $0.4
million of gross proceeds and recognition of $0.4
million of forward share issuance liability on the condensed consolidated balance sheets. Upon final settlement of the true-up mechanism,
the Company derecognized the related forward share issuance liability and recorded a loss on settlement of the forward share issuance
of $0.1
million within financing costs on the condensed consolidated statements of operations during three and six months ended June 30, 2026.
Other ELOC puts during the three and six months ended June 30, 2026 were settled within the same day, and the resulting changes in fair
value were not material. Proceeds received upon the Company&#x2019;s draws under the ELOC and the related share issuances are recognized
in equity based on the gross proceeds received. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Company issued warrants to purchase up to
120
shares of common stock (the &#x201c;ELOC Warrants&#x201d;) on July 20, 2025 in consideration for Ascent&#x2019;s commitment. The ELOC Warrants
were determined to be equity-classified and were expensed as financing fees along with other issuance costs associated with the ELOC.
The ELOC Warrants were fair valued at $0.9
million and were not remeasured after the initial issuance. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; 

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company&#x2019;s financial instruments consist
of accounts payable, warrant liabilities, promissory notes, convertible loans payable, convertible promissory notes and convertible senior
notes. The Company states accounts payable, promissory notes and convertible senior notes at their carrying value, which approximates
fair value due to the short time to the expected payment. See Note 3 for instruments valued under Level 3.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; 

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Ascent PIPE
Notes &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; In connection with the Business Combination,
the Company assumed the rights and obligations under the PIPE Subscription Agreement, which provides for the issuance of Senior Secured
Convertible Promissory Notes (the &#x201c;Ascent PIPE Notes&#x201d;) in an aggregate principal amount of up to $22.2
million. At Closing Date, the Company elected the fair value option (&#x201c;FVO&#x201d;) under ASC 825, Financial Instruments to recognize
the issued Ascent PIPE Notes. Accordingly, no features of the Ascent PIPE Notes are bifurcated and separately accounted for. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; 

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;On April 2, 2026, the Company entered into Amendment
No. 4 to our PIPE Subscription Agreement and related Pledge Agreement with Ascent (&#x201c;Amendment No. 4&#x201d;). Under Amendment No.
4, the Company may, subject to the terms and conditions of the amended agreements, request funding with an aggregate principal amount
of up to $12.2
million under the facility, which the investor may provide at its discretion. The $12.2 million principal amount referenced in Amendment
No. 4 represents the remaining available borrowing capacity under the existing Ascent PIPE financing arrangement and is not in addition
to the original aggregate facility. As consideration for providing additional funding in April 2026, the Company issued Ascent certain
warrants as lender fees that were recognized as financing costs on the condensed consolidated statements of operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;In accordance with ASC 825, the Company has elected
the FVO for each outstanding Ascent PIPE Note on an instrument-by-instrument basis. Each Ascent PIPE Note is accounted for as a separate
unit of account and the FVO is irrevocable once elected for the respective instrument. At each reporting date, the Ascent PIPE Notes are
measured at fair value, with changes in fair value recognized in earnings, except for the portion attributable to instrument-specific
credit risk, which is presented in other comprehensive income. During the three and six months ended June 30, 2026, the Company did not
record any changes in fair value to other comprehensive income. As of June&#160;30, 2026, the Ascent PIPE Notes are included in convertible
senior notes and loans payable at fair value within the condensed consolidated balance sheets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; 

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Common Stock
Warrants&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company evaluates freestanding warrants under
ASC 480, Distinguishing Liabilities from Equity, and ASC 815-40, Contracts in Entity&#x2019;s Own Equity, to determine whether the warrants
should be classified as liabilities or equity. The Company accounts for warrants for shares of the Company&#x2019;s common stock that are
not indexed to its own stock as liabilities at fair value on the balance sheet. Liability-classified common stock warrants are subject
to remeasurement to fair value as of each subsequent balance sheet date and as of any respective exercise date, with changes in fair value
recorded in the Company&#x2019;s condensed consolidated statements of operations. For common stock warrants that meet all of the criteria
for equity classification, the common stock warrants are recorded as a component of additional paid-in capital and are not remeasured
to fair value in subsequent reporting periods.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The fair value of common stock warrants is determined
using an option-pricing model, such as the Black-Scholes model, incorporating assumptions including the fair value of the Company&#x2019;s
common stock, exercise price, contractual term, expected volatility, risk-free interest rate and expected dividend yield.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Legal costs incurred in connection with the issuance
of equity-classified warrants are capitalized as a reduction to additional paid-in capital if the warrants are issued in conjunction with
an equity financing or equity-linked arrangement, and expensed immediately only if the costs are not directly attributable to the issuance.
Legal and professional fees incurred in connection with the issuance of liability-classified warrants, including those failing equity
classification under ASC 815-40 are expensed immediately to the condensed consolidated statements of operations as incurred.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;When a warrant is issued in connection with a
financing arrangement for which the Company has elected the fair value option, the issuance-date fair value of the warrant is recognized
as a financing cost when incurred, with an offsetting credit to warrant liability (for liability-classified warrants) or additional paid-in
capital (for equity-classified warrants). &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;  

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;A modification or exchange of an equity-classified
warrant that remains equity-classified after modification is measured based on the excess, if any, of the fair value of the modified warrant
over its fair value immediately before the modification. Any incremental fair value is recognized in the same manner as the original warrant
issuance. A modification or exchange of a liability-classified warrant that remains liability-classified is measured at the change in
fair value at the modification date, with any increase in fair value recognized in the condensed consolidated statements of operations.
When a liability-classified warrant is modified such that it no longer meets the conditions that precluded equity classification, the
warrant liability is remeasured to fair value immediately before the modification, with the change in fair value recognized in the condensed
consolidated statements of operations, and the resulting fair value is reclassified to additional paid-in capital. If no incremental value
is transferred to the counterparty as a result of the modification, no adjustment is made to financing costs.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The effect of a down-round feature that meets
the applicable definition is excluded from the assessment of whether the warrant is indexed to the Company&#x2019;s own stock. If a down-round
feature is triggered, the value of the effect of the feature is recognized as a deemed dividend and as a reduction of income available
to common stockholders in the computation of basic earnings per share.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; 

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Stock-Based
Compensation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Stock-based compensation expense related to stock
options granted to employees and non-employees is recognized based on the grant date estimated fair values using the Black-Scholes option
pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense ratably over the requisite
service period. The Company accounts for forfeitures as they occur. Option valuation models, including the Black-Scholes option-pricing
model, require the input of highly subjective assumptions, and changes in the assumptions used can materially affect the grant-date fair
value of an award. These assumptions include the risk-free rate of interest, expected dividend yield, expected volatility, and the expected
life of the award. Since the Company did not have sufficient historical information to develop reasonable expectations about future exercise
behavior, the expected term for options issued to employees was calculated as the mean of the option vesting period and contractual term
(the &#x201c;Simplified Method&#x201d;). The expected term for options issued to non-employees is the contractual term.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; 

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Recently
issued accounting standards not yet adopted&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;In November 2024, the FASB issued ASU 2024-03,
Disaggregation of Income Statement Expenses (&#x201c;DISE&#x201d;). ASU 2024-03 requires disaggregated disclosure of income statement expenses
for public business entities. ASU 2024-03 does not change the expense captions an entity presents on the face of the income statement;
rather, it requires disaggregation of certain expense captions into specified categories in disclosures within the footnotes to the financial
statements. As revised by ASU No. 2025-01, Income Statement&#x2014;Reporting Comprehensive Income&#x2014;Expense Disaggregation Disclosures,
the provisions of ASU 2024-03 are effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years
beginning after December 15, 2027, with early adoption permitted. With the exception of expanding disclosures to include more granular
income statement expense categories, the Company does not expect the adoption of ASU 2024-03 to have a material effect on its condensed
consolidated financial statements taken as a whole.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;In May 2025, the FASB issued ASU 2025-03 which
revises the guidance in ASC 805 on identifying the accounting acquirer in a business combination in which the legal acquiree is a variable
interest entity (VIE). ASU 2025-03 is effective for fiscal years beginning after December 15, 2026, including interim periods within those
fiscal years. Early adoption is permitted. The amendments in ASU 2025-03 must be applied prospectively to any business combination that
occurs after the initial adoption date. The Company is currently evaluating the impact of the guidance on its condensed consolidated financial
statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;In December 2025, the FASB issued ASU 2025-10,
Government Grants (Topic 832): Accounting for Government Grants Received by Business Entities. ASU 2025-10 established authoritative guidance
for the accounting for a government grant received by a business entity, including guidance for a grant related to an asset and a grant
related to income. This guidance is effective for annual reporting periods beginning after December 15, 2028, and interim reporting periods
within those annual reporting periods. The Company is currently evaluating the impact of the guidance on its condensed consolidated financial
statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;In December 2025, the FASB issued ASU 2025-11,
Interim Reporting (Topic 270): Narrow-Scope Improvements. ASU 2025-11 clarifies the applicability of interim reporting guidance under
GAAP, provides a comprehensive list of interim disclosure requirements within Topic 270, and introduces a disclosure principle requiring
entities to provide information about events and changes occurring after the end of the most recent annual reporting period that have
a material impact on the entity. The ASU does not change the fundamental nature of interim reporting or expand or reduce existing interim
disclosure requirements. ASU 2025-11 is effective for interim reporting periods within annual reporting periods beginning after December
15, 2027 for public business entities, with early adoption permitted. The Company is currently evaluating the impact of this guidance
on its interim financial reporting and related disclosures.&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="cref_853412475" id="ixv-3817">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;Basis of Presentation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company&#x2019;s condensed consolidated financial
statements include the accounts of Profusa and its wholly-owned subsidiary. The accompanying unaudited condensed consolidated financial
statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;)
for interim financial information and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. The condensed consolidated financial
statements include all adjustments (consisting only of normal recurring adjustments) that management believes are necessary for the fair
statement of the Company&#x2019;s financial information. These interim results are not necessarily indicative of results to be expected
for the full fiscal year or any future interim period. The condensed consolidated balance sheet as of June&#160;30, 2026 has been derived
from the audited financial statements at that date but does not include all of the information and footnotes required by GAAP for complete
financial statements. The interim condensed financial statements should be read in conjunction with the audited financial statements and
notes thereto contained in the Company&#x2019;s Form 10-K for the year ended December&#160;31, 2025, as filed with the Securities and Exchange
Commission.&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <pfsa:ReverseStockSplitPolicyPolicyTextBlock contextRef="cref_853412475" id="ixv-3824">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;Reverse Stock Splits&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; On August 17, 2026, the Company effected a 1-for-4
reverse stock split of its common stock (the &#x201c;August Reverse Stock Split&#x201d;). The August Reverse Stock Split did not change
the par value of the common stock, which remained $0.0001
per share, or the authorized number of shares of common stock. No fractional shares were issued in connection with the August Reverse
Stock Split. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; On July 7, 2026, the Company effected a 1-for-25
reverse stock split of its common stock (the &#x201c;July Reverse Stock Split&#x201d;). The July Reverse Stock Split did not change the
par value of the common stock, which remained $0.0001
per share, or the authorized number of shares of common stock. No fractional shares were issued in connection with the July Reverse Stock
Split. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;On February 9, 2026, the Company effected a 1-for-75
reverse stock split of its common stock (the &#x201c;February Reverse Stock Split&#x201d;). The February Reverse Stock Split did not change
the par value of the common stock, which remained $0.0001 per share, or the authorized number of shares of common stock. No fractional
shares were issued in connection with the February Reverse Stock Split.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The August Reverse Stock Split, the July Reverse
Stock Split, and the February Reverse Stock Split are collectively referred to herein as the &#x201c;Reverse Stock Splits.&#x201d; All share
and per share information has been retroactively adjusted to reflect the Reverse Stock Splits for all periods presented.&lt;/p&gt;</pfsa:ReverseStockSplitPolicyPolicyTextBlock>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="cref_549261231" id="ixv-13404">1-for-4</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_573187633"
      decimals="4"
      id="ixv-13405"
      unitRef="uref_138178116">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="cref_1087692109" id="ixv-13406">1-for-25</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_725547165"
      decimals="4"
      id="ixv-13407"
      unitRef="uref_138178116">0.0001</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:UseOfEstimates contextRef="cref_853412475" id="ixv-3844">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Use of Estimates&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The preparation of condensed consolidated financial
statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and
liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenue and expenses in the condensed consolidated
financial statements and accompanying notes. The Company regularly assesses these estimates, including those related to accrued liabilities,
valuation of the convertible notes and convertible loans payable at fair value, warrants, valuation allowance for deferred tax assets,
incremental borrowing rate, forward share issuance liabilities, and valuation of stock-based awards. Actual results could differ from
these estimates, and such differences could be material to the Company&#x2019;s financial position and results of operations.&#160;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="cref_853412475" id="ixv-3851">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;Segment Information&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;ASC 280, &#x201c;Segment Reporting&#x201d; (&#x201c;ASC
280&#x201d;), defines operating segments as components of an enterprise where discrete financial information is available that is evaluated
regularly by the chief operating decision-maker (&#x201c;CODM&#x201d;) in deciding how to allocate resources and in assessing performance.
The Company operates as a single operating segment. The Company&#x2019;s CODM is the chief executive officer, who has ultimate responsibility
for the operating performance of the Company and the allocation of resources. The CODM uses cash flows as the primary measure to manage
the business and does not segment the business for internal reporting or decision making.&lt;/p&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef="cref_853412475" id="ixv-3858">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Reclassification
of Prior Period Presentation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Certain prior period amounts have been reclassified
to conform to the current period presentation. The reclassification had no impact on loss from operations, net loss, net loss per share,
total assets, total liabilities, stockholders&#x2019; deficit, or cash flows.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;During the three and six months ended June 30,
2026, the Company reclassified amounts previously presented as interest expense related to the Company&#x2019;s convertible debt held at
fair value to loss on change in the fair value of convertible notes in the condensed consolidated statements of operations. The Company
also reclassified related party note payables from convertible senior notes and loans payable at fair value and promissory notes into
convertible and promissory notes payable to related parties on the condensed consolidated balance sheets. These reclassifications were
not material to the condensed consolidated financial statements.&lt;/p&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <pfsa:ChangeInAccountingEstimatePolicyTextBlock contextRef="cref_853412475" id="ixv-3866">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Change in Accounting
Estimate&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; During the three months ended June 30, 2026,
the Company obtained additional information and completed a further evaluation of the applicability of certain Treasury regulations and
related tax guidance to the excise tax liability assumed in connection with the Business Combination. Based on this additional information,
management revised its estimate of the amount expected to be payable and concluded that the previously recorded excise tax liability was
no longer required, except for approximately $44
thousand of costs associated with seeking confirmation of the applicable tax treatment. The revision represented a change in accounting
estimate and was recognized prospectively in the period of change. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; As a result, during the three and six months
ended June 30, 2026, the Company reduced its excise tax payable by $1.9
million and increased additional paid-in capital by $1.9
million. The change in estimate decreased current and total liabilities and decreased total stockholders&#x2019; deficit by approximately
$1.9
million as of June 30, 2026. The change had no effect on the Company&#x2019;s net loss, net loss per share, or cash flows for the three
and six months ended June 30, 2026. &lt;/p&gt;</pfsa:ChangeInAccountingEstimatePolicyTextBlock>
    <us-gaap:TaxesOther
      contextRef="cref_496962156"
      decimals="-3"
      id="ixv-13408"
      unitRef="uref_1340915823">44000</us-gaap:TaxesOther>
    <us-gaap:TaxesPayableCurrentAndNoncurrent
      contextRef="cref_988890546"
      decimals="-5"
      id="ixv-13409"
      unitRef="uref_1340915823">1900000</us-gaap:TaxesPayableCurrentAndNoncurrent>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="cref_988890546"
      decimals="-5"
      id="ixv-13410"
      unitRef="uref_1340915823">1900000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:OtherLiabilities
      contextRef="cref_988890546"
      decimals="-5"
      id="ixv-13411"
      unitRef="uref_1340915823">1900000</us-gaap:OtherLiabilities>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="cref_853412475" id="ixv-3882">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;Leases&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company determines if an arrangement is or
contains a lease at inception by evaluating various factors, including if the contract conveys the right to control the use of an identified
asset for a period of time in exchange for consideration and other facts and circumstances. Lease classification is determined at the
lease commencement date. Lease liabilities and their corresponding right-of-use (&#x201c;ROU&#x201d;) assets are recognized at commencement
date and recorded based on the present value of lease payments over the expected lease term. The implicit rates within the Company&#x2019;s
operating leases are generally not determinable and therefore the Company estimates the incremental borrowing rate at the lease commencement
date to determine the present value of lease payments. The determination of the incremental borrowing rate requires judgment. The Company
determines the incremental borrowing rate for each lease using an estimated borrowing rate, adjusted for various factors including level
of collateralization and term to align with the terms of the lease. The ROU asset also might include lease prepayments, offset by lease
incentives. Certain leases include options to extend or terminate the lease. Lease terms include options to extend or terminate the lease
when it is reasonably certain we will exercise that option.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company has made accounting policy elections
to (i) not recognize ROU assets or lease liabilities for short-term leases (leases with lease terms of 12 months or less); and (ii) combine
lease and non-lease components. Variable lease payments are recognized in the condensed consolidated statements of operations when incurred
and include certain non-lease components, such as maintenance and other services provided by the lessor to the extent the charges are
variable. The cash flow impact from the change in operating lease right-of-use asset and the operating lease liability during the six
months ended June 30, 2026 is presented within the change in accrued expenses and other current liabilities on the condensed consolidated
statements of cash flows.&lt;/p&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <pfsa:EquityLineOfCreditPolicyTextBlock contextRef="cref_853412475" id="ixv-3892">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;ELOC&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; On July 28, 2025, the Company entered into the
ELOC Purchase Agreement and a related registration rights agreement with Ascent. Subject to the terms and conditions of the ELOC Purchase
Agreement, the Company has the right, but not the obligation, to sell up to $100.0
million of shares of its common stock to Ascent from time to time at a discount to the lowest daily volume-weighted average price (&#x201c;VWAP&#x201d;)
of the Company&#x2019;s common stock, subject to specified caps and limitations. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The ELOC comprises a purchased put option and
a forward share issuance that do not qualify for equity classification. Accordingly, the ELOC is measured at fair value, with changes
between the put date and settlement date recognized in earnings. During the three and six months ended June 30, 2026, certain Advance
Notices provided that the purchase price would be funded upon delivery of shares to Ascent rather than upon Ascent&#x2019;s subsequent
resale of such shares, at a purchase price equal to 97%
of the lowest VWAP of the Company&#x2019;s common stock during the ten trading days prior to the applicable Advance Notice date, subject
to a true-up mechanism requiring the Company to issue additional shares if 97%
of the lowest VWAP during the adjustment period was lower than the price used at closing. During the three and six months ended June 30,
2026, the Company issued 16,030
shares of common stock under an Advance Notice consisting of 13,712
shares initially delivered and 2,318
true-up shares, as adjusted for the Reverse Stock Splits, resulting in the Company&#x2019;s receipt of $0.4
million of gross proceeds and recognition of $0.4
million of forward share issuance liability on the condensed consolidated balance sheets. Upon final settlement of the true-up mechanism,
the Company derecognized the related forward share issuance liability and recorded a loss on settlement of the forward share issuance
of $0.1
million within financing costs on the condensed consolidated statements of operations during three and six months ended June 30, 2026.
Other ELOC puts during the three and six months ended June 30, 2026 were settled within the same day, and the resulting changes in fair
value were not material. Proceeds received upon the Company&#x2019;s draws under the ELOC and the related share issuances are recognized
in equity based on the gross proceeds received. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Company issued warrants to purchase up to
120
shares of common stock (the &#x201c;ELOC Warrants&#x201d;) on July 20, 2025 in consideration for Ascent&#x2019;s commitment. The ELOC Warrants
were determined to be equity-classified and were expensed as financing fees along with other issuance costs associated with the ELOC.
The ELOC Warrants were fair valued at $0.9
million and were not remeasured after the initial issuance. &lt;/p&gt;</pfsa:EquityLineOfCreditPolicyTextBlock>
    <us-gaap:PurchaseObligation
      contextRef="cref_1474767452"
      decimals="-5"
      id="ixv-13412"
      unitRef="uref_1340915823">100000000</us-gaap:PurchaseObligation>
    <pfsa:PercentageOfPurchasePrice
      contextRef="cref_496962156"
      decimals="2"
      id="ixv-13413"
      unitRef="uref_527123470">0.97</pfsa:PercentageOfPurchasePrice>
    <pfsa:PercentageOfPurchasePrice
      contextRef="cref_853412475"
      decimals="2"
      id="ixv-13414"
      unitRef="uref_527123470">0.97</pfsa:PercentageOfPurchasePrice>
    <pfsa:PercentageOfAdditionalShares
      contextRef="cref_496962156"
      decimals="2"
      id="ixv-13415"
      unitRef="uref_527123470">0.97</pfsa:PercentageOfAdditionalShares>
    <pfsa:PercentageOfAdditionalShares
      contextRef="cref_853412475"
      decimals="2"
      id="ixv-13416"
      unitRef="uref_527123470">0.97</pfsa:PercentageOfAdditionalShares>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_1636204611"
      decimals="0"
      id="ixv-13417"
      unitRef="uref_2062431040">16030</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_1636204611"
      decimals="0"
      id="ixv-13418"
      unitRef="uref_2062431040">16030</us-gaap:CommonStockSharesIssued>
    <pfsa:AdvanceNoticeShares
      contextRef="cref_190850052"
      decimals="0"
      id="fc_236444256"
      unitRef="uref_2062431040">13712</pfsa:AdvanceNoticeShares>
    <pfsa:AdvanceNoticeShares
      contextRef="cref_1232708550"
      decimals="0"
      id="fc_852990633"
      unitRef="uref_2062431040">13712</pfsa:AdvanceNoticeShares>
    <pfsa:TrueupCommonSharesIssued
      contextRef="cref_190850052"
      decimals="0"
      id="fc_190850052"
      unitRef="uref_2062431040">2318</pfsa:TrueupCommonSharesIssued>
    <pfsa:TrueupCommonSharesIssued
      contextRef="cref_1232708550"
      decimals="0"
      id="fc_1232708550"
      unitRef="uref_2062431040">2318</pfsa:TrueupCommonSharesIssued>
    <pfsa:GrossProceeds
      contextRef="cref_720646264"
      decimals="-5"
      id="ixv-13423"
      unitRef="uref_1340915823">400000</pfsa:GrossProceeds>
    <pfsa:GrossProceeds
      contextRef="cref_1877472753"
      decimals="-5"
      id="ixv-13424"
      unitRef="uref_1340915823">400000</pfsa:GrossProceeds>
    <pfsa:ShareIssuanceLiability
      contextRef="cref_496962156"
      decimals="-5"
      id="ixv-13425"
      unitRef="uref_1340915823">400000</pfsa:ShareIssuanceLiability>
    <pfsa:ShareIssuanceLiability
      contextRef="cref_853412475"
      decimals="-5"
      id="ixv-13426"
      unitRef="uref_1340915823">400000</pfsa:ShareIssuanceLiability>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="cref_496962156"
      decimals="-5"
      id="ixv-13427"
      unitRef="uref_1340915823">100000</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="cref_853412475"
      decimals="-5"
      id="ixv-13428"
      unitRef="uref_1340915823">100000</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_1894852061"
      decimals="0"
      id="ixv-13429"
      unitRef="uref_2062431040">120</us-gaap:CommonStockSharesIssued>
    <us-gaap:AssetsFairValueAdjustment
      contextRef="cref_853412475"
      decimals="-5"
      id="ixv-13430"
      unitRef="uref_1340915823">900000</us-gaap:AssetsFairValueAdjustment>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="cref_853412475" id="ixv-3902">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company&#x2019;s financial instruments consist
of accounts payable, warrant liabilities, promissory notes, convertible loans payable, convertible promissory notes and convertible senior
notes. The Company states accounts payable, promissory notes and convertible senior notes at their carrying value, which approximates
fair value due to the short time to the expected payment. See Note 3 for instruments valued under Level 3.&lt;/p&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <pfsa:AscentPIPENotesPolicyTextBlock contextRef="cref_853412475" id="ixv-3908">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Ascent PIPE
Notes &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; In connection with the Business Combination,
the Company assumed the rights and obligations under the PIPE Subscription Agreement, which provides for the issuance of Senior Secured
Convertible Promissory Notes (the &#x201c;Ascent PIPE Notes&#x201d;) in an aggregate principal amount of up to $22.2
million. At Closing Date, the Company elected the fair value option (&#x201c;FVO&#x201d;) under ASC 825, Financial Instruments to recognize
the issued Ascent PIPE Notes. Accordingly, no features of the Ascent PIPE Notes are bifurcated and separately accounted for. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; 

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;On April 2, 2026, the Company entered into Amendment
No. 4 to our PIPE Subscription Agreement and related Pledge Agreement with Ascent (&#x201c;Amendment No. 4&#x201d;). Under Amendment No.
4, the Company may, subject to the terms and conditions of the amended agreements, request funding with an aggregate principal amount
of up to $12.2
million under the facility, which the investor may provide at its discretion. The $12.2 million principal amount referenced in Amendment
No. 4 represents the remaining available borrowing capacity under the existing Ascent PIPE financing arrangement and is not in addition
to the original aggregate facility. As consideration for providing additional funding in April 2026, the Company issued Ascent certain
warrants as lender fees that were recognized as financing costs on the condensed consolidated statements of operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;In accordance with ASC 825, the Company has elected
the FVO for each outstanding Ascent PIPE Note on an instrument-by-instrument basis. Each Ascent PIPE Note is accounted for as a separate
unit of account and the FVO is irrevocable once elected for the respective instrument. At each reporting date, the Ascent PIPE Notes are
measured at fair value, with changes in fair value recognized in earnings, except for the portion attributable to instrument-specific
credit risk, which is presented in other comprehensive income. During the three and six months ended June 30, 2026, the Company did not
record any changes in fair value to other comprehensive income. As of June&#160;30, 2026, the Ascent PIPE Notes are included in convertible
senior notes and loans payable at fair value within the condensed consolidated balance sheets.&lt;/p&gt;</pfsa:AscentPIPENotesPolicyTextBlock>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount
      contextRef="cref_988890546"
      decimals="-5"
      id="ixv-13431"
      unitRef="uref_1340915823">22200000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount
      contextRef="cref_1377884820"
      decimals="-5"
      id="ixv-13432"
      unitRef="uref_1340915823">12200000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <pfsa:WarrantsPolicyTextBlock contextRef="cref_853412475" id="ixv-3927">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Common Stock
Warrants&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company evaluates freestanding warrants under
ASC 480, Distinguishing Liabilities from Equity, and ASC 815-40, Contracts in Entity&#x2019;s Own Equity, to determine whether the warrants
should be classified as liabilities or equity. The Company accounts for warrants for shares of the Company&#x2019;s common stock that are
not indexed to its own stock as liabilities at fair value on the balance sheet. Liability-classified common stock warrants are subject
to remeasurement to fair value as of each subsequent balance sheet date and as of any respective exercise date, with changes in fair value
recorded in the Company&#x2019;s condensed consolidated statements of operations. For common stock warrants that meet all of the criteria
for equity classification, the common stock warrants are recorded as a component of additional paid-in capital and are not remeasured
to fair value in subsequent reporting periods.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The fair value of common stock warrants is determined
using an option-pricing model, such as the Black-Scholes model, incorporating assumptions including the fair value of the Company&#x2019;s
common stock, exercise price, contractual term, expected volatility, risk-free interest rate and expected dividend yield.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Legal costs incurred in connection with the issuance
of equity-classified warrants are capitalized as a reduction to additional paid-in capital if the warrants are issued in conjunction with
an equity financing or equity-linked arrangement, and expensed immediately only if the costs are not directly attributable to the issuance.
Legal and professional fees incurred in connection with the issuance of liability-classified warrants, including those failing equity
classification under ASC 815-40 are expensed immediately to the condensed consolidated statements of operations as incurred.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;When a warrant is issued in connection with a
financing arrangement for which the Company has elected the fair value option, the issuance-date fair value of the warrant is recognized
as a financing cost when incurred, with an offsetting credit to warrant liability (for liability-classified warrants) or additional paid-in
capital (for equity-classified warrants). &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;A modification or exchange of an equity-classified
warrant that remains equity-classified after modification is measured based on the excess, if any, of the fair value of the modified warrant
over its fair value immediately before the modification. Any incremental fair value is recognized in the same manner as the original warrant
issuance. A modification or exchange of a liability-classified warrant that remains liability-classified is measured at the change in
fair value at the modification date, with any increase in fair value recognized in the condensed consolidated statements of operations.
When a liability-classified warrant is modified such that it no longer meets the conditions that precluded equity classification, the
warrant liability is remeasured to fair value immediately before the modification, with the change in fair value recognized in the condensed
consolidated statements of operations, and the resulting fair value is reclassified to additional paid-in capital. If no incremental value
is transferred to the counterparty as a result of the modification, no adjustment is made to financing costs.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The effect of a down-round feature that meets
the applicable definition is excluded from the assessment of whether the warrant is indexed to the Company&#x2019;s own stock. If a down-round
feature is triggered, the value of the effect of the feature is recognized as a deemed dividend and as a reduction of income available
to common stockholders in the computation of basic earnings per share.&lt;/p&gt;</pfsa:WarrantsPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="cref_853412475" id="ixv-3952">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Stock-Based
Compensation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Stock-based compensation expense related to stock
options granted to employees and non-employees is recognized based on the grant date estimated fair values using the Black-Scholes option
pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense ratably over the requisite
service period. The Company accounts for forfeitures as they occur. Option valuation models, including the Black-Scholes option-pricing
model, require the input of highly subjective assumptions, and changes in the assumptions used can materially affect the grant-date fair
value of an award. These assumptions include the risk-free rate of interest, expected dividend yield, expected volatility, and the expected
life of the award. Since the Company did not have sufficient historical information to develop reasonable expectations about future exercise
behavior, the expected term for options issued to employees was calculated as the mean of the option vesting period and contractual term
(the &#x201c;Simplified Method&#x201d;). The expected term for options issued to non-employees is the contractual term.&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="cref_853412475" id="ixv-3958">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Recently
issued accounting standards not yet adopted&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;In November 2024, the FASB issued ASU 2024-03,
Disaggregation of Income Statement Expenses (&#x201c;DISE&#x201d;). ASU 2024-03 requires disaggregated disclosure of income statement expenses
for public business entities. ASU 2024-03 does not change the expense captions an entity presents on the face of the income statement;
rather, it requires disaggregation of certain expense captions into specified categories in disclosures within the footnotes to the financial
statements. As revised by ASU No. 2025-01, Income Statement&#x2014;Reporting Comprehensive Income&#x2014;Expense Disaggregation Disclosures,
the provisions of ASU 2024-03 are effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years
beginning after December 15, 2027, with early adoption permitted. With the exception of expanding disclosures to include more granular
income statement expense categories, the Company does not expect the adoption of ASU 2024-03 to have a material effect on its condensed
consolidated financial statements taken as a whole.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;In May 2025, the FASB issued ASU 2025-03 which
revises the guidance in ASC 805 on identifying the accounting acquirer in a business combination in which the legal acquiree is a variable
interest entity (VIE). ASU 2025-03 is effective for fiscal years beginning after December 15, 2026, including interim periods within those
fiscal years. Early adoption is permitted. The amendments in ASU 2025-03 must be applied prospectively to any business combination that
occurs after the initial adoption date. The Company is currently evaluating the impact of the guidance on its condensed consolidated financial
statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;In December 2025, the FASB issued ASU 2025-10,
Government Grants (Topic 832): Accounting for Government Grants Received by Business Entities. ASU 2025-10 established authoritative guidance
for the accounting for a government grant received by a business entity, including guidance for a grant related to an asset and a grant
related to income. This guidance is effective for annual reporting periods beginning after December 15, 2028, and interim reporting periods
within those annual reporting periods. The Company is currently evaluating the impact of the guidance on its condensed consolidated financial
statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;In December 2025, the FASB issued ASU 2025-11,
Interim Reporting (Topic 270): Narrow-Scope Improvements. ASU 2025-11 clarifies the applicability of interim reporting guidance under
GAAP, provides a comprehensive list of interim disclosure requirements within Topic 270, and introduces a disclosure principle requiring
entities to provide information about events and changes occurring after the end of the most recent annual reporting period that have
a material impact on the entity. The ASU does not change the fundamental nature of interim reporting or expand or reduce existing interim
disclosure requirements. ASU 2025-11 is effective for interim reporting periods within annual reporting periods beginning after December
15, 2027 for public business entities, with early adoption permitted. The Company is currently evaluating the impact of this guidance
on its interim financial reporting and related disclosures.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="cref_853412475" id="ixv-3983">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;3 &#x2014;&#160;Fair Value
Measurement&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Assets and liabilities recorded at fair value
on a recurring basis in the condensed consolidated balance sheets are categorized based upon the level of judgment associated with the
inputs used to measure their fair values. Fair value represents the price that would be received to sell an asset or paid to transfer
a liability in an orderly transaction between market participants at the measurement date. Valuation techniques used to measure fair value
must maximize the use of observable inputs and minimize the use of unobservable inputs. The authoritative guidance on fair value measurements
establishes a three-tier fair value hierarchy for disclosure of fair value measurements as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Level 1 &#x2014;&#160; Inputs are unadjusted,
quoted prices in active markets for identical assets or liabilities at the measurement date;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Level 2 &#x2014;&#160; Inputs are observable,
unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets
or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for
substantially the full term of the related assets or liabilities; and&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Level&#160;3&#160;&#x2014;&#160;Unobservable inputs
that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;In determining fair value, the Company utilizes
valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible as
well as considers counterparty credit risk in its assessment of fair value.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Assets and liabilities measured at fair value
are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company&#x2019;s
assessment of the significance of a particular input to the fair value measurement in its entirety requires management to make judgments
and consider factors specific to the asset or liability.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company measures certain financial instruments
at fair value using valuation techniques that require the use of observable and unobservable inputs and assumptions, including, as applicable,
risk-free interest rates, expected terms, expected volatility, credit risk, market yields, conversion or exercise prices, the fair value
of the Company&#x2019;s common stock, and other instrument-specific terms and market inputs. The risk-free interest rate for each applicable
financial instrument is based on the U.S. Treasury yield curve in effect as of the valuation date for a term commensurate with the expected
term, contractual term, or estimated settlement period of the instrument, as applicable. Expected volatility, when applicable, may differ
among financial instruments due to differences in expected terms, contractual maturities, settlement provisions, conversion or exercise
features, valuation methodologies, market inputs, and the historical periods used to estimate volatility.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; 

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;As of June&#160;30, 2026 and December&#160;31,
2025, the Company&#x2019;s financial assets and liabilities measured at fair value on a recurring basis, were as follows (in thousands):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;As of June 30, 2026&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Level 1&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Level 2&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Level 3&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td style="font-weight: bold;"&gt;Liabilities:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="width: 52%; text-align: left;"&gt;Convertible notes due to related parties held at fair value&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1014181908;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1499031780;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;4,743&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;4,743&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left;"&gt;Convertible loans payable at fair value&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1194482741;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_896289894;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;8,162&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;8,162&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left;"&gt;Warrant liabilities - Private Placement Warrants&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_161393837;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_946089074;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;2&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;2&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Warrant liabilities - Representative&#x2019;s Warrants&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1853496641;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_912067788;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_2092241241;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_229538959;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt;"&gt;Total liabilities measured at fair value&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1290442340;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1150907625;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;12,907&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;12,907&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in;"&gt;&lt;/p&gt;

  

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;As of December 31, 2025&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Level 1&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Level 2&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Level 3&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td style="font-weight: bold;"&gt;Assets:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="width: 52%; text-align: left;"&gt;Digital assets (Bitcoin)&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;1,445&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_41616020;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_2061553027;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;1,445&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="font-weight: bold;"&gt;Liabilities:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left;"&gt;Convertible notes due to related parties held at fair value&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_149630768;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_560326791;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;4,160&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;4,160&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left;"&gt;Convertible loans payable at fair value&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1380963926;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1111838196;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;7,877&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;7,877&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left;"&gt;Warrant liabilities - Private Placement Warrants&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_647000154;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_377660832;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;277&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;277&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Warrant liabilities - Representative&#x2019;s Warrants&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1938583770;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1379488162;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;21&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;21&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt;"&gt;Total liabilities measured at fair value&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_614302253;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1710058319;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;12,335&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;12,335&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;i&gt;Warrant Liabilities&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; 

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The key inputs into the Monte Carlo simulation
model for the Private Placement and the Representative&#x2019;s warrant liabilities, as affected by the Reverse Stock Splits, were as follows
at June&#160;30, 2026 and December&#160;31, 2025:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;June 30,&lt;br/&gt; 2026&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;December&#160;31,&lt;br/&gt; 2025&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td style="font-weight: bold;"&gt;Input&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="width: 76%; text-align: left;"&gt;Risk-free interest rate&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;4.17&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;%&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;3.79&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left;"&gt;Expected term (years)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;4.03&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;4.53&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left;"&gt;Expected volatility&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;69.40&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;139.20&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td&gt;Exercise price&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;86,250.00&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;86,250.00&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td&gt;Fair value of Common stock&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;11.65&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;786.00&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; Each Private Placement and the Representative&#x2019;s
warrant entitles the registered holder to purchase 1/7,500 of one
share of our common stock at a price of $86,250.00
per whole share, as affected by the Reverse Stock Splits. Pursuant to the warrant agreement, a warrant holder may exercise its warrants
only for a whole number of shares of common stock. This means only a number of warrants that in the aggregate equal a whole number of
shares may be exercised at a given time by a warrant holder. No fractional warrants will be issued and only whole warrants will trade.
&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt; 

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The following table provides a summary of the
changes in the fair value of the Company&#x2019;s Level 3 warrant liabilities that are measured at fair value on a recurring basis for
the three and six months ended June 30, 2026 (in thousands):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Private Placement Warrants&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Representative&#x2019;s Warrants&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid;"&gt;Ascent Warrants&lt;sup&gt;(1)&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Total &lt;br/&gt; Level 3&lt;br/&gt; Warrant liabilities&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; width: 52%; font-weight: bold;"&gt;Fair value at January 1, 2026&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;277&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;&#160;&#160;&#160;&#160;&#160;21&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1963797799;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;298&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt;"&gt;Gain in fair value of warrant liabilities&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(240&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(18&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_763554049;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(258&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold;"&gt;Fair value at March 31, 2026&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;37&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;3&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_248509124;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;40&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: normal; font-style: normal;"&gt;Issuance of warrants&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1434415381;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_332852027;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;2,178&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;2,178&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left;"&gt;Gain in fair value of warrant liabilities&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(35&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(3&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(380&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(418&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt;"&gt;Reclassification of warrant liability to
        additional paid-in capital&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1366381371;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1600085982;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(1,798&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(1,798&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; padding-bottom: 2.5pt;"&gt;Fair value at June 30, 2026&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;2&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_511051940;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1781900980;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;2&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: top; text-align: justify;"&gt;
    &lt;td style="width: 0.25in; text-align: left;"&gt;(1)&lt;/td&gt;
    &lt;td style="text-align: justify;"&gt;
    See Note 8 for the key inputs used in the Black-Scholes option pricing model in calculating the fair
                    value of the Ascent Warrants during the three and six months ended June 30, 2026.&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; 

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;i&gt;Related party convertible notes payable&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Tasly Convertible Note was valued using
a Probability Weighted Expected Return Model to fair value the convertible note. The intrinsic conversion value as of June&#160;30, 2026
and December&#160;31, 2025 was $0
for the Tasly Convertible Note. As of June&#160;30, 2026 and December&#160;31, 2025, the Tasly Convertible Note has matured and is payable
at the principal amounts plus accrued interest. Therefore, the fair value of the note is the face amount of the debt, and as of June&#160;30,
2026 and December&#160;31, 2025, accrued interest was added to the liability balance. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;On March 20, 2026, the Convertible Promissory
Note - Related Party was amended which extended the maturity date through December 31, 2026 - See Note 5 for further information. As of
June&#160;30, 2026, the Convertible Promissory Note - Related Party was valued using a Monte Carlo simulation model due to the amendments
during the three months ended June&#160;30, 2026.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; As of December&#160;31, 2025, the Convertible
Promissory Note - Related Party had matured, remained outstanding and the intrinsic value was $0.
Because the remaining contractual term was &lt;span style="-sec-ix-hidden:fc_333186512;"&gt;zero&lt;/span&gt; and the conversion feature had no intrinsic
value, the fair value of the Convertible Promissory Note - Related Party as of December&#160;31, 2025 was determined based on its outstanding
principal amount and accrued interest. Accordingly, option-pricing assumptions, including expected volatility and the risk-free interest
rate, were not applicable as of December&#160;31, 2025. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; 

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The key inputs into the Monte Carlo simulation
model for the Convertible Promissory Note - Related Party were as follows at June&#160;30, 2026, as affected by the July and August Reverse
Stock Splits:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td style="font-weight: bold;"&gt;Input&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="width: 88%; text-align: left;"&gt;Debt rate&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;13.90&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left;"&gt;Remaining term (years)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;0.5&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left;"&gt;Expected volatility&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;233.00&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td&gt;Fair value of Common stock&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;11.65&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; 

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Collectively, the Tasly Convertible Note and
the Convertible Promissory Note - Related Party are referred to as &#x201c;Related Party Convertible Notes Payable&#x201d;. The following
table provides a summary of the changes in the fair value of the Company&#x2019;s Level 3 Related Party Convertible Notes Payable for the
three and six months ended June 30, 2026 and 2025 (in thousands):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Tasly Convertible Note - Related Party&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Convertible Promissory Note - Related Party&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Total &lt;br/&gt; Level 3&lt;br/&gt; Related&#160;Party&lt;br/&gt;
        Convertible&lt;br/&gt; Notes&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="width: 64%; font-weight: bold; padding-bottom: 1.5pt;"&gt;Fair value as of January 1, 2026&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right;"&gt;2,290&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right;"&gt;1,870&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right;"&gt;4,160&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Loss on change in the fair value of related party convertible debt&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;242&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1394063579;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;242&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;Fair value as of March 31, 2026&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;2,532&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;1,870&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;4,402&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Loss on change in the fair value of related party convertible debt&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;97&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;244&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;341&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;Fair value as of June 30, 2026&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;2,629&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;2,114&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;4,743&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Tasly Convertible Note - Related Party&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="width: 88%; font-weight: bold;"&gt;Fair value as of January 1, 2025&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;2,234&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Loss on change in the fair value of related party convertible notes&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;156&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;Fair value as of March 31, 2025&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;2,390&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Loss on change in the fair value of related party convertible notes&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;153&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;Fair value as of June 30, 2025&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;2,543&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; 

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;i&gt;Convertible Loans Payable &lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company uses a Monte Carlo simulation model
to value the convertible loans payable, which represents the issued Ascent PIPE Notes. The convertible loans payable were classified within
Level 3 of the fair value hierarchy due to the use of unobservable inputs. Inherent in pricing models are assumptions related to expected
share-price volatility, expected life and risk-free interest rate. The Company estimates the volatility of its common stock based on historical
volatility that matches the expected remaining life of the convertible loans payable. The risk-free interest rate is based on the U.S.
Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the loans. The expected life
of the loans are assumed to be equivalent to their remaining contractual term.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; 

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The key inputs into the Monte Carlo simulation
model for the convertible loans payable were as follows at June&#160;30, 2026 and December&#160;31, 2025, as affected by the Reverse Stock
Splits:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;June 30,&lt;br/&gt; 2026&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;December&#160;31,&lt;br/&gt; 2025&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td style="font-weight: bold;"&gt;Input&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="width: 76%; text-align: left;"&gt;Risk-free interest rate&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;4.01&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;%&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;3.48&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left;"&gt;Expected term (years)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;0.16&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;1.03&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left;"&gt;Expected volatility&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;64.52&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;68.30&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td&gt;Fair value of Common stock&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;11.65&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;786.00&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; 

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The following table provides a summary of the
changes in the fair value of the Company&#x2019;s Level 3 convertible loans payable for the three and six months ended June 30, 2026 (in
thousands):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Convertible&#160;Loans &lt;br/&gt; Payable&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="width: 88%; font-weight: bold;"&gt;Fair value as of January 1, 2026&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;7,877&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td&gt;Repayments of debt&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(195&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left;"&gt;Conversion of debt to equity&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(1,260&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Loss on change in the fair value of convertible loans payable&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;555&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;Fair value as of March 31, 2026&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;6,977&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left;"&gt;Proceeds received&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;1,500&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td&gt;Repayments of debt&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(765&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left;"&gt;Loss on change in the fair value of convertible loans payable&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;3,910&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Conversion of debt to equity&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(3,460&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;Fair value as of June 30, 2026&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;8,162&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The fair value of the Company&#x2019;s convertible
loans payable settled through conversion was determined by multiplying the closing price of the Company&#x2019;s common stock on the applicable
conversion date by the number of shares of common stock issued upon settlement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; 

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Loss on change in the fair value of convertible
notes on the condensed consolidated statements of operations comprise of the change in fair value of the related party convertible notes
payable and convertible loans payable and its related accrued interest on the convertible notes. As of June&#160;30, 2026, the convertible
loans payable is due within 12 months of the balance sheet date and is therefore recorded as a current liability within convertible senior
notes and loans payable at fair value on the condensed consolidated balance sheets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;i&gt;Digital Asset&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; On March 11, 2026, the Company&#x2019;s management
made the determination to terminate the Company&#x2019;s Bitcoin treasury reserve strategy in light of current market conditions and the
Company&#x2019;s evaluation of its capital allocation priorities. During the six months ended June 30, 2026, the Company sold 16.51
Bitcoins for an aggregate amount of $1.2
million, resulting in realized losses of $0.3
million included in the condensed consolidated statements of operations. As of June&#160;30, 2026 and December&#160;31, 2025, digital
assets were $0
and $1.4
million, respectively. &lt;/p&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="cref_853412475" id="ixv-4001">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;As of June&#160;30, 2026 and December&#160;31,
2025, the Company&#x2019;s financial assets and liabilities measured at fair value on a recurring basis, were as follows (in thousands):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;As of June 30, 2026&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Level 1&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Level 2&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Level 3&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td style="font-weight: bold;"&gt;Liabilities:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="width: 52%; text-align: left;"&gt;Convertible notes due to related parties held at fair value&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1014181908;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1499031780;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;4,743&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;4,743&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left;"&gt;Convertible loans payable at fair value&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1194482741;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_896289894;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;8,162&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;8,162&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left;"&gt;Warrant liabilities - Private Placement Warrants&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_161393837;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_946089074;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;2&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;2&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Warrant liabilities - Representative&#x2019;s Warrants&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1853496641;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_912067788;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_2092241241;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_229538959;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt;"&gt;Total liabilities measured at fair value&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1290442340;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1150907625;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;12,907&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;12,907&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in;"&gt;&lt;/p&gt;

  

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;As of December 31, 2025&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Level 1&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Level 2&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Level 3&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td style="font-weight: bold;"&gt;Assets:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="width: 52%; text-align: left;"&gt;Digital assets (Bitcoin)&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;1,445&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_41616020;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_2061553027;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;1,445&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="font-weight: bold;"&gt;Liabilities:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left;"&gt;Convertible notes due to related parties held at fair value&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_149630768;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_560326791;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;4,160&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;4,160&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left;"&gt;Convertible loans payable at fair value&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1380963926;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1111838196;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;7,877&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;7,877&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left;"&gt;Warrant liabilities - Private Placement Warrants&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_647000154;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_377660832;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;277&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;277&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Warrant liabilities - Representative&#x2019;s Warrants&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1938583770;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1379488162;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;21&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;21&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt;"&gt;Total liabilities measured at fair value&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_614302253;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1710058319;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;12,335&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;12,335&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="cref_962984040"
      decimals="-3"
      id="ixv-13433"
      unitRef="uref_1340915823">4743000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="cref_988890546"
      decimals="-3"
      id="ixv-13434"
      unitRef="uref_1340915823">4743000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="cref_962984040"
      decimals="-3"
      id="ixv-13435"
      unitRef="uref_1340915823">8162000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="cref_988890546"
      decimals="-3"
      id="ixv-13436"
      unitRef="uref_1340915823">8162000</us-gaap:ConvertibleDebtNoncurrent>
    <pfsa:WarrantLiabilities
      contextRef="cref_1846470091"
      decimals="-3"
      id="ixv-13437"
      unitRef="uref_1340915823">2000</pfsa:WarrantLiabilities>
    <pfsa:WarrantLiabilities
      contextRef="cref_554893378"
      decimals="-3"
      id="fc_637441695"
      unitRef="uref_1340915823">2000</pfsa:WarrantLiabilities>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="cref_962984040"
      decimals="-3"
      id="ixv-13439"
      unitRef="uref_1340915823">12907000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="cref_988890546"
      decimals="-3"
      id="ixv-13440"
      unitRef="uref_1340915823">12907000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:CryptoAssetFairValueCurrent
      contextRef="cref_339012237"
      decimals="-3"
      id="ixv-13441"
      unitRef="uref_1340915823">1445000</us-gaap:CryptoAssetFairValueCurrent>
    <us-gaap:CryptoAssetFairValueCurrent
      contextRef="cref_592262246"
      decimals="-3"
      id="ixv-13442"
      unitRef="uref_1340915823">1445000</us-gaap:CryptoAssetFairValueCurrent>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="cref_2104304165"
      decimals="-3"
      id="ixv-13443"
      unitRef="uref_1340915823">4160000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="cref_592262246"
      decimals="-3"
      id="ixv-13444"
      unitRef="uref_1340915823">4160000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="cref_2104304165"
      decimals="-3"
      id="ixv-13445"
      unitRef="uref_1340915823">7877000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="cref_592262246"
      decimals="-3"
      id="ixv-13446"
      unitRef="uref_1340915823">7877000</us-gaap:ConvertibleDebtNoncurrent>
    <pfsa:WarrantLiabilities
      contextRef="cref_1649060390"
      decimals="-3"
      id="ixv-13447"
      unitRef="uref_1340915823">277000</pfsa:WarrantLiabilities>
    <pfsa:WarrantLiabilities
      contextRef="cref_1500117593"
      decimals="-3"
      id="fc_1236870389"
      unitRef="uref_1340915823">277000</pfsa:WarrantLiabilities>
    <pfsa:WarrantLiabilities
      contextRef="cref_1641325391"
      decimals="-3"
      id="ixv-13449"
      unitRef="uref_1340915823">21000</pfsa:WarrantLiabilities>
    <pfsa:WarrantLiabilities
      contextRef="cref_63415997"
      decimals="-3"
      id="fc_2060361707"
      unitRef="uref_1340915823">21000</pfsa:WarrantLiabilities>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="cref_2104304165"
      decimals="-3"
      id="ixv-13451"
      unitRef="uref_1340915823">12335000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="cref_592262246"
      decimals="-3"
      id="ixv-13452"
      unitRef="uref_1340915823">12335000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock contextRef="cref_853412475" id="ixv-4327">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The key inputs into the Monte Carlo simulation
model for the Private Placement and the Representative&#x2019;s warrant liabilities, as affected by the Reverse Stock Splits, were as follows
at June&#160;30, 2026 and December&#160;31, 2025:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;June 30,&lt;br/&gt; 2026&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;December&#160;31,&lt;br/&gt; 2025&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td style="font-weight: bold;"&gt;Input&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="width: 76%; text-align: left;"&gt;Risk-free interest rate&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;4.17&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;%&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;3.79&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left;"&gt;Expected term (years)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;4.03&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;4.53&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left;"&gt;Expected volatility&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;69.40&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;139.20&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td&gt;Exercise price&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;86,250.00&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;86,250.00&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td&gt;Fair value of Common stock&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;11.65&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;786.00&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The key inputs into the Monte Carlo simulation
model for the convertible loans payable were as follows at June&#160;30, 2026 and December&#160;31, 2025, as affected by the Reverse Stock
Splits:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;June 30,&lt;br/&gt; 2026&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;December&#160;31,&lt;br/&gt; 2025&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td style="font-weight: bold;"&gt;Input&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="width: 76%; text-align: left;"&gt;Risk-free interest rate&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;4.01&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;%&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;3.48&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left;"&gt;Expected term (years)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;0.16&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;1.03&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left;"&gt;Expected volatility&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;64.52&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;68.30&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td&gt;Fair value of Common stock&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;11.65&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;786.00&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="cref_39081096"
      decimals="2"
      id="ixv-13453"
      unitRef="uref_527123470">4.17</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="cref_1814801564"
      decimals="2"
      id="ixv-13454"
      unitRef="uref_527123470">3.79</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="cref_1840681411"
      decimals="2"
      id="ixv-13455"
      unitRef="uref_527123470">4.03</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="cref_644213327"
      decimals="2"
      id="ixv-13456"
      unitRef="uref_527123470">4.53</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="cref_1953658540"
      decimals="2"
      id="ixv-13457"
      unitRef="uref_527123470">69.4</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="cref_373797147"
      decimals="2"
      id="ixv-13458"
      unitRef="uref_527123470">139.2</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="cref_1918530263"
      decimals="2"
      id="ixv-13459"
      unitRef="uref_527123470">86250</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="cref_260734898"
      decimals="2"
      id="ixv-13460"
      unitRef="uref_527123470">86250</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="cref_1263350621"
      decimals="2"
      id="ixv-13461"
      unitRef="uref_527123470">11.65</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="cref_2137903473"
      decimals="2"
      id="ixv-13462"
      unitRef="uref_527123470">786</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <pfsa:NumberOfShares
      contextRef="cref_853412475"
      decimals="0"
      id="ixv-13463"
      unitRef="uref_2062431040">1</pfsa:NumberOfShares>
    <us-gaap:SharePrice
      contextRef="cref_603114473"
      decimals="2"
      id="ixv-13464"
      unitRef="uref_138178116">86250</us-gaap:SharePrice>
    <us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock contextRef="cref_853412475" id="ixv-4404">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The following table provides a summary of the
changes in the fair value of the Company&#x2019;s Level 3 warrant liabilities that are measured at fair value on a recurring basis for
the three and six months ended June 30, 2026 (in thousands):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Private Placement Warrants&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Representative&#x2019;s Warrants&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid;"&gt;Ascent Warrants&lt;sup&gt;(1)&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Total &lt;br/&gt; Level 3&lt;br/&gt; Warrant liabilities&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; width: 52%; font-weight: bold;"&gt;Fair value at January 1, 2026&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;277&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;&#160;&#160;&#160;&#160;&#160;21&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1963797799;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;298&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt;"&gt;Gain in fair value of warrant liabilities&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(240&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(18&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_763554049;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(258&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold;"&gt;Fair value at March 31, 2026&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;37&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;3&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_248509124;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;40&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: normal; font-style: normal;"&gt;Issuance of warrants&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1434415381;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_332852027;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;2,178&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;2,178&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left;"&gt;Gain in fair value of warrant liabilities&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(35&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(3&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(380&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(418&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt;"&gt;Reclassification of warrant liability to
        additional paid-in capital&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1366381371;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1600085982;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(1,798&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(1,798&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; padding-bottom: 2.5pt;"&gt;Fair value at June 30, 2026&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;2&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_511051940;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1781900980;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;2&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="cref_1983616198"
      decimals="-3"
      id="ixv-13465"
      unitRef="uref_1340915823">277000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="cref_144596688"
      decimals="-3"
      id="ixv-13466"
      unitRef="uref_1340915823">21000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="cref_1499422870"
      decimals="-3"
      id="ixv-13467"
      unitRef="uref_1340915823">298000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="cref_439831922"
      decimals="-3"
      id="ixv-13468"
      unitRef="uref_1340915823">-240000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="cref_2119320024"
      decimals="-3"
      id="ixv-13469"
      unitRef="uref_1340915823">-18000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="cref_385375310"
      decimals="-3"
      id="ixv-13470"
      unitRef="uref_1340915823">-258000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="cref_1265355780"
      decimals="-3"
      id="ixv-13471"
      unitRef="uref_1340915823">37000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="cref_1131121924"
      decimals="-3"
      id="ixv-13472"
      unitRef="uref_1340915823">3000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="cref_2034627019"
      decimals="-3"
      id="ixv-13473"
      unitRef="uref_1340915823">40000</us-gaap:WarrantsAndRightsOutstanding>
    <pfsa:WarrantIssued
      contextRef="cref_1559462887"
      decimals="-3"
      id="fc_931644489"
      unitRef="uref_1340915823">2178000</pfsa:WarrantIssued>
    <pfsa:WarrantIssued
      contextRef="cref_679743220"
      decimals="-3"
      id="ixv-13475"
      unitRef="uref_1340915823">2178000</pfsa:WarrantIssued>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="cref_1216300098"
      decimals="-3"
      id="ixv-13476"
      unitRef="uref_1340915823">-35000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="cref_880231378"
      decimals="-3"
      id="ixv-13477"
      unitRef="uref_1340915823">-3000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="cref_1559462887"
      decimals="-3"
      id="fc_2046609879"
      unitRef="uref_1340915823">-380000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="cref_679743220"
      decimals="-3"
      id="ixv-13479"
      unitRef="uref_1340915823">-418000</us-gaap:FairValueAdjustmentOfWarrants>
    <pfsa:ReclassificationOfWarrantLiabilityToAdditionalPaidinCapital
      contextRef="cref_1559462887"
      decimals="-3"
      id="fc_1559462887"
      unitRef="uref_1340915823">-1798000</pfsa:ReclassificationOfWarrantLiabilityToAdditionalPaidinCapital>
    <pfsa:ReclassificationOfWarrantLiabilityToAdditionalPaidinCapital
      contextRef="cref_679743220"
      decimals="-3"
      id="ixv-13481"
      unitRef="uref_1340915823">-1798000</pfsa:ReclassificationOfWarrantLiabilityToAdditionalPaidinCapital>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="cref_1353231876"
      decimals="-3"
      id="ixv-13482"
      unitRef="uref_1340915823">2000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="cref_1440330822"
      decimals="-3"
      id="ixv-13483"
      unitRef="uref_1340915823">2000</us-gaap:WarrantsAndRightsOutstanding>
    <pfsa:ConversionValues
      contextRef="cref_988890546"
      decimals="-3"
      id="fc_278745277"
      unitRef="uref_1340915823">0</pfsa:ConversionValues>
    <pfsa:ConversionValues
      contextRef="cref_592262246"
      decimals="-3"
      id="fc_674135469"
      unitRef="uref_1340915823">0</pfsa:ConversionValues>
    <pfsa:ScheduleOfKeyInputsIntoTheMonteCarloSimulationModelForTheConvertiblePromissoryNoteTableTextBlock contextRef="cref_853412475" id="ixv-4586">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The key inputs into the Monte Carlo simulation
model for the Convertible Promissory Note - Related Party were as follows at June&#160;30, 2026, as affected by the July and August Reverse
Stock Splits:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td style="font-weight: bold;"&gt;Input&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="width: 88%; text-align: left;"&gt;Debt rate&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;13.90&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left;"&gt;Remaining term (years)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;0.5&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left;"&gt;Expected volatility&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;233.00&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td&gt;Fair value of Common stock&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;11.65&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;</pfsa:ScheduleOfKeyInputsIntoTheMonteCarloSimulationModelForTheConvertiblePromissoryNoteTableTextBlock>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="cref_1444226790"
      decimals="2"
      id="ixv-13487"
      unitRef="uref_527123470">13.9</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="cref_1848064682"
      decimals="1"
      id="ixv-13488"
      unitRef="uref_527123470">0.5</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="cref_474503820"
      decimals="2"
      id="ixv-13489"
      unitRef="uref_527123470">233</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="cref_2039798321"
      decimals="2"
      id="ixv-13490"
      unitRef="uref_527123470">11.65</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="cref_853412475" id="ixv-4621">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Collectively, the Tasly Convertible Note and
the Convertible Promissory Note - Related Party are referred to as &#x201c;Related Party Convertible Notes Payable&#x201d;. The following
table provides a summary of the changes in the fair value of the Company&#x2019;s Level 3 Related Party Convertible Notes Payable for the
three and six months ended June 30, 2026 and 2025 (in thousands):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Tasly Convertible Note - Related Party&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Convertible Promissory Note - Related Party&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Total &lt;br/&gt; Level 3&lt;br/&gt; Related&#160;Party&lt;br/&gt;
        Convertible&lt;br/&gt; Notes&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="width: 64%; font-weight: bold; padding-bottom: 1.5pt;"&gt;Fair value as of January 1, 2026&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right;"&gt;2,290&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right;"&gt;1,870&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right;"&gt;4,160&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Loss on change in the fair value of related party convertible debt&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;242&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1394063579;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;242&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;Fair value as of March 31, 2026&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;2,532&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;1,870&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;4,402&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Loss on change in the fair value of related party convertible debt&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;97&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;244&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;341&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;Fair value as of June 30, 2026&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;2,629&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;2,114&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;4,743&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Tasly Convertible Note - Related Party&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="width: 88%; font-weight: bold;"&gt;Fair value as of January 1, 2025&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;2,234&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Loss on change in the fair value of related party convertible notes&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;156&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;Fair value as of March 31, 2025&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;2,390&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Loss on change in the fair value of related party convertible notes&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;153&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;Fair value as of June 30, 2025&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;2,543&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="cref_867040326"
      decimals="-3"
      id="ixv-13491"
      unitRef="uref_1340915823">2290000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="cref_1865825429"
      decimals="-3"
      id="ixv-13492"
      unitRef="uref_1340915823">1870000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="cref_1162265563"
      decimals="-3"
      id="ixv-13493"
      unitRef="uref_1340915823">4160000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="cref_2082906046"
      decimals="-3"
      id="ixv-13494"
      unitRef="uref_1340915823">242000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="cref_1220106736"
      decimals="-3"
      id="ixv-13495"
      unitRef="uref_1340915823">242000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="cref_2082299376"
      decimals="-3"
      id="ixv-13496"
      unitRef="uref_1340915823">2532000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="cref_1576903624"
      decimals="-3"
      id="ixv-13497"
      unitRef="uref_1340915823">1870000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="cref_1138967112"
      decimals="-3"
      id="ixv-13498"
      unitRef="uref_1340915823">4402000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="cref_1494627373"
      decimals="-3"
      id="ixv-13499"
      unitRef="uref_1340915823">97000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="cref_2054901614"
      decimals="-3"
      id="ixv-13500"
      unitRef="uref_1340915823">244000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="cref_1643901266"
      decimals="-3"
      id="ixv-13501"
      unitRef="uref_1340915823">341000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="cref_213427050"
      decimals="-3"
      id="ixv-13502"
      unitRef="uref_1340915823">2629000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="cref_370576236"
      decimals="-3"
      id="ixv-13503"
      unitRef="uref_1340915823">2114000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="cref_113009238"
      decimals="-3"
      id="ixv-13504"
      unitRef="uref_1340915823">4743000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="cref_1199347720"
      decimals="-3"
      id="ixv-13505"
      unitRef="uref_1340915823">2234000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="cref_1907849123"
      decimals="-3"
      id="ixv-13506"
      unitRef="uref_1340915823">156000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="cref_1287881122"
      decimals="-3"
      id="ixv-13507"
      unitRef="uref_1340915823">2390000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="cref_284285301"
      decimals="-3"
      id="ixv-13508"
      unitRef="uref_1340915823">153000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="cref_1934275296"
      decimals="-3"
      id="ixv-13509"
      unitRef="uref_1340915823">2543000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="cref_1875503243"
      decimals="2"
      id="ixv-13510"
      unitRef="uref_527123470">4.01</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="cref_1960713392"
      decimals="2"
      id="ixv-13511"
      unitRef="uref_527123470">3.48</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="cref_1249148369"
      decimals="2"
      id="ixv-13512"
      unitRef="uref_527123470">0.16</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="cref_279329609"
      decimals="2"
      id="ixv-13513"
      unitRef="uref_527123470">1.03</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="cref_1264764146"
      decimals="2"
      id="ixv-13514"
      unitRef="uref_527123470">64.52</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="cref_1221446360"
      decimals="2"
      id="ixv-13515"
      unitRef="uref_527123470">68.3</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="cref_894978972"
      decimals="2"
      id="ixv-13516"
      unitRef="uref_527123470">11.65</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="cref_1122969955"
      decimals="2"
      id="ixv-13517"
      unitRef="uref_527123470">786</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock contextRef="cref_853412475" id="ixv-4828">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The following table provides a summary of the
changes in the fair value of the Company&#x2019;s Level 3 convertible loans payable for the three and six months ended June 30, 2026 (in
thousands):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Convertible&#160;Loans &lt;br/&gt; Payable&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="width: 88%; font-weight: bold;"&gt;Fair value as of January 1, 2026&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;7,877&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td&gt;Repayments of debt&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(195&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left;"&gt;Conversion of debt to equity&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(1,260&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Loss on change in the fair value of convertible loans payable&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;555&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;Fair value as of March 31, 2026&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;6,977&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left;"&gt;Proceeds received&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;1,500&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td&gt;Repayments of debt&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(765&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left;"&gt;Loss on change in the fair value of convertible loans payable&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;3,910&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Conversion of debt to equity&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(3,460&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;Fair value as of June 30, 2026&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;8,162&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock>
    <pfsa:LoansPayableRelatedPartyAtFairValue
      contextRef="cref_1806077489"
      decimals="-3"
      id="ixv-13518"
      unitRef="uref_1340915823">7877000</pfsa:LoansPayableRelatedPartyAtFairValue>
    <us-gaap:RepaymentsOfDebt
      contextRef="cref_1312882388"
      decimals="-3"
      id="ixv-13519"
      unitRef="uref_1340915823">195000</us-gaap:RepaymentsOfDebt>
    <pfsa:StockIssuedDuringPeriodValueIssuanceOfSharesInConnectionWithTheConversionOfThePIPENote
      contextRef="cref_1312882388"
      decimals="-3"
      id="ixv-13520"
      unitRef="uref_1340915823">1260000</pfsa:StockIssuedDuringPeriodValueIssuanceOfSharesInConnectionWithTheConversionOfThePIPENote>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="cref_1312882388"
      decimals="-3"
      id="ixv-13521"
      unitRef="uref_1340915823">555000</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <pfsa:LoansPayableRelatedPartyAtFairValue
      contextRef="cref_181399372"
      decimals="-3"
      id="ixv-13522"
      unitRef="uref_1340915823">6977000</pfsa:LoansPayableRelatedPartyAtFairValue>
    <pfsa:ProceedsReceived
      contextRef="cref_652785231"
      decimals="-3"
      id="ixv-13523"
      unitRef="uref_1340915823">1500000</pfsa:ProceedsReceived>
    <us-gaap:RepaymentsOfDebt
      contextRef="cref_652785231"
      decimals="-3"
      id="ixv-13524"
      unitRef="uref_1340915823">765000</us-gaap:RepaymentsOfDebt>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="cref_652785231"
      decimals="-3"
      id="ixv-13525"
      unitRef="uref_1340915823">3910000</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <pfsa:StockIssuedDuringPeriodValueIssuanceOfSharesInConnectionWithTheConversionOfThePIPENote
      contextRef="cref_652785231"
      decimals="-3"
      id="ixv-13526"
      unitRef="uref_1340915823">3460000</pfsa:StockIssuedDuringPeriodValueIssuanceOfSharesInConnectionWithTheConversionOfThePIPENote>
    <pfsa:LoansPayableRelatedPartyAtFairValue
      contextRef="cref_1770842783"
      decimals="-3"
      id="ixv-13527"
      unitRef="uref_1340915823">8162000</pfsa:LoansPayableRelatedPartyAtFairValue>
    <pfsa:SoldBitcoins
      contextRef="cref_853412475"
      decimals="2"
      id="ixv-13528"
      unitRef="uref_527123470">16.51</pfsa:SoldBitcoins>
    <us-gaap:CryptoAssetCost
      contextRef="cref_988890546"
      decimals="-5"
      id="ixv-13529"
      unitRef="uref_1340915823">1200000</us-gaap:CryptoAssetCost>
    <us-gaap:CryptoAssetFairValue
      contextRef="cref_988890546"
      decimals="-5"
      id="ixv-13530"
      unitRef="uref_1340915823">300000</us-gaap:CryptoAssetFairValue>
    <us-gaap:CryptoAssetMining
      contextRef="cref_853412475"
      decimals="0"
      id="ixv-13531"
      unitRef="uref_1340915823">0</us-gaap:CryptoAssetMining>
    <us-gaap:CryptoAssetMining
      contextRef="cref_477349365"
      decimals="-5"
      id="ixv-13532"
      unitRef="uref_1340915823">1400000</us-gaap:CryptoAssetMining>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock contextRef="cref_853412475" id="ixv-4918">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;4 &#x2014;&#160;Balance
Sheet Components&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Prepaid expenses
and other current assets (in thousands):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;June 30,&lt;br/&gt; 2026&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;
        &lt;p style="margin-top: 0; margin-bottom: 0;"&gt;December&#160;31,&lt;br/&gt; 2025&lt;/p&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="width: 76%; text-align: left;"&gt;Prepaid insurance&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;9&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;441&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Prepaid expenses&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;113&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;100&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="padding-left: 0.125in; text-align: justify; padding-bottom: 2.5pt;"&gt;Total prepaid expenses and other current assets&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;122&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;541&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;Accrued Liabilities (in thousands):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;June 30,&lt;br/&gt; 2026&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;December&#160;31,&lt;br/&gt; 2025&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="width: 76%; text-align: left;"&gt;Accrued compensation&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;(4,016&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;)&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;(4,066&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Accrued other liabilities&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(2,207&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(1,915&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt;"&gt;Total accrued liabilities&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;(6,223&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;(5,981&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock contextRef="cref_853412475" id="ixv-4923">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Prepaid expenses
and other current assets (in thousands):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;June 30,&lt;br/&gt; 2026&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;
        &lt;p style="margin-top: 0; margin-bottom: 0;"&gt;December&#160;31,&lt;br/&gt; 2025&lt;/p&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="width: 76%; text-align: left;"&gt;Prepaid insurance&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;9&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;441&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Prepaid expenses&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;113&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;100&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="padding-left: 0.125in; text-align: justify; padding-bottom: 2.5pt;"&gt;Total prepaid expenses and other current assets&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;122&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;541&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock>
    <us-gaap:PrepaidInsurance
      contextRef="cref_988890546"
      decimals="-3"
      id="ixv-13533"
      unitRef="uref_1340915823">9000</us-gaap:PrepaidInsurance>
    <us-gaap:PrepaidInsurance
      contextRef="cref_592262246"
      decimals="-3"
      id="ixv-13534"
      unitRef="uref_1340915823">441000</us-gaap:PrepaidInsurance>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="cref_988890546"
      decimals="-3"
      id="ixv-13535"
      unitRef="uref_1340915823">113000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="cref_592262246"
      decimals="-3"
      id="ixv-13536"
      unitRef="uref_1340915823">100000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="cref_988890546"
      decimals="-3"
      id="ixv-13537"
      unitRef="uref_1340915823">122000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="cref_592262246"
      decimals="-3"
      id="ixv-13538"
      unitRef="uref_1340915823">541000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="cref_853412475" id="ixv-4972">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;Accrued Liabilities (in thousands):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;June 30,&lt;br/&gt; 2026&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;December&#160;31,&lt;br/&gt; 2025&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="width: 76%; text-align: left;"&gt;Accrued compensation&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;(4,016&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;)&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;(4,066&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Accrued other liabilities&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(2,207&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(1,915&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt;"&gt;Total accrued liabilities&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;(6,223&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;(5,981&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedEmployeeBenefitsCurrent
      contextRef="cref_988890546"
      decimals="-3"
      id="ixv-13539"
      unitRef="uref_1340915823">4016000</us-gaap:AccruedEmployeeBenefitsCurrent>
    <us-gaap:AccruedEmployeeBenefitsCurrent
      contextRef="cref_592262246"
      decimals="-3"
      id="ixv-13540"
      unitRef="uref_1340915823">4066000</us-gaap:AccruedEmployeeBenefitsCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="cref_988890546"
      decimals="-3"
      id="ixv-13541"
      unitRef="uref_1340915823">2207000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="cref_592262246"
      decimals="-3"
      id="ixv-13542"
      unitRef="uref_1340915823">1915000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="cref_988890546"
      decimals="-3"
      id="ixv-13543"
      unitRef="uref_1340915823">6223000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="cref_592262246"
      decimals="-3"
      id="ixv-13544"
      unitRef="uref_1340915823">5981000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:DebtDisclosureTextBlock contextRef="cref_853412475" id="ixv-5028">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;5
&#x2014;&#160;Debt&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; 

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The following tables sets forth a summary of
the debt instruments and their changes during the&#160;three and six months ended June 30, 2026 and 2025 (in thousands):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Convertible &lt;br/&gt; Loans Payable&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Tasly Convertible&lt;br/&gt; Note&#160;-&#160;Related&lt;br/&gt;
        Party&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Convertible Promissory&lt;br/&gt; Note&#160;-&#160;Related&lt;br/&gt;
        Party&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Convertible &lt;br/&gt; Senior&lt;br/&gt; Notes&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Promissory Notes&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;PPP Loan&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;D&amp;amp;O Insurance Financing&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="width: 26%; font-weight: bold; text-indent: -0.125in; padding-left: 0.125in;"&gt;Balance at January 1, 2026&lt;/td&gt;
    &lt;td style="width: 0.5%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;7,877&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;2,290&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;1,870&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;42&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;1,049&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;1,390&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;297&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in;"&gt;Debt repayments&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(195&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_741686741;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1123562661;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_411448295;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(24&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1422744864;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(222&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in;"&gt;Change in fair value&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;555&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;242&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_815338591;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1120041276;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_355055345;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_740072080;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_817662186;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in;"&gt;Conversion of debt to equity&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(1,260&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_625290624;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1732463026;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1095239976;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1703443675;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1777932412;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1370697288;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in;"&gt;Debt forgiven&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1591706187;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1575221502;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_2049795016;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_26389377;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1196344204;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(1,392&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in;"&gt;Accrued stated interest&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_548664657;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_162603099;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1342787577;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;1&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;15&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;2&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1947972587;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.125in;"&gt;Balance at March 31,
        2026; Current debt&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;6,977&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;2,532&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;1,870&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;43&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;1,040&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_331585081;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;75&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in;"&gt;Issuance of debt&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;1,500&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1433235312;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1297511385;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1765185523;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1291574257;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1432709797;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_374712761;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in;"&gt;Debt repayments&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(765&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1231569308;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_590782202;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1425216027;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1431677020;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1314215860;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(75&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in;"&gt;Change in fair value&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;3,910&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;97&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;244&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_635689269;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1187634311;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_268324749;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_554662285;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in;"&gt;Conversion of debt to equity&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(3,460&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_154967678;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1320907053;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1912374246;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1429651243;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1487040249;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1152359340;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in;"&gt;Debt forgiven&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_633164231;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1652242228;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_89252809;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_675468233;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1322252669;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_104208705;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_516545939;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in;"&gt;Accrued stated interest&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1158532364;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1740708361;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_205627344;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;2&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;14&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_960828265;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1065622223;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.125in;"&gt;Balance at June 30,
        2026; Current debt&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;8,162&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;2,629&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;2,114&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;45&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;1,054&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_2084895650;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1608739325;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="vertical-align: top; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="vertical-align: top; text-align: left;"&gt;Accounting basis&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&lt;span style="font-size: 10pt;"&gt;&#160;Fair
        value option &lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&lt;span style="font-size: 10pt;"&gt;&#160;Fair
        value option &lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&lt;span style="font-size: 10pt;"&gt;&#160;Fair
        value option &lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&lt;span style="font-size: 10pt;"&gt;&#160;Effective
        interest method &lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&lt;span style="font-size: 10pt;"&gt;&#160;Simple
        interest method &lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&lt;span style="font-size: 10pt;"&gt;&#160;Compounding
        Interest &lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&lt;span style="font-size: 10pt;"&gt;Simple
        interest method&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="vertical-align: top; text-align: left; text-indent: -0.125in; padding-left: 0.125in;"&gt;Interest rate&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;10%
        - 12%&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;24%&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&lt;span style="-sec-ix-hidden:fc_616849018;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&lt;span style="font-size: 10pt;"&gt;&#160;0%-12%
        &lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&lt;span style="font-size: 10pt;"&gt;&#160;0%-12%
        &lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;1%&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;7%&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top;"&gt;Conversion price(s) per share, as affected
        by the Reverse Stock Splits&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&lt;span style="font-size: 10pt;"&gt;various
        &lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;$14,400.00&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&lt;span style="font-size: 10pt;"&gt;&#160;7,500.00
        and $16,650.00&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&lt;span style="font-size: 10pt;"&gt;&#160;$3,750.00,
        $16,650.00, and $30,000.00&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&lt;span style="-sec-ix-hidden:fc_706740288;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&lt;span style="-sec-ix-hidden:fc_1759056592;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&lt;span style="-sec-ix-hidden:fc_986038095;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top;"&gt;Maturity&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&lt;span style="font-size: 10pt;"&gt;various&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&lt;span style="font-size: 10pt;"&gt;3/31/2024&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&lt;span style="font-size: 10pt;"&gt;12/31/2026&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&lt;span style="font-size: 10pt;"&gt;7/11/2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&lt;span style="font-size: 10pt;"&gt;various&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&lt;span style="-sec-ix-hidden:fc_823388662;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&lt;span style="font-size: 10pt;"&gt;4/11/2026&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; 

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Junior Convertible Notes&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Tasly Convertible Note - Related Party&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Convertible &lt;br/&gt; Senior&lt;br/&gt; Notes&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Promissory Notes&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;PPP Loan&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; width: 40%; font-weight: bold;"&gt;Balance at January 1, 2025&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;18,419&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;2,234&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;25,268&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;910&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;1,376&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in;"&gt;Issuance of debt&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_733099946;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1681646948;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;750&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_621654645;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1335500869;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left;"&gt;Change in fair value&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1445692272;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;156&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_498699758;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1502939321;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_657741355;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left;"&gt;Stated interest&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;545&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_914156588;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;572&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;15&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;3&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt;"&gt;Amortization of debt discount and issuance
        costs&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;1&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_703909118;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(1&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1045442393;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1605500249;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt;"&gt;Balance at March 31,
        2025; Current debt&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;18,965&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;2,390&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;26,589&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;925&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;1,379&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in;"&gt;Issuance of debt&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1920364349;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_974205172;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;700&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_438897670;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_2134421991;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left;"&gt;Change in fair value&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_978537416;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(38&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1875831696;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1371145217;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1330609207;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left;"&gt;Stated interest&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;553&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;191&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;604&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;15&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;4&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt;"&gt;Amortization of debt discount and issuance
        costs&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;15&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_280326152;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;2&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1920628771;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_751310220;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt;"&gt;Balance at June 30,
        2025; Current debt&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;19,533&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;2,543&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;27,895&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;940&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;1,383&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; 

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Convertible
Notes&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;i&gt;Convertible Loans Payable&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; As of June&#160;30, 2026, the Company had issued
an aggregate principal of $13.9
million of Ascent PIPE Notes, consisting of approximately $12.2
million of notes issued in July and September 2025 (&#x201c;2025 Ascent PIPE Notes&#x201d;) and $1.7
million of notes issued in April 2026. The 2025 Ascent PIPE Notes bear interest at 10%
per annum on the outstanding unconverted principal balance. A minimum interest amount equal to 10%
of the original principal is fully earned at issuance, reduced by interest subsequently accrued. Cash payments are subject to a 5%
fee. Upon an event of default, the interest rate increases to 24%
per annum and a 10%
late fee applies to overdue amounts. The 2025 Ascent PIPE Notes mature on January 11, 2027. The 2025 Ascent PIPE Notes are convertible
at the holder&#x2019;s option at a conversion price equal to the lower of the applicable conversion price or 95%
of the lowest daily volume-weighted average price (&#x201c;VWAP&#x201d;) of the Company&#x2019;s common stock during the 10
trading days immediately preceding the applicable conversion date, subject to the applicable floor price and customary anti-dilution protections.The
Ascent PIPE Notes may be prepaid upon 10
business days&#x2019; prior notice (absent an event of default), subject to Ascent&#x2019;s conversion rights, and requires mandatory prepayment
upon Subsequent Offerings, as defined by the PIPE Subscription Agreement. Conversion is subject to a beneficial ownership cap of 9.99%.
&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; On April 2, 2026, the Company entered into Amendment
No. 4 to the PIPE Subscription Agreement and related Pledge Agreement with Ascent (&#x201c;Amendment No. 4&#x201d;). Under Amendment No.
4, the Company may request funding with an aggregate principal amount of up to $12.2
million under the facility, subject to the terms and conditions of the amended agreements. The $12.2
million principal amount referenced in Amendment No. 4 represents the remaining available borrowing capacity under the existing Ascent
PIPE financing arrangement and is not in addition to the original aggregate facility. Amendment No. 4 also modified certain terms of the
related Pledge Agreement, including revising the release condition to provide that the applicable release condition will be satisfied
upon payment in full, whether in cash or through conversion, of an aggregate principal amount of $1.7
million of notes issued in the additional closings. In addition, the Company has agreed with Ascent that any mandatory prepayment amounts
received under the notes will first be applied to obligations related to such additional notes and thereafter to certain previously issued
secured convertible promissory notes. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; In connection with the additional closing on
April 2, 2026, the Company issued an Ascent PIPE Note with an aggregate principal amount of approximately $0.6
million. The note matures on April 2, 2027, bears interest at 12%
per annum and is convertible into shares of the Company&#x2019;s common stock, subject to the terms of the note. The note is convertible
at the holder&#x2019;s option at a conversion price equal to the lower of the applicable conversion price or 95%
of the lowest daily VWAP of the Company&#x2019;s common stock during the 10
trading days immediately preceding the applicable conversion date, subject to the terms of the note, including applicable floor price
and adjustment provisions. As consideration for Ascent&#x2019;s participation in the April 2, 2026 additional closing, Ascent earned a
warrant (&#x201c;Ascent Warrant&#x201d;) to purchase 11,111
shares of the Company&#x2019;s common stock at an exercise price of $50.00
per share, as adjusted for the July and August Reverse Stock Splits. The Ascent Warrant was exercisable on a cash or cashless basis for
a period of five years and was subject to a 9.99%
beneficial ownership limitation and customary anti-dilution adjustments. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; In connection with the additional closing on
April 20, 2026, the Company issued an Ascent PIPE Note with an aggregate principal amount of approximately $1.1
million. The note matures on April 20, 2027, bears interest at 12%
per annum and is convertible into shares of the Company&#x2019;s common stock, subject to the terms of the note. In connection with the
April 20, 2026 closing, the Company entered into a side letter agreement with Ascent pursuant to which Ascent waived certain defaults
under the Purchase Agreement and the Company issued a replacement Ascent Warrant that replaced the warrant earned on April 2, 2026. The
replacement warrant increased the number of shares issuable upon exercise from 11,111
shares to 33,333
shares, as adjusted for the July and August Reverse Stock Splits, retained an exercise price of $50.00
per share and is exercisable on a cash or cashless basis through April 20, 2031. The Company recognized $2.2
million of warrant expense in connection with the Ascent Warrant issuance during the three and six months ended June 30, 2026 presented
under financing costs on the condensed consolidated statements of operations. See Note 8 - Common Stock Warrants for inputs to estimate
the fair value of the warrant at issuance. The Company also agreed to provide Ascent with demand and piggyback registration rights with
respect to the underlying shares. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;In connection with the issuance of the replacement
warrant, Ascent entered into a lock-up agreement with the Company, dated April 20, 2026, pursuant to which Ascent agreed not to transfer
the shares underlying the replacement warrant for 120 days, expiring August 22, 2026, subject to customary exceptions. Any permitted transferee
is required to execute a lock-up agreement on substantially similar terms.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;On April 29, 2026, the Company and Ascent Partners
Fund LLC entered into an amendment for the Ascent Warrant, which eliminated the provisions relating to the automatic conversion or assumption
of the Ascent Warrant in connection with fundamental transactions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; During the three and six months ended June 30,
2026, the Company repaid $0.8
million and $1.0
million, respectively, of principal on the Ascent PIPE Notes. Ascent converted an aggregate of $0.8
million and $1.9
million of principal and accrued interest balance into 18,702
and 26,968
shares, respectively, of the Company&#x2019;s common stock during the three and six months ended June 30, 2026. The shares of common stock
issued had a total fair value of $4.7
million upon conversion. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; 

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Company elected to apply the fair value
option to account for the Ascent PIPE Notes and as such, no features of the Ascent PIPE Notes are bifurcated and separately accounted
for. As of June&#160;30, 2026, the convertible loans payable had a fair value of $8.2
million and it is classified under Convertible senior notes and loans payable at fair value on the condensed consolidated balance sheets,
as the loan is due within 12 months from the balance sheet date. As of December&#160;31, 2025, the convertible loans payable was fair
valued at $7.9
million and was classified as long-term in the condensed consolidated balance sheets under convertible loans payable at fair value. As
of June&#160;30, 2026 and December&#160;31, 2025, the Company had accrued interest of $0.5
million and $0.7
million on the convertible loans payable. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;i&gt;Tasly Convertible Note - Related Party&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; In June 2023, the Company entered into a short-term
loan agreement with a related party for borrowings of up to $1.6
million, the full amount of which had been drawn by February 2024. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The loans bear interest at a rate of 12%
per annum and originally matured on December
31, 2023. The original maturity date was extended to March&#160;31, 2024, subject to the parties&#x2019; decision to extend
thereafter. Upon an event of default, the interest rate increases to 24%
per annum until the payment date. The lender has the option to convert the entire outstanding balance and accrued but unpaid interest
under the Tasly Convertible Note into either (i) senior unsecured promissory notes on substantially the same terms as the outstanding
Convertible Senior Notes, or (ii) the Company&#x2019;s common stock at a conversion price of $14,400.00
per share, as adjusted for the Reverse Stock Splits. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Company elected to apply the fair value
option to account for the Tasly Convertible Note and as such, no features of the Tasly Convertible Note are bifurcated and separately
accounted for. The fair value of the Tasly Convertible Note was $2.6
million and $2.3
million, as of June&#160;30, 2026 and December&#160;31, 2025. There was accrued interest of $1.0
million and $0.7
million as of June&#160;30, 2026 and December&#160;31, 2025, respectively, on the Tasly Convertible Note. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Tasly Convertible Note is recorded under
convertible and promissory notes payable to related parties on the condensed consolidated balance sheets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;i&gt;Convertible Promissory Note &#x2013; Related
Party&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Company now holds the convertible working
capital promissory note which was previously held by Northview Acquisition Corporation with NorthView Sponsor I, LLC, the sponsor of NorthView
(the &#x201c;Sponsor&#x201d;) for up to $2.5
million. The related party convertible promissory note is non-interest bearing and became convertible on the Closing Date. The Sponsor
may elect to convert all or any portion of the unpaid principal balance of this Note into warrants, at a price of $7,500.00
per warrant. The note also allows for the conversion of the outstanding principal balance to be repaid in shares of the Company&#x2019;s
common stock at a price of $16,650.00
per share at the election of the Sponsor, as adjusted for the Reverse Stock Splits. On March 20, 2026, the related party convertible promissory
note was amended to extend the maturity date from January 11, 2026 to December 31, 2026. The Company elected to apply the fair value option
to account for the convertible promissory note and as such, no features of the convertible promissory note are bifurcated and separately
accounted for. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; On April 6, 2026, the Company amended the related
party convertible promissory note to update the conversion price to $76.00
per share, as adjusted for the Reverse Stock Splits, and concurrently approved the potential conversion of the entire outstanding principal
balance of $1.9
million. The agreement amendment was subsequently rescinded on April 7, 2026 and is voided. The contemplated conversion was not consummated,
&lt;span style="-sec-ix-hidden:fc_1909185797;"&gt;no&lt;/span&gt; conversion shares were issued and the entire outstanding principal balance remained
outstanding. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; 

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; On April 24, 2026, the Company entered into
a Note Modification and Conversion Agreement with NorthView Sponsor I LLC, amending that certain Promissory Note to establish an outstanding
non-interest-bearing principal balance of $1.9
million, retained the December 31, 2026 maturity date and provided the holder with the option to convert the outstanding principal into
shares of the Company&#x2019;s common stock. Subsequently, on April 29, 2026, the Company entered into Amendment No. 1 to the Note Modification
and Conversion Agreement, adding a covenant that restricts the issuance of conversion shares in excess of 19.99%
of the issued and outstanding common stock unless and until prior stockholder approval is obtained. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; On June 23, 2026, the Company&#x2019;s stockholders
approved Proposal 4 relating to the related party convertible promissory note, which permitted issuance in excess of 19.99%
of the Company&#x2019;s outstanding common stock upon conversion of the note which terminated the 19.99%
conversion shares restriction upon stockholder approval. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; As of June&#160;30, 2026 and December&#160;31,
2025, the convertible promissory note fair value of $2.1
million and $1.9
million, respectively, was classified under convertible and promissory notes payable to related parties on the condensed consolidated
balance sheets. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;i&gt;Junior Convertible Notes&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The annual effective interest rate for the junior
convertible notes was estimated between 12.54%
to 53.28%
for three and six months ended June 30, 2025. The interest expense for the three and six months ended June 30, 2025 was $0.6
million and $1.1
million, respectively. The junior convertible notes were converted into 373
shares of the Company&#x2019;s common stock based on $19.6
million of principal and accrued interest as of the Closing Date, as adjusted for the Reverse Stock Splits. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;i&gt;Convertible Senior Notes &lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; &lt;span style="background-color: white;"&gt;As of
&lt;/span&gt;June&#160;30, 2026&lt;span style="background-color: white;"&gt;, the outstanding balance of convertible senior notes is less than $0.1
million, all of which is with unrelated parties. The Company is currently in default; accordingly, the Company classified the entire outstanding
amount &lt;/span&gt;under convertible senior notes and loans payable at fair value &lt;span style="background-color: white;"&gt;on the &lt;/span&gt;condensed
&lt;span style="background-color: white;"&gt;consolidated balance shee&lt;/span&gt;ts. As of June&#160;30, 2025, $9.7
million of the $27.9
million of convertible senior notes is outstanding with related parties. The annual effective interest rate of convertible senior notes
was estimated at 12.15%
for the three and six months ended June 30, 2025. The annual effective interest rate on the convertible senior notes for the three and
six months ended June 30, 2026 was not meaningful due to the immaterial outstanding balance. The interest expense for the three and six
months ended June 30, 2026 was not material. Interest expense for the three and six months ended June 30, 2025 was $0.6
million and $1.2
million, respectively. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Promissory Notes&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The carrying value of the promissory notes as
of June&#160;30, 2026 and December&#160;31, 2025 was $1.1
million and $1.0
million, respectively, representing past due amounts because the maturity dates of the promissory notes has passed. As of June&#160;30,
2026 and December&#160;31, 2025, outstanding balance of promissory notes due to related parties was $0.4
million, and are classified under convertible and promissory notes payable to related parties and the remainder is classified under promissory
notes on the condensed consolidated balance sheets. Interest expense on the Company&#x2019;s promissory notes was less than $0.1&#160;million
for three and six months ended June 30, 2026 and 2025. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; 

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Paycheck Protection Program (&#x201c;PPP&#x201d;)&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Company applied for forgiveness of the 2nd
PPP Loan in December 2025 and was notified in February 2026 that the loan had been forgiven. The Company recognized a gain on the extinguishment
of the 2nd PPP Loan of $1.4
million within Gain on extinguishment of PPP loan in the condensed consolidated statements of operations during the six months ended June
30, 2026. Interest expense on the PPP loan for the six months ended June 30, 2026 was not material. Interest expense on the PPP loan for
the three and six months ended June 30, 2025 was not material. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Director
and Officer (D&amp;amp;O) Insurance Financing&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; During the six months ended June 30, 2026, the
Company made aggregate payments of $0.3
million against the obligation and recognized approximately $0.3
million of insurance expense and an immaterial amount of interest expense. As of June&#160;30, 2026 and December&#160;31, 2025, the remaining
financing obligation was $0
and $0.3
million, respectively, which is recorded under promissory notes and other on the Company&#x2019;s condensed consolidated balance sheets.
&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Minimum Future
Payments for the Company&#x2019;s Outstanding Borrowings&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; 

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;As of June&#160;30, 2026, the contractual future
minimum payments for the Company&#x2019;s outstanding borrowing arrangements were as follows (in&#160;thousands):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Remaining&lt;br/&gt; six months&lt;br/&gt; of 2026&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;2027&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="width: 64%; text-align: left;"&gt;Tasly convertible note - related party&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;2,629&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1505952347;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;2,629&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left;"&gt;Convertible promissory note - related party&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;2,114&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1588240824;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;2,114&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left;"&gt;Convertible loans payable&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_964200383;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;8,162&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;8,162&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left;"&gt;Convertible senior notes&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;45&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_991599179;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;45&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Promissory notes&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;1,054&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1495778935;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;1,054&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;Total contractual obligations&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;5,842&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;8,162&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;14,004&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock contextRef="cref_853412475" id="ixv-5032">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The following tables sets forth a summary of
the debt instruments and their changes during the&#160;three and six months ended June 30, 2026 and 2025 (in thousands):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Convertible &lt;br/&gt; Loans Payable&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Tasly Convertible&lt;br/&gt; Note&#160;-&#160;Related&lt;br/&gt;
        Party&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Convertible Promissory&lt;br/&gt; Note&#160;-&#160;Related&lt;br/&gt;
        Party&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Convertible &lt;br/&gt; Senior&lt;br/&gt; Notes&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Promissory Notes&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;PPP Loan&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;D&amp;amp;O Insurance Financing&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="width: 26%; font-weight: bold; text-indent: -0.125in; padding-left: 0.125in;"&gt;Balance at January 1, 2026&lt;/td&gt;
    &lt;td style="width: 0.5%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;7,877&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;2,290&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;1,870&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;42&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;1,049&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;1,390&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;297&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in;"&gt;Debt repayments&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(195&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_741686741;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1123562661;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_411448295;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(24&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1422744864;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(222&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in;"&gt;Change in fair value&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;555&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;242&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_815338591;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1120041276;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_355055345;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_740072080;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_817662186;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in;"&gt;Conversion of debt to equity&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(1,260&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_625290624;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1732463026;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1095239976;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1703443675;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1777932412;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1370697288;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in;"&gt;Debt forgiven&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1591706187;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1575221502;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_2049795016;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_26389377;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1196344204;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(1,392&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in;"&gt;Accrued stated interest&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_548664657;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_162603099;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1342787577;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;1&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;15&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;2&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1947972587;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.125in;"&gt;Balance at March 31,
        2026; Current debt&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;6,977&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;2,532&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;1,870&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;43&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;1,040&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_331585081;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;75&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in;"&gt;Issuance of debt&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;1,500&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1433235312;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1297511385;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1765185523;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1291574257;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1432709797;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_374712761;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in;"&gt;Debt repayments&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(765&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1231569308;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_590782202;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1425216027;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1431677020;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1314215860;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(75&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in;"&gt;Change in fair value&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;3,910&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;97&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;244&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_635689269;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1187634311;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_268324749;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_554662285;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in;"&gt;Conversion of debt to equity&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(3,460&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_154967678;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1320907053;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1912374246;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1429651243;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1487040249;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1152359340;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in;"&gt;Debt forgiven&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_633164231;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1652242228;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_89252809;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_675468233;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1322252669;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_104208705;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_516545939;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in;"&gt;Accrued stated interest&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1158532364;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1740708361;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_205627344;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;2&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;14&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_960828265;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1065622223;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.125in;"&gt;Balance at June 30,
        2026; Current debt&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;8,162&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;2,629&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;2,114&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;45&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;1,054&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_2084895650;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1608739325;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="vertical-align: top; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="vertical-align: top; text-align: left;"&gt;Accounting basis&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&lt;span style="font-size: 10pt;"&gt;&#160;Fair
        value option &lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&lt;span style="font-size: 10pt;"&gt;&#160;Fair
        value option &lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&lt;span style="font-size: 10pt;"&gt;&#160;Fair
        value option &lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&lt;span style="font-size: 10pt;"&gt;&#160;Effective
        interest method &lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&lt;span style="font-size: 10pt;"&gt;&#160;Simple
        interest method &lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&lt;span style="font-size: 10pt;"&gt;&#160;Compounding
        Interest &lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&lt;span style="font-size: 10pt;"&gt;Simple
        interest method&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="vertical-align: top; text-align: left; text-indent: -0.125in; padding-left: 0.125in;"&gt;Interest rate&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;10%
        - 12%&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;24%&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&lt;span style="-sec-ix-hidden:fc_616849018;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&lt;span style="font-size: 10pt;"&gt;&#160;0%-12%
        &lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&lt;span style="font-size: 10pt;"&gt;&#160;0%-12%
        &lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;1%&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;7%&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top;"&gt;Conversion price(s) per share, as affected
        by the Reverse Stock Splits&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&lt;span style="font-size: 10pt;"&gt;various
        &lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;$14,400.00&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&lt;span style="font-size: 10pt;"&gt;&#160;7,500.00
        and $16,650.00&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&lt;span style="font-size: 10pt;"&gt;&#160;$3,750.00,
        $16,650.00, and $30,000.00&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&lt;span style="-sec-ix-hidden:fc_706740288;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&lt;span style="-sec-ix-hidden:fc_1759056592;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&lt;span style="-sec-ix-hidden:fc_986038095;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top;"&gt;Maturity&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&lt;span style="font-size: 10pt;"&gt;various&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&lt;span style="font-size: 10pt;"&gt;3/31/2024&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&lt;span style="font-size: 10pt;"&gt;12/31/2026&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&lt;span style="font-size: 10pt;"&gt;7/11/2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&lt;span style="font-size: 10pt;"&gt;various&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&lt;span style="-sec-ix-hidden:fc_823388662;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;&lt;span style="font-size: 10pt;"&gt;4/11/2026&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Junior Convertible Notes&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Tasly Convertible Note - Related Party&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Convertible &lt;br/&gt; Senior&lt;br/&gt; Notes&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Promissory Notes&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;PPP Loan&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; width: 40%; font-weight: bold;"&gt;Balance at January 1, 2025&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;18,419&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;2,234&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;25,268&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;910&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;1,376&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in;"&gt;Issuance of debt&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_733099946;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1681646948;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;750&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_621654645;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1335500869;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left;"&gt;Change in fair value&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1445692272;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;156&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_498699758;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1502939321;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_657741355;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left;"&gt;Stated interest&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;545&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_914156588;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;572&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;15&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;3&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt;"&gt;Amortization of debt discount and issuance
        costs&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;1&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_703909118;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(1&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1045442393;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1605500249;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt;"&gt;Balance at March 31,
        2025; Current debt&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;18,965&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;2,390&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;26,589&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;925&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;1,379&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in;"&gt;Issuance of debt&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1920364349;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_974205172;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;700&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_438897670;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_2134421991;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left;"&gt;Change in fair value&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_978537416;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(38&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1875831696;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1371145217;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1330609207;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left;"&gt;Stated interest&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;553&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;191&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;604&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;15&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;4&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt;"&gt;Amortization of debt discount and issuance
        costs&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;15&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_280326152;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;2&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1920628771;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_751310220;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt;"&gt;Balance at June 30,
        2025; Current debt&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;19,533&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;2,543&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;27,895&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;940&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;1,383&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentFairValue
      contextRef="cref_1659609866"
      decimals="-3"
      id="ixv-13545"
      unitRef="uref_1340915823">7877000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="cref_558633562"
      decimals="-3"
      id="ixv-13546"
      unitRef="uref_1340915823">2290000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="cref_1486589709"
      decimals="-3"
      id="ixv-13547"
      unitRef="uref_1340915823">1870000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="cref_964975286"
      decimals="-3"
      id="ixv-13548"
      unitRef="uref_1340915823">42000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="cref_938099005"
      decimals="-3"
      id="ixv-13549"
      unitRef="uref_1340915823">1049000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="cref_1530643582"
      decimals="-3"
      id="ixv-13550"
      unitRef="uref_1340915823">1390000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="cref_1691449733"
      decimals="-3"
      id="ixv-13551"
      unitRef="uref_1340915823">297000</us-gaap:DebtInstrumentFairValue>
    <pfsa:DebtRepayments
      contextRef="cref_1956424655"
      decimals="-3"
      id="ixv-13552"
      unitRef="uref_1340915823">195000</pfsa:DebtRepayments>
    <pfsa:DebtRepayments
      contextRef="cref_233839587"
      decimals="-3"
      id="ixv-13553"
      unitRef="uref_1340915823">24000</pfsa:DebtRepayments>
    <pfsa:DebtRepayments
      contextRef="cref_632922629"
      decimals="-3"
      id="ixv-13554"
      unitRef="uref_1340915823">222000</pfsa:DebtRepayments>
    <pfsa:ConversionOfDebtToEquity
      contextRef="cref_1956424655"
      decimals="-3"
      id="ixv-13555"
      unitRef="uref_1340915823">555000</pfsa:ConversionOfDebtToEquity>
    <pfsa:ConversionOfDebtToEquity
      contextRef="cref_469666132"
      decimals="-3"
      id="ixv-13556"
      unitRef="uref_1340915823">242000</pfsa:ConversionOfDebtToEquity>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="cref_1956424655"
      decimals="-3"
      id="ixv-13557"
      unitRef="uref_1340915823">1260000</us-gaap:FairValueAdjustmentOfWarrants>
    <pfsa:DebtForgiveness
      contextRef="cref_575229552"
      decimals="-3"
      id="fc_1418234002"
      unitRef="uref_1340915823">-1392000</pfsa:DebtForgiveness>
    <pfsa:AccruedStatedInterest
      contextRef="cref_1858606938"
      decimals="-3"
      id="ixv-13559"
      unitRef="uref_1340915823">1000</pfsa:AccruedStatedInterest>
    <pfsa:AccruedStatedInterest
      contextRef="cref_233839587"
      decimals="-3"
      id="ixv-13560"
      unitRef="uref_1340915823">15000</pfsa:AccruedStatedInterest>
    <pfsa:AccruedStatedInterest
      contextRef="cref_575229552"
      decimals="-3"
      id="ixv-13561"
      unitRef="uref_1340915823">2000</pfsa:AccruedStatedInterest>
    <us-gaap:DebtInstrumentFairValue
      contextRef="cref_1838377757"
      decimals="-3"
      id="ixv-13562"
      unitRef="uref_1340915823">6977000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="cref_1726074040"
      decimals="-3"
      id="ixv-13563"
      unitRef="uref_1340915823">2532000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="cref_1867653040"
      decimals="-3"
      id="ixv-13564"
      unitRef="uref_1340915823">1870000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="cref_231997891"
      decimals="-3"
      id="ixv-13565"
      unitRef="uref_1340915823">43000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="cref_909296507"
      decimals="-3"
      id="ixv-13566"
      unitRef="uref_1340915823">1040000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="cref_1703614914"
      decimals="-3"
      id="ixv-13567"
      unitRef="uref_1340915823">75000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="cref_1767342225"
      decimals="-3"
      id="ixv-13568"
      unitRef="uref_1340915823">1500000</us-gaap:ProceedsFromIssuanceOfDebt>
    <pfsa:DebtRepayments
      contextRef="cref_1767342225"
      decimals="-3"
      id="ixv-13569"
      unitRef="uref_1340915823">765000</pfsa:DebtRepayments>
    <pfsa:DebtRepayments
      contextRef="cref_1314037718"
      decimals="-3"
      id="ixv-13570"
      unitRef="uref_1340915823">75000</pfsa:DebtRepayments>
    <pfsa:ConversionOfDebtToEquity
      contextRef="cref_1767342225"
      decimals="-3"
      id="ixv-13571"
      unitRef="uref_1340915823">3910000</pfsa:ConversionOfDebtToEquity>
    <pfsa:ConversionOfDebtToEquity
      contextRef="cref_1720775043"
      decimals="-3"
      id="ixv-13572"
      unitRef="uref_1340915823">97000</pfsa:ConversionOfDebtToEquity>
    <pfsa:ConversionOfDebtToEquity
      contextRef="cref_1732842588"
      decimals="-3"
      id="ixv-13573"
      unitRef="uref_1340915823">244000</pfsa:ConversionOfDebtToEquity>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="cref_1767342225"
      decimals="-3"
      id="ixv-13574"
      unitRef="uref_1340915823">3460000</us-gaap:FairValueAdjustmentOfWarrants>
    <pfsa:AccruedStatedInterest
      contextRef="cref_879442911"
      decimals="-3"
      id="ixv-13575"
      unitRef="uref_1340915823">2000</pfsa:AccruedStatedInterest>
    <pfsa:AccruedStatedInterest
      contextRef="cref_795889418"
      decimals="-3"
      id="ixv-13576"
      unitRef="uref_1340915823">14000</pfsa:AccruedStatedInterest>
    <us-gaap:DebtInstrumentFairValue
      contextRef="cref_1001554303"
      decimals="-3"
      id="ixv-13577"
      unitRef="uref_1340915823">8162000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="cref_1727949712"
      decimals="-3"
      id="ixv-13578"
      unitRef="uref_1340915823">2629000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="cref_1145002775"
      decimals="-3"
      id="ixv-13579"
      unitRef="uref_1340915823">2114000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="cref_616795955"
      decimals="-3"
      id="ixv-13580"
      unitRef="uref_1340915823">45000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="cref_1512439617"
      decimals="-3"
      id="ixv-13581"
      unitRef="uref_1340915823">1054000</us-gaap:DebtInstrumentFairValue>
    <pfsa:DebtAccountingBasis contextRef="cref_143335751" id="ixv-5582">&#160;Fair
        value option </pfsa:DebtAccountingBasis>
    <pfsa:DebtAccountingBasis contextRef="cref_482928940" id="ixv-5588">&#160;Fair
        value option </pfsa:DebtAccountingBasis>
    <pfsa:DebtAccountingBasis contextRef="cref_920647719" id="ixv-5594">&#160;Fair
        value option </pfsa:DebtAccountingBasis>
    <pfsa:DebtAccountingBasis contextRef="cref_1828519998" id="ixv-5600">&#160;Effective
        interest method </pfsa:DebtAccountingBasis>
    <pfsa:DebtAccountingBasis contextRef="cref_1395954209" id="ixv-5606">&#160;Simple
        interest method </pfsa:DebtAccountingBasis>
    <pfsa:DebtAccountingBasis contextRef="cref_150233668" id="ixv-5612">&#160;Compounding
        Interest </pfsa:DebtAccountingBasis>
    <pfsa:DebtAccountingBasis contextRef="cref_1998870429" id="ixv-5618">Simple
        interest method</pfsa:DebtAccountingBasis>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="cref_1225942580"
      decimals="2"
      id="ixv-13582"
      unitRef="uref_527123470">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="cref_1685313687"
      decimals="2"
      id="ixv-13583"
      unitRef="uref_527123470">0.12</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="cref_1727949712"
      decimals="2"
      id="ixv-13584"
      unitRef="uref_527123470">0.24</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="cref_239084172"
      decimals="2"
      id="ixv-13585"
      unitRef="uref_527123470">0</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="cref_1103899081"
      decimals="2"
      id="ixv-13586"
      unitRef="uref_527123470">0.12</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="cref_1184042403"
      decimals="2"
      id="ixv-13587"
      unitRef="uref_527123470">0</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="cref_725364953"
      decimals="2"
      id="ixv-13588"
      unitRef="uref_527123470">0.12</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="cref_1350234277"
      decimals="2"
      id="ixv-13589"
      unitRef="uref_527123470">0.01</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="cref_249402601"
      decimals="2"
      id="ixv-13590"
      unitRef="uref_527123470">0.07</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <pfsa:DebtConversionPricesPerShare contextRef="cref_143335751" id="ixv-5659">various
        </pfsa:DebtConversionPricesPerShare>
    <pfsa:DebtConversionPricesPerShare contextRef="cref_482928940" id="ixv-13591">14,400.00</pfsa:DebtConversionPricesPerShare>
    <pfsa:DebtConversionPricesPerShare contextRef="cref_1105431510" id="ixv-13592">7,500.00</pfsa:DebtConversionPricesPerShare>
    <pfsa:DebtConversionPricesPerShare contextRef="cref_1479801101" id="ixv-13593">16,650.00</pfsa:DebtConversionPricesPerShare>
    <pfsa:DebtConversionPricesPerShare contextRef="cref_1828519998" id="ixv-13594">3,750.00</pfsa:DebtConversionPricesPerShare>
    <pfsa:DebtConversionPricesPerShare contextRef="cref_900716984" id="ixv-13595">16,650.00</pfsa:DebtConversionPricesPerShare>
    <pfsa:DebtConversionPricesPerShare contextRef="cref_782487662" id="ixv-13596">30,000.00</pfsa:DebtConversionPricesPerShare>
    <us-gaap:DebtInstrumentMaturityDate contextRef="cref_482928940" id="ixv-13597">2024-03-31</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="cref_920647719" id="ixv-13598">2026-12-31</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="cref_1828519998" id="ixv-13599">2025-07-11</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="cref_1998870429" id="ixv-13600">2026-04-11</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentFairValue
      contextRef="cref_1953581452"
      decimals="-3"
      id="ixv-13601"
      unitRef="uref_1340915823">18419000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="cref_128811614"
      decimals="-3"
      id="ixv-13602"
      unitRef="uref_1340915823">2234000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="cref_1275188923"
      decimals="-3"
      id="ixv-13603"
      unitRef="uref_1340915823">25268000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="cref_567134068"
      decimals="-3"
      id="ixv-13604"
      unitRef="uref_1340915823">910000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="cref_2068785483"
      decimals="-3"
      id="ixv-13605"
      unitRef="uref_1340915823">1376000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="cref_1887753489"
      decimals="-3"
      id="ixv-13606"
      unitRef="uref_1340915823">750000</us-gaap:ProceedsFromIssuanceOfDebt>
    <pfsa:ConversionOfDebtToEquity
      contextRef="cref_1960383429"
      decimals="-3"
      id="ixv-13607"
      unitRef="uref_1340915823">156000</pfsa:ConversionOfDebtToEquity>
    <pfsa:StatedInterest
      contextRef="cref_795156743"
      decimals="-3"
      id="ixv-13608"
      unitRef="uref_1340915823">545000</pfsa:StatedInterest>
    <pfsa:StatedInterest
      contextRef="cref_1887753489"
      decimals="-3"
      id="ixv-13609"
      unitRef="uref_1340915823">572000</pfsa:StatedInterest>
    <pfsa:StatedInterest
      contextRef="cref_1132075286"
      decimals="-3"
      id="ixv-13610"
      unitRef="uref_1340915823">15000</pfsa:StatedInterest>
    <pfsa:StatedInterest
      contextRef="cref_124060944"
      decimals="-3"
      id="ixv-13611"
      unitRef="uref_1340915823">3000</pfsa:StatedInterest>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="cref_795156743"
      decimals="-3"
      id="ixv-13612"
      unitRef="uref_1340915823">1000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="cref_1887753489"
      decimals="-3"
      id="ixv-13613"
      unitRef="uref_1340915823">-1000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:DebtInstrumentFairValue
      contextRef="cref_1708146614"
      decimals="-3"
      id="ixv-13614"
      unitRef="uref_1340915823">18965000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="cref_1663177274"
      decimals="-3"
      id="ixv-13615"
      unitRef="uref_1340915823">2390000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="cref_1550908874"
      decimals="-3"
      id="ixv-13616"
      unitRef="uref_1340915823">26589000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="cref_839579100"
      decimals="-3"
      id="ixv-13617"
      unitRef="uref_1340915823">925000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="cref_1224068254"
      decimals="-3"
      id="ixv-13618"
      unitRef="uref_1340915823">1379000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="cref_1858504101"
      decimals="-3"
      id="ixv-13619"
      unitRef="uref_1340915823">700000</us-gaap:ProceedsFromIssuanceOfDebt>
    <pfsa:ConversionOfDebtToEquity
      contextRef="cref_1896784723"
      decimals="-3"
      id="ixv-13620"
      unitRef="uref_1340915823">-38000</pfsa:ConversionOfDebtToEquity>
    <pfsa:StatedInterest
      contextRef="cref_986438284"
      decimals="-3"
      id="ixv-13621"
      unitRef="uref_1340915823">553000</pfsa:StatedInterest>
    <pfsa:StatedInterest
      contextRef="cref_1896784723"
      decimals="-3"
      id="ixv-13622"
      unitRef="uref_1340915823">191000</pfsa:StatedInterest>
    <pfsa:StatedInterest
      contextRef="cref_1858504101"
      decimals="-3"
      id="ixv-13623"
      unitRef="uref_1340915823">604000</pfsa:StatedInterest>
    <pfsa:StatedInterest
      contextRef="cref_1506143925"
      decimals="-3"
      id="ixv-13624"
      unitRef="uref_1340915823">15000</pfsa:StatedInterest>
    <pfsa:StatedInterest
      contextRef="cref_687569782"
      decimals="-3"
      id="ixv-13625"
      unitRef="uref_1340915823">4000</pfsa:StatedInterest>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="cref_986438284"
      decimals="-3"
      id="ixv-13626"
      unitRef="uref_1340915823">15000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="cref_1858504101"
      decimals="-3"
      id="ixv-13627"
      unitRef="uref_1340915823">2000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:DebtInstrumentFairValue
      contextRef="cref_564467413"
      decimals="-3"
      id="ixv-13628"
      unitRef="uref_1340915823">19533000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="cref_1750623848"
      decimals="-3"
      id="ixv-13629"
      unitRef="uref_1340915823">2543000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="cref_774196741"
      decimals="-3"
      id="ixv-13630"
      unitRef="uref_1340915823">27895000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="cref_1509580890"
      decimals="-3"
      id="ixv-13631"
      unitRef="uref_1340915823">940000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="cref_326829935"
      decimals="-3"
      id="ixv-13632"
      unitRef="uref_1340915823">1383000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="cref_1391318560"
      decimals="-5"
      id="ixv-13633"
      unitRef="uref_1340915823">13900000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ConvertibleNotesPayableCurrent
      contextRef="cref_1621573025"
      decimals="-5"
      id="ixv-13634"
      unitRef="uref_1340915823">12200000</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:ConvertibleNotesPayableCurrent
      contextRef="cref_1174028695"
      decimals="-5"
      id="ixv-13635"
      unitRef="uref_1340915823">1700000</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="cref_699838351"
      decimals="2"
      id="ixv-13636"
      unitRef="uref_527123470">0.10</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="cref_699838351"
      decimals="2"
      id="ixv-13637"
      unitRef="uref_527123470">0.10</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <pfsa:CashPayments
      contextRef="cref_853412475"
      decimals="2"
      id="ixv-13638"
      unitRef="uref_527123470">0.05</pfsa:CashPayments>
    <us-gaap:ShortTermDebtInterestRateIncrease
      contextRef="cref_1854029298"
      decimals="2"
      id="ixv-13639"
      unitRef="uref_527123470">0.24</us-gaap:ShortTermDebtInterestRateIncrease>
    <us-gaap:DebtInstrumentInterestRateIncreaseDecrease
      contextRef="cref_699838351"
      decimals="2"
      id="ixv-13640"
      unitRef="uref_527123470">0.10</us-gaap:DebtInstrumentInterestRateIncreaseDecrease>
    <pfsa:ConversionPricePercentage
      contextRef="cref_853412475"
      decimals="2"
      id="ixv-13641"
      unitRef="uref_527123470">0.95</pfsa:ConversionPricePercentage>
    <pfsa:TradingDays contextRef="cref_4641836" id="ixv-13642">P10D</pfsa:TradingDays>
    <pfsa:BusinessDays contextRef="cref_853412475" id="ixv-13643">P10D</pfsa:BusinessDays>
    <pfsa:BeneficialOwnershipLimitationPercentage
      contextRef="cref_699838351"
      decimals="4"
      id="fc_699838351"
      unitRef="uref_527123470">0.0999</pfsa:BeneficialOwnershipLimitationPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="cref_2052371366"
      decimals="-5"
      id="ixv-13645"
      unitRef="uref_1340915823">12200000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="cref_1504193733"
      decimals="-5"
      id="ixv-13646"
      unitRef="uref_1340915823">12200000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="cref_2067957749"
      decimals="-5"
      id="ixv-13647"
      unitRef="uref_1340915823">1700000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="cref_742915857"
      decimals="-5"
      id="ixv-13648"
      unitRef="uref_1340915823">600000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ShortTermDebtPercentageBearingFixedInterestRate
      contextRef="cref_2066662965"
      decimals="2"
      id="ixv-13649"
      unitRef="uref_527123470">0.12</us-gaap:ShortTermDebtPercentageBearingFixedInterestRate>
    <pfsa:ConversionPricePercentage
      contextRef="cref_836594507"
      decimals="2"
      id="ixv-13650"
      unitRef="uref_527123470">0.95</pfsa:ConversionPricePercentage>
    <pfsa:TradingDays contextRef="cref_836594507" id="ixv-13651">P10D</pfsa:TradingDays>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="cref_2067957749"
      decimals="0"
      id="ixv-13652"
      unitRef="uref_2062431040">11111</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="cref_64592548"
      decimals="2"
      id="fc_64592548"
      unitRef="uref_138178116">50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <pfsa:BeneficialOwnershipLimitationPercentage
      contextRef="cref_125224100"
      decimals="4"
      id="fc_125224100"
      unitRef="uref_527123470">0.0999</pfsa:BeneficialOwnershipLimitationPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="cref_280602754"
      decimals="-5"
      id="ixv-13655"
      unitRef="uref_1340915823">1100000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ShortTermDebtPercentageBearingFixedInterestRate
      contextRef="cref_2007779218"
      decimals="2"
      id="ixv-13656"
      unitRef="uref_527123470">0.12</us-gaap:ShortTermDebtPercentageBearingFixedInterestRate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="cref_465977170"
      decimals="0"
      id="ixv-13657"
      unitRef="uref_2062431040">11111</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="cref_1416218782"
      decimals="0"
      id="ixv-13658"
      unitRef="uref_2062431040">33333</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="cref_35443710"
      decimals="2"
      id="ixv-13659"
      unitRef="uref_138178116">50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <pfsa:WarrantExpense
      contextRef="cref_853412475"
      decimals="-5"
      id="ixv-13660"
      unitRef="uref_1340915823">2200000</pfsa:WarrantExpense>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="cref_1803770222"
      decimals="-5"
      id="ixv-13661"
      unitRef="uref_1340915823">800000</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="cref_1247065944"
      decimals="-5"
      id="ixv-13662"
      unitRef="uref_1340915823">1000000</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:ConvertibleNotesPayable
      contextRef="cref_299885455"
      decimals="-5"
      id="ixv-13663"
      unitRef="uref_1340915823">800000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable
      contextRef="cref_1458494491"
      decimals="-5"
      id="ixv-13664"
      unitRef="uref_1340915823">1900000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="cref_1337257417"
      decimals="0"
      id="ixv-13665"
      unitRef="uref_2062431040">18702</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="cref_4641836"
      decimals="0"
      id="ixv-13666"
      unitRef="uref_2062431040">26968</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ShorttermDebtFairValue
      contextRef="cref_1621573025"
      decimals="-5"
      id="ixv-13667"
      unitRef="uref_1340915823">4700000</us-gaap:ShorttermDebtFairValue>
    <us-gaap:ShorttermDebtFairValue
      contextRef="cref_1239202785"
      decimals="-5"
      id="ixv-13668"
      unitRef="uref_1340915823">8200000</us-gaap:ShorttermDebtFairValue>
    <us-gaap:OtherLoansPayable
      contextRef="cref_1142370945"
      decimals="-5"
      id="ixv-13669"
      unitRef="uref_1340915823">7900000</us-gaap:OtherLoansPayable>
    <us-gaap:DepositLiabilitiesAccruedInterest
      contextRef="cref_988890546"
      decimals="-5"
      id="ixv-13670"
      unitRef="uref_1340915823">500000</us-gaap:DepositLiabilitiesAccruedInterest>
    <us-gaap:DepositLiabilitiesAccruedInterest
      contextRef="cref_592262246"
      decimals="-5"
      id="ixv-13671"
      unitRef="uref_1340915823">700000</us-gaap:DepositLiabilitiesAccruedInterest>
    <us-gaap:ShortTermBankLoansAndNotesPayable
      contextRef="cref_137095580"
      decimals="-5"
      id="ixv-13672"
      unitRef="uref_1340915823">1600000</us-gaap:ShortTermBankLoansAndNotesPayable>
    <us-gaap:ShortTermDebtPercentageBearingFixedInterestRate
      contextRef="cref_137095580"
      decimals="2"
      id="ixv-13673"
      unitRef="uref_527123470">0.12</us-gaap:ShortTermDebtPercentageBearingFixedInterestRate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="cref_2063090379" id="ixv-13674">2023-12-31</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:InvestmentInterestRate
      contextRef="cref_988890546"
      decimals="2"
      id="ixv-13675"
      unitRef="uref_527123470">0.24</us-gaap:InvestmentInterestRate>
    <us-gaap:CommonStockConvertibleConversionPriceDecrease
      contextRef="cref_4641836"
      decimals="2"
      id="ixv-13676"
      unitRef="uref_138178116">14400</us-gaap:CommonStockConvertibleConversionPriceDecrease>
    <us-gaap:ConvertibleDebt
      contextRef="cref_919073489"
      decimals="-5"
      id="ixv-13677"
      unitRef="uref_1340915823">2600000</us-gaap:ConvertibleDebt>
    <us-gaap:ConvertibleDebt
      contextRef="cref_1093374776"
      decimals="-5"
      id="ixv-13678"
      unitRef="uref_1340915823">2300000</us-gaap:ConvertibleDebt>
    <pfsa:AccruedStatedInterest
      contextRef="cref_2063090379"
      decimals="-5"
      id="ixv-13679"
      unitRef="uref_1340915823">1000000</pfsa:AccruedStatedInterest>
    <pfsa:AccruedStatedInterest
      contextRef="cref_1163422627"
      decimals="-5"
      id="ixv-13680"
      unitRef="uref_1340915823">700000</pfsa:AccruedStatedInterest>
    <us-gaap:ConvertibleNotesPayableCurrent
      contextRef="cref_1458494491"
      decimals="-5"
      id="ixv-13681"
      unitRef="uref_1340915823">2500000</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:WarrantExercisePriceIncrease
      contextRef="cref_853412475"
      decimals="2"
      id="ixv-13682"
      unitRef="uref_138178116">7500</us-gaap:WarrantExercisePriceIncrease>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_988890546"
      decimals="2"
      id="ixv-13683"
      unitRef="uref_138178116">16650</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:CommonStockConvertibleConversionPriceDecrease
      contextRef="cref_267912151"
      decimals="2"
      id="ixv-13684"
      unitRef="uref_138178116">76</us-gaap:CommonStockConvertibleConversionPriceDecrease>
    <us-gaap:DebtInstrumentIssuedPrincipal
      contextRef="cref_267912151"
      decimals="-5"
      id="ixv-13685"
      unitRef="uref_1340915823">1900000</us-gaap:DebtInstrumentIssuedPrincipal>
    <us-gaap:DebtInstrumentIssuedPrincipal
      contextRef="cref_1025699883"
      decimals="-5"
      id="ixv-13686"
      unitRef="uref_1340915823">1900000</us-gaap:DebtInstrumentIssuedPrincipal>
    <us-gaap:DebtConversionOriginalDebtInterestRateOfDebt
      contextRef="cref_1025699883"
      decimals="4"
      id="ixv-13687"
      unitRef="uref_527123470">0.1999</us-gaap:DebtConversionOriginalDebtInterestRateOfDebt>
    <us-gaap:DebtConversionOriginalDebtInterestRateOfDebt
      contextRef="cref_1627526449"
      decimals="4"
      id="ixv-13688"
      unitRef="uref_527123470">0.1999</us-gaap:DebtConversionOriginalDebtInterestRateOfDebt>
    <us-gaap:DebtConversionOriginalDebtInterestRateOfDebt
      contextRef="cref_1627526449"
      decimals="4"
      id="ixv-13689"
      unitRef="uref_527123470">0.1999</us-gaap:DebtConversionOriginalDebtInterestRateOfDebt>
    <us-gaap:ConvertibleNotesPayableCurrent
      contextRef="cref_1239202785"
      decimals="-5"
      id="ixv-13690"
      unitRef="uref_1340915823">2100000</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:ConvertibleNotesPayableCurrent
      contextRef="cref_6246743"
      decimals="-5"
      id="ixv-13691"
      unitRef="uref_1340915823">1900000</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="cref_2003996832"
      decimals="4"
      id="ixv-13692"
      unitRef="uref_527123470">0.1254</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="cref_1943710765"
      decimals="4"
      id="ixv-13693"
      unitRef="uref_527123470">0.1254</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="cref_201115319"
      decimals="4"
      id="ixv-13694"
      unitRef="uref_527123470">0.5328</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="cref_1333971396"
      decimals="4"
      id="ixv-13695"
      unitRef="uref_527123470">0.5328</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:InterestExpenseDebt
      contextRef="cref_1771939082"
      decimals="-5"
      id="ixv-13696"
      unitRef="uref_1340915823">600000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="cref_330754979"
      decimals="-5"
      id="ixv-13697"
      unitRef="uref_1340915823">1100000</us-gaap:InterestExpenseDebt>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="cref_1101054349"
      decimals="0"
      id="ixv-13698"
      unitRef="uref_2062431040">373</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockSplit
      contextRef="cref_853412475"
      decimals="-5"
      id="ixv-13699"
      unitRef="uref_1340915823">19600000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockSplit>
    <us-gaap:ConvertibleDebt
      contextRef="cref_370897421"
      decimals="-5"
      id="ixv-13700"
      unitRef="uref_1340915823">100000</us-gaap:ConvertibleDebt>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="cref_1493331618"
      decimals="-5"
      id="ixv-13701"
      unitRef="uref_1340915823">9700000</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="cref_1949920802"
      decimals="-5"
      id="ixv-13702"
      unitRef="uref_1340915823">27900000</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="cref_1232237483"
      decimals="4"
      id="ixv-13703"
      unitRef="uref_527123470">0.1215</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="cref_985413407"
      decimals="4"
      id="ixv-13704"
      unitRef="uref_527123470">0.1215</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:InterestExpenseDebt
      contextRef="cref_276287916"
      decimals="-5"
      id="ixv-13705"
      unitRef="uref_1340915823">600000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="cref_1101054349"
      decimals="-5"
      id="ixv-13706"
      unitRef="uref_1340915823">1200000</us-gaap:InterestExpenseDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="cref_1011423167"
      decimals="-5"
      id="ixv-13707"
      unitRef="uref_1340915823">1100000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="cref_448710947"
      decimals="-5"
      id="ixv-13708"
      unitRef="uref_1340915823">1000000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ConvertibleNotesPayable
      contextRef="cref_1286433117"
      decimals="-5"
      id="ixv-13709"
      unitRef="uref_1340915823">400000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable
      contextRef="cref_2038731489"
      decimals="-5"
      id="ixv-13710"
      unitRef="uref_1340915823">400000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:InterestExpenseDebt
      contextRef="cref_707439183"
      decimals="-5"
      id="ixv-13711"
      unitRef="uref_1340915823">100000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="cref_1158212978"
      decimals="-5"
      id="ixv-13712"
      unitRef="uref_1340915823">100000</us-gaap:InterestExpenseDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="cref_857227374"
      decimals="-5"
      id="ixv-13713"
      unitRef="uref_1340915823">1400000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:ContractualObligation
      contextRef="cref_988890546"
      decimals="-5"
      id="ixv-13714"
      unitRef="uref_1340915823">300000</us-gaap:ContractualObligation>
    <us-gaap:GeneralInsuranceExpense
      contextRef="cref_853412475"
      decimals="-5"
      id="ixv-13715"
      unitRef="uref_1340915823">300000</us-gaap:GeneralInsuranceExpense>
    <us-gaap:AssetRetirementObligation
      contextRef="cref_988890546"
      decimals="-6"
      id="ixv-13716"
      unitRef="uref_1340915823">0</us-gaap:AssetRetirementObligation>
    <us-gaap:AssetRetirementObligation
      contextRef="cref_592262246"
      decimals="-5"
      id="ixv-13717"
      unitRef="uref_1340915823">300000</us-gaap:AssetRetirementObligation>
    <pfsa:ScheduleOfContractualFutureMinimumPaymentsTableTextBlock contextRef="cref_853412475" id="ixv-6146">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;As of June&#160;30, 2026, the contractual future
minimum payments for the Company&#x2019;s outstanding borrowing arrangements were as follows (in&#160;thousands):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Remaining&lt;br/&gt; six months&lt;br/&gt; of 2026&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;2027&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="width: 64%; text-align: left;"&gt;Tasly convertible note - related party&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;2,629&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1505952347;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;2,629&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left;"&gt;Convertible promissory note - related party&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;2,114&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1588240824;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;2,114&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left;"&gt;Convertible loans payable&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_964200383;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;8,162&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;8,162&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left;"&gt;Convertible senior notes&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;45&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_991599179;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;45&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Promissory notes&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;1,054&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1495778935;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;1,054&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;Total contractual obligations&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;5,842&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;8,162&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;14,004&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;</pfsa:ScheduleOfContractualFutureMinimumPaymentsTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="cref_1620108994"
      decimals="-3"
      id="ixv-13718"
      unitRef="uref_1340915823">2629000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:LongTermDebt
      contextRef="cref_1620108994"
      decimals="-3"
      id="ixv-13719"
      unitRef="uref_1340915823">2629000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="cref_990767968"
      decimals="-3"
      id="ixv-13720"
      unitRef="uref_1340915823">2114000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:LongTermDebt
      contextRef="cref_990767968"
      decimals="-3"
      id="ixv-13721"
      unitRef="uref_1340915823">2114000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="cref_516374104"
      decimals="-3"
      id="ixv-13722"
      unitRef="uref_1340915823">8162000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebt
      contextRef="cref_516374104"
      decimals="-3"
      id="ixv-13723"
      unitRef="uref_1340915823">8162000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="cref_1457165476"
      decimals="-3"
      id="ixv-13724"
      unitRef="uref_1340915823">45000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:LongTermDebt
      contextRef="cref_1457165476"
      decimals="-3"
      id="ixv-13725"
      unitRef="uref_1340915823">45000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="cref_1703656236"
      decimals="-3"
      id="ixv-13726"
      unitRef="uref_1340915823">1054000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:LongTermDebt
      contextRef="cref_1703656236"
      decimals="-3"
      id="ixv-13727"
      unitRef="uref_1340915823">1054000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="cref_1727000301"
      decimals="-3"
      id="ixv-13728"
      unitRef="uref_1340915823">5842000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="cref_1727000301"
      decimals="-3"
      id="ixv-13729"
      unitRef="uref_1340915823">8162000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebt
      contextRef="cref_1727000301"
      decimals="-3"
      id="ixv-13730"
      unitRef="uref_1340915823">14004000</us-gaap:LongTermDebt>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="cref_853412475" id="ixv-6254">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;6
&#x2014;&#160;Commitments and Contingencies&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Operating Lease Obligations&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; On January 27, 2026, the Company executed a
15 month lease agreement for its office and lab facilities for a total consideration of $0.3
million to be paid over the lease term. The incremental borrowing rate estimated at the lease commencement date was determined to be 11.45%.
The lease terminates at the end of February 2027. Concurrently, the Company executed sublease agreements with sublessees for a six month
period for a portion of the leased space. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; For the three months ended June 30, 2026, operating
lease expense and sublease income was $0.1
million and $0.1
million, respectively. For the six months ended June 30, 2026, operating lease expense and sublease income was $0.2
million and $0.1
million, respectively. Variable lease and short-term lease expenses for the same periods were not material. Sublease income was recorded
in other income on the condensed consolidated statements of operations. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; For the three and six months ended June 30,
2025, operating lease expense was $0.2
million and $0.3
million, respectively. Variable lease and short-term lease expenses for the same periods were $0.1
million. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; As of June&#160;30, 2026, the operating lease
right-of-use asset of $0.1
million was recognized within right-of-use asset on the Company&#x2019;s condensed consolidated balance sheets. As of June&#160;30, 2026,
the operating lease liability of $0.1
million is recognized within accrued expenses and other current liabilities on the Company&#x2019;s condensed consolidated balance sheets.
&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Contingencies and Indemnifications&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;From time to time, the Company may have certain
contingent liabilities that arise in the ordinary course of its business activities. The Company accrues a liability for such matters
when it is probable that future expenditures will be made and that such expenditures can be reasonably estimated. Significant judgment
is required to determine both probability and the estimated amount.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; Under an advisory agreement with The Benchmark
Company, LLC, the Company may be required to pay up to an additional $0.3
million in advisory fees. As of the balance sheet date, this amount represents a contingent commitment that has not been recorded as a
liability, as the amount payable is currently not estimable, as it may be reduced by future services performed under the agreement. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;In the normal course of business, the Company
enters into contracts and agreements that contain a variety of representations and warranties and provide for general indemnifications.
The Company&#x2019;s exposure under these agreements is unknown because it involves claims that may be made against the Company in the
future, but that have not yet been made. To date, the Company has not paid any claims; however, the Company may record charges in the
future as a result of these indemnification obligations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; In December 2025, the Company received a Notice
of Entry of Judgment in connection with litigation brought by a vendor with claims for breach of contract, which was ruled in favor of
the vendor. As of June&#160;30, 2026 and December&#160;31, 2025, the Company had accrued approximately $0.1
million related to the matter. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; In February 2026, the Company received a demand
letter from counsel for a former employee for unpaid wages of approximately $0.2
million, including statutory penalties, and the amount has been accrued as of June&#160;30, 2026 and December&#160;31, 2025. The letter
demands payment and states that litigation may be initiated if the matter is not resolved. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Mayo Clinic
License Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;On February 11, 2026, the Company entered into
a know-how license agreement (the &#x201c;License Agreement&#x201d;), with Mayo Foundation for Medical Education and Research (&#x201c;Mayo&#x201d;).
Pursuant to the License Agreement, Mayo granted the Company an exclusive, worldwide license, with the right to sublicense, under certain
patent rights that may arise during the term of the License Agreement, and a non-exclusive, worldwide license, with the right to sublicense,
to certain know-how, in each case in the fields of continuous oxygen measurement and critical limb-threatening ischemia. Mayo retains
certain customary reserved rights, including rights related to educational, research and clinical programs.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Under the License Agreement, beginning with the
first commercial sale of a licensed product, the Company is required to pay Mayo earned royalties on net sales of licensed products. The
applicable royalty rates vary based on the licensed field and the type of intellectual property coverage applicable to the licensed product.
The Company is also obligated to make nonrefundable milestone payments to Mayo upon the first achievement of specified commercial, regulatory
and clinical events for each licensed product and to pay Mayo a percentage of certain sublicense income received by the Company. As of
June&#160;30, 2026, no commercial sales, milestone events or sublicense income had occurred under the License Agreement, and no amounts
were due to Mayo.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The License Agreement contains customary provisions
regarding diligence, confidentiality, use of name, representations and warranties, disclaimers, indemnification, insurance, compliance
with applicable laws and termination rights. Unless earlier terminated, the License Agreement expires upon the later of the expiration
of the last-to-expire licensed foreground patent right or the fifteenth anniversary of the first commercial sale of the last launched
licensed product. Upon expiration of the Company&#x2019;s obligation to pay earned royalties, and subject to the Company&#x2019;s compliance
with its obligations, the Company will have a fully paid-up license.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Asset Purchase
Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;On April 1, 2026, the Company entered into a
Letter of Intent (&#x201c;LOI&#x201d;) with Bio Insights LLC for the proposed acquisition of Bio Insight LLC&#x2019;s PanOmics Assay. On
April 21, 2026, the Company entered into an Asset Purchase Agreement (the &#x201c;Asset Purchase Agreement&#x201d;) with Bio Insights LLC
(&#x201c;Seller&#x201d;), pursuant to which the Company agreed to acquire substantially all of the know-how assets related to Seller&#x2019;s
PanOmics Assay, an integrated NGS multi-omics analysis platform used in drug discovery and precision medicine (the &#x201c;Purchased Assets&#x201d;).
The Purchased Assets include proprietary methodologies, data, processes, algorithms, software, databases, and related goodwill, but exclude
patent rights and biological samples (which remain with Seller, subject to an exclusive sample access license granted to the Company).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The aggregate purchase price is $30,000,000,
payable through issuance of Series A Convertible Preferred Stock (the &#x201c;Preferred Stock&#x201d;), convertible into common stock one
year following issuance based on the closing trading price of the Company&#x2019;s common stock on the date preceding closing. Issuance
of the Preferred Stock and underlying conversion shares (collectively, the &#x201c;Securities&#x201d;) is subject to stockholder approval
as required by Nasdaq Listing Rules 5635(a) and 5635(d). The Securities are subject to a five-year lock-up, with one-fourth released annually
beginning on the first anniversary of issuance. Seller is also entitled to receive a royalty equal to 3%
of net revenue from commercialization of the PanOmics Assay. The Asset Purchase Agreement contains customary representations, warranties,
covenants, and indemnification provisions, including a five-year non-compete, 24-month
transition assistance, and a voting agreement. The closing is subject to customary conditions, and either party may terminate if the closing
has not occurred on or before September 30, 2026. As of June&#160;30, 2026, the closing has not yet occurred and it continues to be subject
to customary conditions. &lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="cref_1398474254"
      decimals="-5"
      id="ixv-13731"
      unitRef="uref_1340915823">300000</us-gaap:OperatingLeaseCost>
    <us-gaap:SubordinatedBorrowingInterestRate
      contextRef="cref_11121223"
      decimals="4"
      id="ixv-13732"
      unitRef="uref_527123470">0.1145</us-gaap:SubordinatedBorrowingInterestRate>
    <us-gaap:OperatingLeaseExpense
      contextRef="cref_2042217600"
      decimals="-5"
      id="ixv-13733"
      unitRef="uref_1340915823">100000</us-gaap:OperatingLeaseExpense>
    <us-gaap:SubleaseIncome
      contextRef="cref_2042217600"
      decimals="-5"
      id="ixv-13734"
      unitRef="uref_1340915823">100000</us-gaap:SubleaseIncome>
    <us-gaap:OperatingLeaseExpense
      contextRef="cref_1841423955"
      decimals="-5"
      id="ixv-13735"
      unitRef="uref_1340915823">200000</us-gaap:OperatingLeaseExpense>
    <us-gaap:SubleaseIncome
      contextRef="cref_1841423955"
      decimals="-5"
      id="ixv-13736"
      unitRef="uref_1340915823">100000</us-gaap:SubleaseIncome>
    <us-gaap:OperatingLeaseExpense
      contextRef="cref_1771939082"
      decimals="-5"
      id="ixv-13737"
      unitRef="uref_1340915823">200000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="cref_330754979"
      decimals="-5"
      id="ixv-13738"
      unitRef="uref_1340915823">300000</us-gaap:OperatingLeaseExpense>
    <us-gaap:ShortTermLeaseCost
      contextRef="cref_330754979"
      decimals="-5"
      id="fc_794127249"
      unitRef="uref_1340915823">100000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="cref_1771939082"
      decimals="-5"
      id="fc_476415184"
      unitRef="uref_1340915823">100000</us-gaap:ShortTermLeaseCost>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="cref_988890546"
      decimals="-5"
      id="ixv-13741"
      unitRef="uref_1340915823">100000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="cref_988890546"
      decimals="-5"
      id="ixv-13742"
      unitRef="uref_1340915823">100000</us-gaap:OperatingLeaseLiability>
    <us-gaap:ProfessionalFees
      contextRef="cref_710033096"
      decimals="-5"
      id="ixv-13743"
      unitRef="uref_1340915823">300000</us-gaap:ProfessionalFees>
    <us-gaap:ProceedsFromLegalSettlements
      contextRef="cref_853412475"
      decimals="-5"
      id="ixv-13744"
      unitRef="uref_1340915823">100000</us-gaap:ProceedsFromLegalSettlements>
    <us-gaap:ProceedsFromLegalSettlements
      contextRef="cref_477349365"
      decimals="-5"
      id="ixv-13745"
      unitRef="uref_1340915823">100000</us-gaap:ProceedsFromLegalSettlements>
    <pfsa:UnpaidWages
      contextRef="cref_1007243374"
      decimals="-5"
      id="ixv-13746"
      unitRef="uref_1340915823">200000</pfsa:UnpaidWages>
    <pfsa:AggregatePurchasePrices
      contextRef="cref_853412475"
      decimals="-3"
      id="ixv-13747"
      unitRef="uref_1340915823">30000000000</pfsa:AggregatePurchasePrices>
    <pfsa:PercentageOfNetRevenues
      contextRef="cref_853412475"
      decimals="2"
      id="ixv-13748"
      unitRef="uref_527123470">0.03</pfsa:PercentageOfNetRevenues>
    <pfsa:TransitionAssistancePeriod contextRef="cref_853412475" id="ixv-13749">P24M</pfsa:TransitionAssistancePeriod>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="cref_853412475" id="ixv-6320">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;Note 7 &#x2014; Stockholders&#x2019;
Deficit&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Preferred
Stock&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; There were no
shares of preferred stock issued and outstanding at June&#160;30, 2026 and December&#160;31, 2025. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Common Stock&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; Each share of common stock is entitled to one
vote. The holders of common stock are also entitled to receive dividends whenever funds are legally available and when declared by the
Board of Directors, subject to prior rights of the preferred stockholders. As of June&#160;30, 2026, &lt;span style="-sec-ix-hidden:fc_328233919;"&gt;no&lt;/span&gt;
dividends have been declared to date. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company reserved shares of common stock,
as adjusted for the recapitalization and for the Reverse Stock Splits, on an as-converted basis, for future issuance as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;June 30, &lt;br/&gt; 2026&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;December 31,&lt;br/&gt; 2025&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="width: 76%; text-align: left;"&gt;Outstanding options under 2025 Plan&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;245&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;103&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left;"&gt;Issuance of options under the 2025 Plan&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;7,816&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;1,003&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left;"&gt;Outstanding common stock warrants&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;35,670&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;2,336&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&lt;span style="font-size: 10pt;"&gt;Issuance of earnout shares &lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;387&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;387&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;44,118&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;3,829&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: top; text-align: justify;"&gt;
    &lt;td style="width: 0in;"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left;"&gt;&lt;span style="font-size: 10pt;"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify;"&gt;&lt;span style="font-size: 10pt;"&gt;
    These earnout shares exclude 129
                    shares, as adjusted for the Reverse Stock Splits, allocated to Milestone III, as Milestone III expired as of December 31, 2025. Milestone
                    III represents an operational milestone for the Company&#x2019;s consummation of a joint venture, for which management has decided not
                    to pursue the joint venture.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesIssued
      contextRef="cref_988890546"
      decimals="0"
      id="ixv-13750"
      unitRef="uref_2062431040">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="cref_988890546"
      decimals="0"
      id="ixv-13751"
      unitRef="uref_2062431040">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="cref_592262246"
      decimals="0"
      id="ixv-13752"
      unitRef="uref_2062431040">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="cref_592262246"
      decimals="0"
      id="ixv-13753"
      unitRef="uref_2062431040">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockVotingRights contextRef="cref_853412475" id="ixv-13754">one</us-gaap:CommonStockVotingRights>
    <us-gaap:ScheduleOfConversionsOfStockTextBlock contextRef="cref_853412475" id="ixv-6339">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company reserved shares of common stock,
as adjusted for the recapitalization and for the Reverse Stock Splits, on an as-converted basis, for future issuance as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;June 30, &lt;br/&gt; 2026&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;December 31,&lt;br/&gt; 2025&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="width: 76%; text-align: left;"&gt;Outstanding options under 2025 Plan&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;245&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;103&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left;"&gt;Issuance of options under the 2025 Plan&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;7,816&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;1,003&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left;"&gt;Outstanding common stock warrants&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;35,670&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;2,336&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&lt;span style="font-size: 10pt;"&gt;Issuance of earnout shares &lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;387&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;387&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;44,118&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;3,829&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: top; text-align: justify;"&gt;
    &lt;td style="width: 0in;"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left;"&gt;&lt;span style="font-size: 10pt;"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify;"&gt;&lt;span style="font-size: 10pt;"&gt;
    These earnout shares exclude 129
                    shares, as adjusted for the Reverse Stock Splits, allocated to Milestone III, as Milestone III expired as of December 31, 2025. Milestone
                    III represents an operational milestone for the Company&#x2019;s consummation of a joint venture, for which management has decided not
                    to pursue the joint venture.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfConversionsOfStockTextBlock>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="cref_1443777198"
      decimals="0"
      id="ixv-13755"
      unitRef="uref_2062431040">245</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="cref_2136082356"
      decimals="0"
      id="ixv-13756"
      unitRef="uref_2062431040">103</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="cref_1273526037"
      decimals="0"
      id="ixv-13757"
      unitRef="uref_2062431040">7816</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="cref_2088078009"
      decimals="0"
      id="ixv-13758"
      unitRef="uref_2062431040">1003</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="cref_72780092"
      decimals="0"
      id="ixv-13759"
      unitRef="uref_2062431040">35670</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="cref_492419163"
      decimals="0"
      id="ixv-13760"
      unitRef="uref_2062431040">2336</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="cref_354173338"
      decimals="0"
      id="fc_354173338"
      unitRef="uref_2062431040">387</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="cref_1950113667"
      decimals="0"
      id="fc_1950113667"
      unitRef="uref_2062431040">387</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="cref_988890546"
      decimals="0"
      id="ixv-13763"
      unitRef="uref_2062431040">44118</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="cref_592262246"
      decimals="0"
      id="ixv-13764"
      unitRef="uref_2062431040">3829</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="cref_126326278"
      decimals="0"
      id="ixv-13766"
      unitRef="uref_2062431040">129</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <pfsa:WarrantsTextBlock contextRef="cref_853412475" id="ixv-6425">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;Note 8 &#x2014; Common Stock Warrants&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; As of June&#160;30, 2026, the Company had five
classes of warrants totaling 20,870,083,
consisting of 9,487,500
Public Warrants, 7,347,500
Private Placement Warrants, 569,250
Representative&#x2019;s Warrants, 132,500
HCW Warrants and 3,333,333
Ascent Warrants. Each Public Warrant, Private Placement Warrant, Representative&#x2019;s Warrant and HCW Warrant is exercisable into 1/7,500
of a share, as affected by the Reverse Stock Splits, but only whole shares of common stock can be issued. Each Ascent Warrant is exercisable
into 1/100 of a share, as affected by the July and August Reverse Stock Splits. &lt;/p&gt; 

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Exercise price&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Expiration date&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Number of shares underlying warrants&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="width: 64%; text-align: left;"&gt;Public Warrants&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;86,250.00&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 11%; text-align: center;"&gt;7/11/2030&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;1,265&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left;"&gt;Private Placement Warrants&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;86,250.00&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center;"&gt;7/11/2030&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;980&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left;"&gt;Representative&#x2019;s Warrants&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;86,250.00&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center;"&gt;7/11/2030&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;75&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left;"&gt;HCW Warrants&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;75.00&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center;"&gt;7/11/2030&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;17&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Ascent Warrants&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right;"&gt;50.00&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt;"&gt;4/20/2031&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;33,333&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: right;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;35,670&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Ascent Warrants were issued on April 2, 2026
and subsequently modified on April 20, 2026 and April 29, 2026. The Ascent Warrants were liability-classified as of April 2, 2026 and
April 20, 2026 as it was determined that these warrants were not indexed to their own stock. The April 29, 2026 amendment resulted in
the Ascent Warrants becoming equity-classified. The
fair value of the Ascent Warrants was calculated under the Black-Scholes option pricing model using the following key inputs, as affected
by the July and August Reverse Stock Splits, during the three and six months ended June 30, 2026:&lt;/p&gt; 

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td style="font-weight: bold;"&gt;Input&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left;"&gt;Risk-free interest rate&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="font-size: 10pt;"&gt;3.86%
        - 4.05&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="width: 88%; text-align: left;"&gt;Expected term (years)&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;5.0&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left;"&gt;Expected volatility&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;267.14&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td&gt;Exercise price&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;50.00&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td&gt;Fair value of Common stock&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="font-size: 10pt;"&gt;53.97
        - $75.64&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; On April 20, 2026, the Ascent Warrants were
modified in which the number of shares issuable under the Ascent Warrants were increased from 11,111
shares to 33,333
shares as part of a side letter agreement - see Note 5 for further information. The April 20 modification resulted in an increase in fair
value of the Ascent Warrants, from $0.8&#160;million
to $2.2&#160;million,
was recognized under financing costs on the condensed consolidated statements of operations during the three and six months ended June
30, 2026. The total financing costs recognized in connection with the Ascent Warrants during the three and six months ended June 30, 2026
was $2.2&#160;million,
representing issuance costs associated with the April 2026 Ascent PIPE Notes. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; On April 29, 2026, the Ascent Warrants were
modified to remove a cash settlement feature, which resulted in the modified Ascent Warrant meeting all of the criteria for equity classification.
The Company recognized a gain of $0.4
million for the change in fair value of the Ascent Warrant liability, prior to reclassifying the warrant liability to additional paid-in
capital. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; As of December&#160;31, 2025, the Company had
four classes of warrants totaling 17,536,750,
consisting of 9,487,500
Public Warrants, 7,347,500
Private Placement Warrants, 569,250
Representative&#x2019;s Warrants, and 132,500
HCW Warrants.
Each warrant is exercisable into 1/7,500 of a share, as affected by the Reverse Stock Splits, but only whole shares of common stock can
be issued. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; 

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Exercise price&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Expiration date&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Number of shares underlying warrants&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="width: 64%; text-align: left;"&gt;Public Warrants&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;86,250.00&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 11%; text-align: center;"&gt;7/11/2030&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;1,265&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left;"&gt;Private Placement Warrants&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;86,250.00&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center;"&gt;7/11/2030&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;980&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left;"&gt;Representative&#x2019;s Warrants&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;86,250.00&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center;"&gt;7/11/2030&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;75&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;HCW Warrants&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right;"&gt;75.00&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt;"&gt;7/11/2030&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;17&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: right;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;2,337&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;</pfsa:WarrantsTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="cref_2011423406"
      decimals="0"
      id="ixv-13767"
      unitRef="uref_2062431040">20870083</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="cref_871387629"
      decimals="0"
      id="ixv-13768"
      unitRef="uref_2062431040">9487500</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="cref_554893378"
      decimals="0"
      id="ixv-13769"
      unitRef="uref_2062431040">7347500</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="cref_679378796"
      decimals="0"
      id="ixv-13770"
      unitRef="uref_2062431040">569250</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="cref_1810070407"
      decimals="0"
      id="ixv-13771"
      unitRef="uref_2062431040">132500</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="cref_966753452"
      decimals="0"
      id="ixv-13772"
      unitRef="uref_2062431040">3333333</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="cref_1515966903"
      decimals="2"
      id="ixv-13773"
      unitRef="uref_138178116">86250</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="cref_310701023" id="ixv-13774">2030-07-11</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="cref_1515966903"
      decimals="0"
      id="ixv-13775"
      unitRef="uref_2062431040">1265</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="cref_554893378"
      decimals="2"
      id="ixv-13776"
      unitRef="uref_138178116">86250</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="cref_1521110747" id="ixv-13777">2030-07-11</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="cref_554893378"
      decimals="0"
      id="ixv-13778"
      unitRef="uref_2062431040">980</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="cref_679378796"
      decimals="2"
      id="ixv-13779"
      unitRef="uref_138178116">86250</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="cref_1745349373" id="ixv-13780">2030-07-11</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="cref_679378796"
      decimals="0"
      id="ixv-13781"
      unitRef="uref_2062431040">75</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="cref_1810070407"
      decimals="2"
      id="ixv-13782"
      unitRef="uref_138178116">75</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="cref_288278288" id="ixv-13783">2030-07-11</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="cref_1810070407"
      decimals="0"
      id="ixv-13784"
      unitRef="uref_2062431040">17</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="cref_966753452"
      decimals="2"
      id="ixv-13785"
      unitRef="uref_138178116">50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="cref_1072514866" id="ixv-13786">2031-04-20</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="cref_966753452"
      decimals="0"
      id="ixv-13787"
      unitRef="uref_2062431040">33333</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="cref_988890546"
      decimals="0"
      id="ixv-13788"
      unitRef="uref_2062431040">35670</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock contextRef="cref_853412475" id="ixv-13789">The
fair value of the Ascent Warrants was calculated under the Black-Scholes option pricing model using the following key inputs, as affected
by the July and August Reverse Stock Splits, during the three and six months ended June 30, 2026:

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td style="font-weight: bold;"&gt;Input&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left;"&gt;Risk-free interest rate&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="font-size: 10pt;"&gt;3.86%
        - 4.05&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="width: 88%; text-align: left;"&gt;Expected term (years)&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;5.0&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left;"&gt;Expected volatility&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;267.14&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td&gt;Exercise price&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;50.00&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td&gt;Fair value of Common stock&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="font-size: 10pt;"&gt;53.97
        - $75.64&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="cref_853412475"
      decimals="4"
      id="ixv-13790"
      unitRef="uref_527123470">0.0386</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="cref_853412475" id="ixv-13791">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="cref_853412475"
      decimals="4"
      id="ixv-13792"
      unitRef="uref_527123470">2.6714</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="cref_988890546"
      decimals="2"
      id="ixv-13793"
      unitRef="uref_138178116">50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:SharePrice
      contextRef="cref_1052881828"
      decimals="2"
      id="ixv-13794"
      unitRef="uref_138178116">53.97</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="cref_552763750"
      decimals="2"
      id="ixv-13795"
      unitRef="uref_138178116">75.64</us-gaap:SharePrice>
    <pfsa:SharesIssuableUponExerciseOfWarrants
      contextRef="cref_1203138532"
      decimals="0"
      id="fc_1203138532"
      unitRef="uref_2062431040">11111</pfsa:SharesIssuableUponExerciseOfWarrants>
    <pfsa:SharesIssuableUponExerciseOfWarrants
      contextRef="cref_1779854870"
      decimals="0"
      id="fc_1779854870"
      unitRef="uref_2062431040">33333</pfsa:SharesIssuableUponExerciseOfWarrants>
    <pfsa:FairValueOfAscentWarrant
      contextRef="cref_113966588"
      decimals="-2"
      id="ixv-13798"
      unitRef="uref_1340915823">800</pfsa:FairValueOfAscentWarrant>
    <pfsa:FairValueOfAscentWarrant
      contextRef="cref_181692182"
      decimals="-2"
      id="ixv-13799"
      unitRef="uref_1340915823">2200</pfsa:FairValueOfAscentWarrant>
    <pfsa:LoanCommitmentAssets
      contextRef="cref_496962156"
      decimals="-2"
      id="fc_267999747"
      unitRef="uref_1340915823">2200</pfsa:LoanCommitmentAssets>
    <pfsa:LoanCommitmentAssets
      contextRef="cref_853412475"
      decimals="-2"
      id="fc_169396185"
      unitRef="uref_1340915823">2200</pfsa:LoanCommitmentAssets>
    <pfsa:GainLossOnAscentWarrant
      contextRef="cref_221860134"
      decimals="-2"
      id="ixv-13802"
      unitRef="uref_1340915823">400</pfsa:GainLossOnAscentWarrant>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="cref_175147910"
      decimals="0"
      id="ixv-13803"
      unitRef="uref_2062431040">17536750</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="cref_211542808"
      decimals="0"
      id="ixv-13804"
      unitRef="uref_2062431040">9487500</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="cref_1500117593"
      decimals="0"
      id="ixv-13805"
      unitRef="uref_2062431040">7347500</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="cref_63415997"
      decimals="0"
      id="ixv-13806"
      unitRef="uref_2062431040">569250</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="cref_911624918"
      decimals="0"
      id="ixv-13807"
      unitRef="uref_2062431040">132500</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="cref_853412475" id="ixv-13808">
Each warrant is exercisable into 1/7,500 of a share, as affected by the Reverse Stock Splits, but only whole shares of common stock can
be issued.

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Exercise price&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Expiration date&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Number of shares underlying warrants&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="width: 64%; text-align: left;"&gt;Public Warrants&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;86,250.00&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 11%; text-align: center;"&gt;7/11/2030&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;1,265&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left;"&gt;Private Placement Warrants&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;86,250.00&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center;"&gt;7/11/2030&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;980&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left;"&gt;Representative&#x2019;s Warrants&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;86,250.00&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center;"&gt;7/11/2030&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;75&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left;"&gt;HCW Warrants&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;75.00&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center;"&gt;7/11/2030&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;17&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Ascent Warrants&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right;"&gt;50.00&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt;"&gt;4/20/2031&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;33,333&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: right;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;35,670&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Exercise price&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Expiration date&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Number of shares underlying warrants&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="width: 64%; text-align: left;"&gt;Public Warrants&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;86,250.00&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 11%; text-align: center;"&gt;7/11/2030&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;1,265&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left;"&gt;Private Placement Warrants&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;86,250.00&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center;"&gt;7/11/2030&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;980&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left;"&gt;Representative&#x2019;s Warrants&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;86,250.00&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center;"&gt;7/11/2030&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;75&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;HCW Warrants&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right;"&gt;75.00&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt;"&gt;7/11/2030&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;17&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: right;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;2,337&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="cref_1060540123"
      decimals="2"
      id="ixv-13809"
      unitRef="uref_138178116">86250</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="cref_1030451730" id="ixv-13810">2030-07-11</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="cref_1060540123"
      decimals="0"
      id="ixv-13811"
      unitRef="uref_2062431040">1265</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="cref_1500117593"
      decimals="2"
      id="ixv-13812"
      unitRef="uref_138178116">86250</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="cref_2101963542" id="ixv-13813">2030-07-11</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="cref_1500117593"
      decimals="0"
      id="ixv-13814"
      unitRef="uref_2062431040">980</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="cref_63415997"
      decimals="2"
      id="ixv-13815"
      unitRef="uref_138178116">86250</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="cref_15407559" id="ixv-13816">2030-07-11</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="cref_63415997"
      decimals="0"
      id="ixv-13817"
      unitRef="uref_2062431040">75</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="cref_911624918"
      decimals="2"
      id="ixv-13818"
      unitRef="uref_138178116">75</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="cref_1653801061" id="ixv-13819">2030-07-11</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="cref_911624918"
      decimals="0"
      id="ixv-13820"
      unitRef="uref_2062431040">17</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="cref_592262246"
      decimals="0"
      id="ixv-13821"
      unitRef="uref_2062431040">2337</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="cref_853412475" id="ixv-6648">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;9
&#x2014;&#160;Stock Option Plan&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; In 2010, Legacy Profusa adopted the 2010 Equity
Incentive Plan (the &#x201c;2010 Plan&#x201d;) under which 1,066
shares, as adjusted for the Reverse Stock Splits, of the Company&#x2019;s common stock have been initially reserved for issuance to employees,
directors and consultants. In October 2025, the Company adopted the 2025 Equity Incentive Plan (the &#x201c;2025 Plan&#x201d;), that will
replace the 2010 Plan. All previously issued options under the 2010 Plan will be held under the new plan, with no additional impact to
the option holders. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; On May 7, 2026, The Company&#x2019;s Board of
Directors approved an amendment to the Company&#x2019;s 2025 Plan to increase the number of shares of common stock reserved and available
for issuance under the 2025 Plan by 6,955
shares, after giving effect to the Company&#x2019;s Reverse Stock Splits. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; As of June&#160;30, 2026, the total authorized
and issuable shares under the 2025 Plan available for grant was 7,816
shares, as adjusted for the Reverse Stock Splits. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; 

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Activity under the Plan, as adjusted for the
recapitalization and Reverse Stock Splits, is set forth below:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Options Outstanding&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold;"&gt;Stock Option Activity&lt;/td&gt;
    &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Number of Options&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Weighted-Average Exercise Price Per Share&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="width: 76%; font-weight: bold;"&gt;Balances at December 31, 2025&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;103&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;23,181.00&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left;"&gt;Options granted&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;144&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;535.11&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Options cancelled&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right;"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="font-weight: bold;"&gt;Balances at March 31, 2026&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;247&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;16,222.92&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left;"&gt;Options granted&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_32881946;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1382895685;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Options cancelled&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(2&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right;"&gt;50,527.10&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;Balances at June 30, 2026&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;245&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: right;"&gt;15,942.88&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;Stock-Based Compensation Expense
by Function&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; 

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The following table is a summary of stock compensation
expense by function recognized for the&#160;three and six months ended June 30, 2026 and 2025 (in thousands):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Three Months Ended &lt;br/&gt; June 30,&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Six Months Ended &lt;br/&gt; June 30,&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;2026&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;2025&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;2026&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;2025&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="width: 52%; text-align: left;"&gt;General and administrative&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;157&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;31&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;312&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;33&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Research and development&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;31&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;51&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;63&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;54&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;Total stock-based compensation&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;188&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;82&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;375&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;87&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Increase in stock based compensation for the
three and six months ended June 30, 2026 is due to incremental grants issued subsequent to June&#160;30, 2025.&lt;/p&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="cref_1976886926"
      decimals="0"
      id="ixv-13822"
      unitRef="uref_2062431040">1066</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="cref_405697873"
      decimals="0"
      id="ixv-13823"
      unitRef="uref_2062431040">6955</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="cref_483527547"
      decimals="0"
      id="ixv-13824"
      unitRef="uref_2062431040">7816</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="cref_853412475" id="ixv-6658">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Activity under the Plan, as adjusted for the
recapitalization and Reverse Stock Splits, is set forth below:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Options Outstanding&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold;"&gt;Stock Option Activity&lt;/td&gt;
    &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Number of Options&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Weighted-Average Exercise Price Per Share&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="width: 76%; font-weight: bold;"&gt;Balances at December 31, 2025&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;103&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;23,181.00&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left;"&gt;Options granted&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;144&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;535.11&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Options cancelled&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right;"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="font-weight: bold;"&gt;Balances at March 31, 2026&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;247&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;16,222.92&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left;"&gt;Options granted&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_32881946;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1382895685;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Options cancelled&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(2&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right;"&gt;50,527.10&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;Balances at June 30, 2026&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;245&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: right;"&gt;15,942.88&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="cref_592262246"
      decimals="0"
      id="ixv-13825"
      unitRef="uref_2062431040">103</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="cref_592262246"
      decimals="2"
      id="ixv-13826"
      unitRef="uref_138178116">23181</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="cref_683057423"
      decimals="0"
      id="ixv-13827"
      unitRef="uref_2062431040">144</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="cref_683057423"
      decimals="2"
      id="ixv-13828"
      unitRef="uref_138178116">535.11</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <pfsa:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsCancelledforfeited
      contextRef="cref_279465061"
      decimals="0"
      id="ixv-13829"
      unitRef="uref_2062431040">0</pfsa:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsCancelledforfeited>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="cref_683057423"
      decimals="0"
      id="ixv-13830"
      unitRef="uref_138178116">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="cref_279465061"
      decimals="0"
      id="ixv-13831"
      unitRef="uref_2062431040">247</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="cref_279465061"
      decimals="2"
      id="ixv-13832"
      unitRef="uref_138178116">16222.92</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <pfsa:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsCancelledforfeited
      contextRef="cref_988890546"
      decimals="0"
      id="ixv-13833"
      unitRef="uref_2062431040">-2</pfsa:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsCancelledforfeited>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="cref_496962156"
      decimals="2"
      id="ixv-13834"
      unitRef="uref_138178116">50527.1</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="cref_988890546"
      decimals="0"
      id="ixv-13835"
      unitRef="uref_2062431040">245</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="cref_988890546"
      decimals="2"
      id="ixv-13836"
      unitRef="uref_138178116">15942.88</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="cref_853412475" id="ixv-6752">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The following table is a summary of stock compensation
expense by function recognized for the&#160;three and six months ended June 30, 2026 and 2025 (in thousands):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Three Months Ended &lt;br/&gt; June 30,&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Six Months Ended &lt;br/&gt; June 30,&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;2026&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;2025&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;2026&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;2025&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="width: 52%; text-align: left;"&gt;General and administrative&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;157&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;31&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;312&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;33&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Research and development&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;31&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;51&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;63&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;54&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;Total stock-based compensation&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;188&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;82&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;375&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;87&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="cref_516476530"
      decimals="-3"
      id="ixv-13837"
      unitRef="uref_1340915823">157000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="cref_1670057360"
      decimals="-3"
      id="ixv-13838"
      unitRef="uref_1340915823">31000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="cref_1674465270"
      decimals="-3"
      id="ixv-13839"
      unitRef="uref_1340915823">312000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="cref_2071186968"
      decimals="-3"
      id="ixv-13840"
      unitRef="uref_1340915823">33000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="cref_1265100041"
      decimals="-3"
      id="ixv-13841"
      unitRef="uref_1340915823">31000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="cref_1825677182"
      decimals="-3"
      id="ixv-13842"
      unitRef="uref_1340915823">51000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="cref_1189771306"
      decimals="-3"
      id="ixv-13843"
      unitRef="uref_1340915823">63000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="cref_1542769222"
      decimals="-3"
      id="ixv-13844"
      unitRef="uref_1340915823">54000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="cref_496962156"
      decimals="-3"
      id="ixv-13845"
      unitRef="uref_1340915823">188000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="cref_1771939082"
      decimals="-3"
      id="ixv-13846"
      unitRef="uref_1340915823">82000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="cref_853412475"
      decimals="-3"
      id="ixv-13847"
      unitRef="uref_1340915823">375000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="cref_330754979"
      decimals="-3"
      id="ixv-13848"
      unitRef="uref_1340915823">87000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="cref_853412475" id="ixv-6838">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;10 &#x2014;&#160;Related
Party Transactions&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company has funded its operations to date
primarily through private sales of convertible preferred stock, convertible notes, convertible loans payable and promissory notes. These
investments have included various related parties. The
following table presents the various significant related party transactions and investments in the Company for the periods presented (in
thousands):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold;"&gt;Related Party&lt;/td&gt;
    &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold;"&gt;Nature of relationship&lt;/td&gt;
    &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold;"&gt;Description of investment or transaction&lt;/td&gt;
    &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;June 30,&lt;br/&gt; 2026&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;December&#160;31,&lt;br/&gt; 2025&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left; width: 25%; vertical-align: top;"&gt;Tasly&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%; vertical-align: top;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 24%; vertical-align: top;"&gt;Shareholder&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%; vertical-align: top;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 25%; text-align: left;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;Convertible
        note held at fair value&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;2,629&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;2,290&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="vertical-align: top; text-align: left;"&gt;NVAC Sponsor I, LLC&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top;"&gt;Shareholder&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;Convertible
        note held at fair value&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;2,114&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;1,870&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="vertical-align: top; text-align: left;"&gt;The founders&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top;"&gt;Shareholder&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;Promissory
        notes&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;410&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;400&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="vertical-align: top; text-align: left;"&gt;NVAC Sponsor I, LLC&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top;"&gt;Shareholder&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;Due
        to Related Party&lt;sup&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;41&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;41&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; For the three months ended June 30, 2026 and
2025, related party interest expense was $5
thousand and $0.5
million, respectively. For the six months ended June 30, 2026 and 2025, related party interest expense was $10
thousand and $1.1
million, respectively. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: top; text-align: justify;"&gt;
    &lt;td style="width: 0in;"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left;"&gt;(1)&lt;/td&gt;
    &lt;td style="text-align: justify;"&gt;
    See Note 5 for full disclosures on debt, including the convertible notes payable, convertible loans
                    payable and promissory notes.&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: top; text-align: justify;"&gt;
    &lt;td style="width: 0in;"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left;"&gt;(2)&lt;/td&gt;
    &lt;td style="text-align: justify;"&gt;
    As of June&#160;30, 2026 and December&#160;31, 2025, $41
                    thousand relating to an administrative service fee remains outstanding which originated from the net assets of the Northview balance sheet
                    that was brought over at the time of the merger at fair value and has had no change.&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock contextRef="cref_853412475" id="ixv-13849">The
following table presents the various significant related party transactions and investments in the Company for the periods presented (in
thousands):

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold;"&gt;Related Party&lt;/td&gt;
    &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold;"&gt;Nature of relationship&lt;/td&gt;
    &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold;"&gt;Description of investment or transaction&lt;/td&gt;
    &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;June 30,&lt;br/&gt; 2026&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;December&#160;31,&lt;br/&gt; 2025&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left; width: 25%; vertical-align: top;"&gt;Tasly&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%; vertical-align: top;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 24%; vertical-align: top;"&gt;Shareholder&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%; vertical-align: top;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 25%; text-align: left;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;Convertible
        note held at fair value&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;2,629&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;2,290&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="vertical-align: top; text-align: left;"&gt;NVAC Sponsor I, LLC&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top;"&gt;Shareholder&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;Convertible
        note held at fair value&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;2,114&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;1,870&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="vertical-align: top; text-align: left;"&gt;The founders&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top;"&gt;Shareholder&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;Promissory
        notes&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;410&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;400&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="vertical-align: top; text-align: left;"&gt;NVAC Sponsor I, LLC&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top;"&gt;Shareholder&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;Due
        to Related Party&lt;sup&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;41&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;41&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: top; text-align: justify;"&gt;
    &lt;td style="width: 0in;"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left;"&gt;(1)&lt;/td&gt;
    &lt;td style="text-align: justify;"&gt;
    See Note 5 for full disclosures on debt, including the convertible notes payable, convertible loans
                    payable and promissory notes.&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: top; text-align: justify;"&gt;
    &lt;td style="width: 0in;"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left;"&gt;(2)&lt;/td&gt;
    &lt;td style="text-align: justify;"&gt;
    As of June&#160;30, 2026 and December&#160;31, 2025, $41
                    thousand relating to an administrative service fee remains outstanding which originated from the net assets of the Northview balance sheet
                    that was brought over at the time of the merger at fair value and has had no change.&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock>
    <us-gaap:NatureOfCommonOwnershipOrManagementControlRelationships contextRef="cref_967183272" id="ixv-13850">Shareholder</us-gaap:NatureOfCommonOwnershipOrManagementControlRelationships>
    <us-gaap:RelatedPartyTransactionDescriptionOfTransaction contextRef="cref_967183272" id="fc_61668738">Convertible
        note held at fair value(1)</us-gaap:RelatedPartyTransactionDescriptionOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="cref_967183272"
      decimals="-3"
      id="fc_967183272"
      unitRef="uref_1340915823">2629000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="cref_2100081469"
      decimals="-3"
      id="fc_2100081469"
      unitRef="uref_1340915823">2290000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:NatureOfCommonOwnershipOrManagementControlRelationships contextRef="cref_116765221" id="ixv-13853">Shareholder</us-gaap:NatureOfCommonOwnershipOrManagementControlRelationships>
    <us-gaap:RelatedPartyTransactionDescriptionOfTransaction contextRef="cref_116765221" id="fc_779432120">Convertible
        note held at fair value(1)</us-gaap:RelatedPartyTransactionDescriptionOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="cref_116765221"
      decimals="-3"
      id="fc_116765221"
      unitRef="uref_1340915823">2114000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="cref_1685443802"
      decimals="-3"
      id="fc_1685443802"
      unitRef="uref_1340915823">1870000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:NatureOfCommonOwnershipOrManagementControlRelationships contextRef="cref_1135426697" id="ixv-13856">Shareholder</us-gaap:NatureOfCommonOwnershipOrManagementControlRelationships>
    <us-gaap:RelatedPartyTransactionDescriptionOfTransaction contextRef="cref_1135426697" id="fc_1380829434">Promissory
        notes(1)</us-gaap:RelatedPartyTransactionDescriptionOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="cref_1135426697"
      decimals="-3"
      id="fc_1135426697"
      unitRef="uref_1340915823">410000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="cref_1476517352"
      decimals="-3"
      id="fc_1476517352"
      unitRef="uref_1340915823">400000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:NatureOfCommonOwnershipOrManagementControlRelationships contextRef="cref_2043099235" id="ixv-13859">Shareholder</us-gaap:NatureOfCommonOwnershipOrManagementControlRelationships>
    <us-gaap:RelatedPartyTransactionDescriptionOfTransaction contextRef="cref_2043099235" id="fc_9224680">Due
        to Related Party(2)</us-gaap:RelatedPartyTransactionDescriptionOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="cref_2043099235"
      decimals="-3"
      id="fc_2043099235"
      unitRef="uref_1340915823">41000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="cref_166583866"
      decimals="-3"
      id="fc_166583866"
      unitRef="uref_1340915823">41000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:InterestExpense
      contextRef="cref_552726845"
      decimals="-3"
      id="ixv-13862"
      unitRef="uref_1340915823">5000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="cref_4447815"
      decimals="-5"
      id="ixv-13863"
      unitRef="uref_1340915823">500000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="cref_1339240323"
      decimals="-3"
      id="ixv-13864"
      unitRef="uref_1340915823">10000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="cref_2144262498"
      decimals="-5"
      id="ixv-13865"
      unitRef="uref_1340915823">1100000</us-gaap:InterestExpense>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="cref_841424808"
      decimals="-3"
      id="ixv-13868"
      unitRef="uref_1340915823">41000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="cref_283228345"
      decimals="-3"
      id="ixv-13869"
      unitRef="uref_1340915823">41000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:EarningsPerShareTextBlock contextRef="cref_853412475" id="ixv-6954">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;11 &#x2014;&#160;Net Loss
per Share Attributable to Common Stockholders&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Basic net loss per share is computed by dividing
net loss by the weighted-average number of shares of common stock outstanding during the period. In periods of net loss, the two-class
method requires that losses be allocated only to common shareholders. The computation of diluted net loss per share does not include dilutive
common stock equivalents in the weighted-average shares outstanding, as the inclusion of common stock equivalents would be antidilutive.
The common stock equivalents consist of stock options, convertible notes and convertible loans payable, warrants, and earnout shares.
Accordingly, for the periods presented in which the Company incurred a net loss, basic and diluted net loss per share are the same.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; 

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The following table sets forth the computation
of basic and diluted net loss per share attributable to common stockholders, as adjusted for the Reverse Stock Splits (in thousands, except
share and per share data):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Three Months Ended &lt;br/&gt; June 30,&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Six Months Ended &lt;br/&gt; June 30,&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;2026&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;2025&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;2026&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;2025&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td&gt;Numerator:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="padding-left: 0.125in; width: 52%; text-align: left; padding-bottom: 2.5pt;"&gt;Net loss&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right;"&gt;(8,755&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left;"&gt;)&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right;"&gt;(2,348&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left;"&gt;)&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right;"&gt;(12,211&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left;"&gt;)&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right;"&gt;(5,064&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td&gt;Denominator:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt;"&gt;Weighted average shares used to compute basic and diluted net
        loss per share&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;57,676&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;258&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;37,372&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;258&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;Net loss per share attributable to common stockholders - basic and diluted:&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;(151.80&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;(9,100.78&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;(326.74&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;(19,627.91&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The following outstanding shares of potentially
dilutive securities, as adjusted for the recapitalization and the Reverse Stock Splits, were excluded from the computation of diluted
net loss per share attributable to common stockholders for the periods presented because including them would have been antidilutive:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;As of June 30,&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;2026&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;2025&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 2.65pt;"&gt;Convertible preferred stock&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1343485248;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;823&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left; padding-left: 2.65pt;"&gt;Convertible notes payable&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_627275894;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;1,956&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left; padding-left: 2.65pt;"&gt;&lt;span style="font-size: 10pt;"&gt;Related party convertible notes payable at fair value &lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;310&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left; padding-left: 2.65pt;"&gt;&lt;span style="font-size: 10pt;"&gt;Convertible loans payable - held at fair value &lt;sup&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;751,012&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_14449110;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="padding-left: 2.65pt;"&gt;Warrants&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;35,670&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_661308655;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left; padding-left: 2.65pt;"&gt;Options to purchase common stock&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;245&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;208&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 2.65pt;"&gt;&lt;span style="font-size: 10pt;"&gt;Earnout shares &lt;sup&gt;(3)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;387&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_219262666;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 2.65pt;"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;787,624&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;2,987&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: top; text-align: justify;"&gt;
    &lt;td style="width: 0in;"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left;"&gt;&lt;span style="font-size: 10pt;"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify;"&gt;&lt;span style="font-size: 10pt;"&gt;
    Includes the assumed issuance of 183
                    shares of common stock for the conversion of Tasly Convertible Notes at $14,400.00
                    per share;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: top; text-align: justify;"&gt;
    &lt;td style="width: 0in;"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left;"&gt;&lt;span style="font-size: 10pt;"&gt;(2)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify;"&gt;&lt;span style="font-size: 10pt;"&gt;
    Includes the assumed issuance of 751,012
                    shares of common stock at the conversion price of $10.87
                    per share for the Ascent PIPE Notes, taking 95%
                    of the lowest closing share price in the 10
                    trading days preceding June 30, 2026;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: top; text-align: justify;"&gt;
    &lt;td style="width: 0in;"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left;"&gt;&lt;span style="font-size: 10pt;"&gt;(3)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify;"&gt;&lt;span style="font-size: 10pt;"&gt;
    These earnout shares exclude 129
                    shares allocated to Milestone III, as Milestone III expired as of December 31, 2025.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="cref_853412475" id="ixv-6960">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The following table sets forth the computation
of basic and diluted net loss per share attributable to common stockholders, as adjusted for the Reverse Stock Splits (in thousands, except
share and per share data):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Three Months Ended &lt;br/&gt; June 30,&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Six Months Ended &lt;br/&gt; June 30,&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;2026&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;2025&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;2026&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;2025&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td&gt;Numerator:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="padding-left: 0.125in; width: 52%; text-align: left; padding-bottom: 2.5pt;"&gt;Net loss&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right;"&gt;(8,755&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left;"&gt;)&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right;"&gt;(2,348&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left;"&gt;)&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right;"&gt;(12,211&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left;"&gt;)&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right;"&gt;(5,064&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td&gt;Denominator:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt;"&gt;Weighted average shares used to compute basic and diluted net
        loss per share&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;57,676&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;258&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;37,372&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;258&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;Net loss per share attributable to common stockholders - basic and diluted:&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;(151.80&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;(9,100.78&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;(326.74&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;(19,627.91&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="cref_496962156"
      decimals="-3"
      id="ixv-13870"
      unitRef="uref_1340915823">-8755000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1771939082"
      decimals="-3"
      id="ixv-13871"
      unitRef="uref_1340915823">-2348000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="cref_853412475"
      decimals="-3"
      id="ixv-13872"
      unitRef="uref_1340915823">-12211000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="cref_330754979"
      decimals="-3"
      id="ixv-13873"
      unitRef="uref_1340915823">-5064000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_496962156"
      decimals="0"
      id="ixv-13874"
      unitRef="uref_2062431040">57676</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_496962156"
      decimals="0"
      id="ixv-13875"
      unitRef="uref_2062431040">57676</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_1771939082"
      decimals="0"
      id="ixv-13876"
      unitRef="uref_2062431040">258</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_1771939082"
      decimals="0"
      id="ixv-13877"
      unitRef="uref_2062431040">258</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_853412475"
      decimals="0"
      id="ixv-13878"
      unitRef="uref_2062431040">37372</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_853412475"
      decimals="0"
      id="ixv-13879"
      unitRef="uref_2062431040">37372</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_330754979"
      decimals="0"
      id="ixv-13880"
      unitRef="uref_2062431040">258</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_330754979"
      decimals="0"
      id="ixv-13881"
      unitRef="uref_2062431040">258</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_496962156"
      decimals="2"
      id="ixv-13882"
      unitRef="uref_138178116">-151.8</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_496962156"
      decimals="2"
      id="ixv-13883"
      unitRef="uref_138178116">-151.8</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_1771939082"
      decimals="2"
      id="ixv-13884"
      unitRef="uref_138178116">-9100.78</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_1771939082"
      decimals="2"
      id="ixv-13885"
      unitRef="uref_138178116">-9100.78</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_853412475"
      decimals="2"
      id="ixv-13886"
      unitRef="uref_138178116">-326.74</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_853412475"
      decimals="2"
      id="ixv-13887"
      unitRef="uref_138178116">-326.74</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_330754979"
      decimals="2"
      id="ixv-13888"
      unitRef="uref_138178116">-19627.91</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_330754979"
      decimals="2"
      id="ixv-13889"
      unitRef="uref_138178116">-19627.91</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="cref_853412475" id="ixv-7076">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The following outstanding shares of potentially
dilutive securities, as adjusted for the recapitalization and the Reverse Stock Splits, were excluded from the computation of diluted
net loss per share attributable to common stockholders for the periods presented because including them would have been antidilutive:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;As of June 30,&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;2026&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;2025&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 2.65pt;"&gt;Convertible preferred stock&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1343485248;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;823&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left; padding-left: 2.65pt;"&gt;Convertible notes payable&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_627275894;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;1,956&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-align: left; padding-left: 2.65pt;"&gt;&lt;span style="font-size: 10pt;"&gt;Related party convertible notes payable at fair value &lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;310&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left; padding-left: 2.65pt;"&gt;&lt;span style="font-size: 10pt;"&gt;Convertible loans payable - held at fair value &lt;sup&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;751,012&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_14449110;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="padding-left: 2.65pt;"&gt;Warrants&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;35,670&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_661308655;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-align: left; padding-left: 2.65pt;"&gt;Options to purchase common stock&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;245&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;208&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 2.65pt;"&gt;&lt;span style="font-size: 10pt;"&gt;Earnout shares &lt;sup&gt;(3)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;387&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_219262666;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 2.65pt;"&gt;Total&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;787,624&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;2,987&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: top; text-align: justify;"&gt;
    &lt;td style="width: 0in;"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left;"&gt;&lt;span style="font-size: 10pt;"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify;"&gt;&lt;span style="font-size: 10pt;"&gt;
    Includes the assumed issuance of 183
                    shares of common stock for the conversion of Tasly Convertible Notes at $14,400.00
                    per share;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: top; text-align: justify;"&gt;
    &lt;td style="width: 0in;"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left;"&gt;&lt;span style="font-size: 10pt;"&gt;(2)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify;"&gt;&lt;span style="font-size: 10pt;"&gt;
    Includes the assumed issuance of 751,012
                    shares of common stock at the conversion price of $10.87
                    per share for the Ascent PIPE Notes, taking 95%
                    of the lowest closing share price in the 10
                    trading days preceding June 30, 2026;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: top; text-align: justify;"&gt;
    &lt;td style="width: 0in;"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left;"&gt;&lt;span style="font-size: 10pt;"&gt;(3)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify;"&gt;&lt;span style="font-size: 10pt;"&gt;
    These earnout shares exclude 129
                    shares allocated to Milestone III, as Milestone III expired as of December 31, 2025.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="cref_521100978"
      decimals="0"
      id="ixv-13890"
      unitRef="uref_2062431040">823</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="cref_487009401"
      decimals="0"
      id="ixv-13891"
      unitRef="uref_2062431040">1956</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="cref_445501554"
      decimals="0"
      id="fc_445501554"
      unitRef="uref_2062431040">310</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="cref_705606665"
      decimals="0"
      id="fc_705606665"
      unitRef="uref_2062431040">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="cref_1103434203"
      decimals="0"
      id="fc_1103434203"
      unitRef="uref_2062431040">751012</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="cref_631897872"
      decimals="0"
      id="ixv-13895"
      unitRef="uref_2062431040">35670</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="cref_525068321"
      decimals="0"
      id="ixv-13896"
      unitRef="uref_2062431040">245</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="cref_893477863"
      decimals="0"
      id="ixv-13897"
      unitRef="uref_2062431040">208</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="cref_1053028611"
      decimals="0"
      id="fc_1053028611"
      unitRef="uref_2062431040">387</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="cref_853412475"
      decimals="0"
      id="ixv-13899"
      unitRef="uref_2062431040">787624</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="cref_330754979"
      decimals="0"
      id="ixv-13900"
      unitRef="uref_2062431040">2987</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="cref_24398820"
      decimals="0"
      id="ixv-13902"
      unitRef="uref_2062431040">183</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:CommonStockConvertibleConversionPriceIncrease
      contextRef="cref_24398820"
      decimals="2"
      id="ixv-13903"
      unitRef="uref_138178116">14400</us-gaap:CommonStockConvertibleConversionPriceIncrease>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="cref_1247065944"
      decimals="0"
      id="ixv-13905"
      unitRef="uref_2062431040">751012</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:CommonStockConvertibleConversionPriceIncrease
      contextRef="cref_1247065944"
      decimals="2"
      id="ixv-13906"
      unitRef="uref_138178116">10.87</us-gaap:CommonStockConvertibleConversionPriceIncrease>
    <pfsa:PercentageOfClosingSharePrice
      contextRef="cref_1621573025"
      decimals="2"
      id="ixv-13907"
      unitRef="uref_527123470">0.95</pfsa:PercentageOfClosingSharePrice>
    <pfsa:TradingDays contextRef="cref_1247065944" id="fc_1247065944">P10D</pfsa:TradingDays>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="cref_126326278"
      decimals="0"
      id="ixv-13910"
      unitRef="uref_2062431040">129</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="cref_853412475" id="ixv-7220">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;12 &#x2014;&#160;Segments&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Company operates as one
operating segment. The
Company&#x2019;s CODM is its &lt;span style="-sec-ix-hidden:fc_1196192841;"&gt;Chief Executive Officer&lt;/span&gt; who reviews financial information
presented on a consolidated net loss basis as reported on the condensed consolidated statement of operations, in order to make decisions
about allocating resources and assessing performance for the entire Company. The CODM also utilizes the Company&#x2019;s long-range plan,
which includes product development roadmaps and long-range financial models, as a key input to resource allocation. The
CODM function approves key operating and strategic decisions. The CODM function views the Company&#x2019;s operations and manages its business
on a consolidated basis and as a single reportable operating segment. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The CODM function is regularly provided with
the following significant segment expenses. Significant expenses include research and development and general and administrative expenses,
which are each separately presented in the Company&#x2019;s condensed consolidated statements of operations. The CODM reviews significant
expenses within both the research and development and the general and administrative categories. Other segment items within net loss include
interest expense, loss on change in fair value of convertible notes, gain on change in fair value of warrant liabilities, loss on disposal
of digital assets, gain on extinguishment of PPP loan, financing costs and other income. See
the condensed consolidated financial statements for other financial information regarding the Company&#x2019;s operating segment.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Three Months Ended&lt;br/&gt; June 30,&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Six Months Ended&lt;br/&gt; June 30,&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;2026&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;2025&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;2026&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;2025&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left;"&gt;Operating expenses:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; width: 52%; text-align: left;"&gt;Research personnel compensation costs, including stock-based
        compensation&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;289&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;320&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;586&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;658&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left;"&gt;Contract research organization and regulatory costs&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;431&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_715458886;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;1,066&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1204118409;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left;"&gt;Administrative personnel compensation costs, including stock-based
        compensation&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;653&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;401&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;1,352&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;736&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left;"&gt;Rent and office costs&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;96&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;118&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;223&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;318&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left;"&gt;Legal and accounting costs&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;379&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;110&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;1,599&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;649&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1.5pt;"&gt;&lt;span style="font-size: 10pt;"&gt;Other expenses
        &lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;697&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;54&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;1,725&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;66&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt;"&gt;Total segment expenses&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;2,545&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;1,003&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;6,551&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;2,427&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt;"&gt;Loss from operations&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(2,545&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(1,003&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(6,551&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(2,427&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left;"&gt;Other income (expense):&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left;"&gt;Loss on change in the fair value of convertible notes&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(4,251&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(153&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(5,048&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(309&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left;"&gt;Gain on change in fair value of warrant liabilities&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;418&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1170691057;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;676&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1211449122;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left;"&gt;Loss on disposal of digital assets&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_871433468;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1370590824;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(295&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_173593206;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left;"&gt;Interest expense (including related parties amounts of $5
        and $533
        for the three months ended June 30, 2026 and 2025, and $10
        and $1,142
        for the six months ended June 30, 2026 and 2025, respectively)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(21&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(1,193&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(39&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(2,328&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left;"&gt;Gain on extinguishment of PPP loan&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_2050868357;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_308529073;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;1,391&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1213716140;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left;"&gt;Financing costs&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(2,410&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1073004091;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(2,470&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_918964688;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1.5pt;"&gt;Other income&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;54&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;1&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;125&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_144128159;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt;"&gt;Total other expense, net&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(6,210&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(1,345&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(5,660&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(2,637&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt;"&gt;Net loss&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;(8,755&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;(2,348&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;(12,211&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;(5,064&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: top; text-align: justify;"&gt;
    &lt;td style="width: 0in;"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left;"&gt;(1)&lt;/td&gt;
    &lt;td style="text-align: justify;"&gt;
    Other expenses includes public relations costs, insurance costs, third party professional services
                    and consulting costs and small balances of research materials and supplies.&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-indent: -24pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company has no significant long-lived assets
recognized on the condensed consolidated balance sheets. The measure of segment assets is reported on the condensed consolidated balance
sheets as total consolidated assets.&lt;/p&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="cref_853412475"
      decimals="0"
      id="ixv-13911"
      unitRef="uref_527123470">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription contextRef="cref_853412475" id="ixv-7225">The
Company&#x2019;s CODM is its Chief Executive Officer who reviews financial information
presented on a consolidated net loss basis as reported on the condensed consolidated statement of operations, in order to make decisions
about allocating resources and assessing performance for the entire Company. The CODM also utilizes the Company&#x2019;s long-range plan,
which includes product development roadmaps and long-range financial models, as a key input to resource allocation.</us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock contextRef="cref_853412475" id="ixv-13912">See
the condensed consolidated financial statements for other financial information regarding the Company&#x2019;s operating segment.

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Three Months Ended&lt;br/&gt; June 30,&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Six Months Ended&lt;br/&gt; June 30,&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom;"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;2026&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;2025&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;2026&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;2025&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left;"&gt;Operating expenses:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; width: 52%; text-align: left;"&gt;Research personnel compensation costs, including stock-based
        compensation&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;289&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;320&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;586&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;658&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left;"&gt;Contract research organization and regulatory costs&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;431&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_715458886;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;1,066&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1204118409;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left;"&gt;Administrative personnel compensation costs, including stock-based
        compensation&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;653&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;401&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;1,352&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;736&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left;"&gt;Rent and office costs&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;96&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;118&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;223&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;318&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left;"&gt;Legal and accounting costs&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;379&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;110&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;1,599&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;649&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1.5pt;"&gt;&lt;span style="font-size: 10pt;"&gt;Other expenses
        &lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;697&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;54&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;1,725&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;66&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt;"&gt;Total segment expenses&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;2,545&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;1,003&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;6,551&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;2,427&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt;"&gt;Loss from operations&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(2,545&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(1,003&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(6,551&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(2,427&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left;"&gt;Other income (expense):&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left;"&gt;Loss on change in the fair value of convertible notes&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(4,251&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(153&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(5,048&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(309&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left;"&gt;Gain on change in fair value of warrant liabilities&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;418&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1170691057;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;676&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1211449122;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left;"&gt;Loss on disposal of digital assets&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_871433468;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1370590824;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(295&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_173593206;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left;"&gt;Interest expense (including related parties amounts of $5
        and $533
        for the three months ended June 30, 2026 and 2025, and $10
        and $1,142
        for the six months ended June 30, 2026 and 2025, respectively)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(21&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(1,193&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(39&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(2,328&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left;"&gt;Gain on extinguishment of PPP loan&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_2050868357;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_308529073;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;1,391&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1213716140;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left;"&gt;Financing costs&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(2,410&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1073004091;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;(2,470&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_918964688;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1.5pt;"&gt;Other income&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;54&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;1&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;125&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_144128159;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt;"&gt;Total other expense, net&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(6,210&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(1,345&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(5,660&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(2,637&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White;"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt;"&gt;Net loss&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;(8,755&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;(2,348&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;(12,211&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;(5,064&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%;"&gt;
  &lt;tbody&gt;
  &lt;tr style="vertical-align: top; text-align: justify;"&gt;
    &lt;td style="width: 0in;"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left;"&gt;(1)&lt;/td&gt;
    &lt;td style="text-align: justify;"&gt;
    Other expenses includes public relations costs, insurance costs, third party professional services
                    and consulting costs and small balances of research materials and supplies.&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;
  &lt;/table&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <us-gaap:ShareBasedCompensation
      contextRef="cref_778583285"
      decimals="-3"
      id="ixv-13913"
      unitRef="uref_1340915823">289000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="cref_433015125"
      decimals="-3"
      id="ixv-13914"
      unitRef="uref_1340915823">320000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="cref_8656465"
      decimals="-3"
      id="ixv-13915"
      unitRef="uref_1340915823">586000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="cref_1613454691"
      decimals="-3"
      id="ixv-13916"
      unitRef="uref_1340915823">658000</us-gaap:ShareBasedCompensation>
    <pfsa:TransactionCosts
      contextRef="cref_778583285"
      decimals="-3"
      id="ixv-13917"
      unitRef="uref_1340915823">431000</pfsa:TransactionCosts>
    <pfsa:TransactionCosts
      contextRef="cref_8656465"
      decimals="-3"
      id="ixv-13918"
      unitRef="uref_1340915823">1066000</pfsa:TransactionCosts>
    <pfsa:AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation
      contextRef="cref_778583285"
      decimals="-3"
      id="ixv-13919"
      unitRef="uref_1340915823">653000</pfsa:AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation>
    <pfsa:AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation
      contextRef="cref_433015125"
      decimals="-3"
      id="ixv-13920"
      unitRef="uref_1340915823">401000</pfsa:AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation>
    <pfsa:AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation
      contextRef="cref_8656465"
      decimals="-3"
      id="ixv-13921"
      unitRef="uref_1340915823">1352000</pfsa:AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation>
    <pfsa:AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation
      contextRef="cref_1613454691"
      decimals="-3"
      id="ixv-13922"
      unitRef="uref_1340915823">736000</pfsa:AdministrativePersonnelCompensationCostsIncludingStockbasedCompensation>
    <pfsa:RentAndOfficeCosts
      contextRef="cref_778583285"
      decimals="-3"
      id="ixv-13923"
      unitRef="uref_1340915823">96000</pfsa:RentAndOfficeCosts>
    <pfsa:RentAndOfficeCosts
      contextRef="cref_433015125"
      decimals="-3"
      id="ixv-13924"
      unitRef="uref_1340915823">118000</pfsa:RentAndOfficeCosts>
    <pfsa:RentAndOfficeCosts
      contextRef="cref_8656465"
      decimals="-3"
      id="ixv-13925"
      unitRef="uref_1340915823">223000</pfsa:RentAndOfficeCosts>
    <pfsa:RentAndOfficeCosts
      contextRef="cref_1613454691"
      decimals="-3"
      id="ixv-13926"
      unitRef="uref_1340915823">318000</pfsa:RentAndOfficeCosts>
    <pfsa:LegalAndAccountingCosts
      contextRef="cref_778583285"
      decimals="-3"
      id="ixv-13927"
      unitRef="uref_1340915823">379000</pfsa:LegalAndAccountingCosts>
    <pfsa:LegalAndAccountingCosts
      contextRef="cref_433015125"
      decimals="-3"
      id="ixv-13928"
      unitRef="uref_1340915823">110000</pfsa:LegalAndAccountingCosts>
    <pfsa:LegalAndAccountingCosts
      contextRef="cref_8656465"
      decimals="-3"
      id="ixv-13929"
      unitRef="uref_1340915823">1599000</pfsa:LegalAndAccountingCosts>
    <pfsa:LegalAndAccountingCosts
      contextRef="cref_1613454691"
      decimals="-3"
      id="ixv-13930"
      unitRef="uref_1340915823">649000</pfsa:LegalAndAccountingCosts>
    <us-gaap:OtherExpenses
      contextRef="cref_778583285"
      decimals="-3"
      id="fc_942276356"
      unitRef="uref_1340915823">697000</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses
      contextRef="cref_433015125"
      decimals="-3"
      id="fc_946079108"
      unitRef="uref_1340915823">54000</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses
      contextRef="cref_8656465"
      decimals="-3"
      id="fc_1413374677"
      unitRef="uref_1340915823">1725000</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses
      contextRef="cref_1613454691"
      decimals="-3"
      id="fc_466026102"
      unitRef="uref_1340915823">66000</us-gaap:OtherExpenses>
    <us-gaap:OperatingExpenses
      contextRef="cref_778583285"
      decimals="-3"
      id="ixv-13935"
      unitRef="uref_1340915823">2545000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="cref_433015125"
      decimals="-3"
      id="ixv-13936"
      unitRef="uref_1340915823">1003000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="cref_8656465"
      decimals="-3"
      id="ixv-13937"
      unitRef="uref_1340915823">6551000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="cref_1613454691"
      decimals="-3"
      id="ixv-13938"
      unitRef="uref_1340915823">2427000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="cref_778583285"
      decimals="-3"
      id="ixv-13939"
      unitRef="uref_1340915823">-2545000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="cref_433015125"
      decimals="-3"
      id="ixv-13940"
      unitRef="uref_1340915823">-1003000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="cref_8656465"
      decimals="-3"
      id="ixv-13941"
      unitRef="uref_1340915823">-6551000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="cref_1613454691"
      decimals="-3"
      id="ixv-13942"
      unitRef="uref_1340915823">-2427000</us-gaap:OperatingIncomeLoss>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="cref_778583285"
      decimals="-3"
      id="ixv-13943"
      unitRef="uref_1340915823">-4251000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="cref_433015125"
      decimals="-3"
      id="ixv-13944"
      unitRef="uref_1340915823">-153000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="cref_8656465"
      decimals="-3"
      id="ixv-13945"
      unitRef="uref_1340915823">-5048000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="cref_1613454691"
      decimals="-3"
      id="ixv-13946"
      unitRef="uref_1340915823">-309000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="cref_778583285"
      decimals="-3"
      id="ixv-13947"
      unitRef="uref_1340915823">-418000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="cref_8656465"
      decimals="-3"
      id="ixv-13948"
      unitRef="uref_1340915823">-676000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="cref_8656465"
      decimals="-3"
      id="ixv-13949"
      unitRef="uref_1340915823">-295000</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:InterestExpenseOther
      contextRef="cref_778583285"
      decimals="-3"
      id="ixv-13950"
      unitRef="uref_1340915823">5000</us-gaap:InterestExpenseOther>
    <us-gaap:InterestExpenseOther
      contextRef="cref_433015125"
      decimals="-3"
      id="ixv-13951"
      unitRef="uref_1340915823">533000</us-gaap:InterestExpenseOther>
    <us-gaap:InterestExpenseOther
      contextRef="cref_8656465"
      decimals="-3"
      id="ixv-13952"
      unitRef="uref_1340915823">10000</us-gaap:InterestExpenseOther>
    <us-gaap:InterestExpenseOther
      contextRef="cref_1613454691"
      decimals="-3"
      id="ixv-13953"
      unitRef="uref_1340915823">1142000</us-gaap:InterestExpenseOther>
    <us-gaap:InterestExpenseNonoperating
      contextRef="cref_778583285"
      decimals="-3"
      id="ixv-13954"
      unitRef="uref_1340915823">21000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating
      contextRef="cref_433015125"
      decimals="-3"
      id="ixv-13955"
      unitRef="uref_1340915823">1193000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating
      contextRef="cref_8656465"
      decimals="-3"
      id="ixv-13956"
      unitRef="uref_1340915823">39000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating
      contextRef="cref_1613454691"
      decimals="-3"
      id="ixv-13957"
      unitRef="uref_1340915823">2328000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="cref_8656465"
      decimals="-3"
      id="ixv-13958"
      unitRef="uref_1340915823">1391000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:FinancingInterestExpense
      contextRef="cref_778583285"
      decimals="-3"
      id="ixv-13959"
      unitRef="uref_1340915823">2410000</us-gaap:FinancingInterestExpense>
    <us-gaap:FinancingInterestExpense
      contextRef="cref_8656465"
      decimals="-3"
      id="ixv-13960"
      unitRef="uref_1340915823">2470000</us-gaap:FinancingInterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="cref_778583285"
      decimals="-3"
      id="ixv-13961"
      unitRef="uref_1340915823">54000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="cref_433015125"
      decimals="-3"
      id="ixv-13962"
      unitRef="uref_1340915823">1000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="cref_8656465"
      decimals="-3"
      id="ixv-13963"
      unitRef="uref_1340915823">125000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="cref_778583285"
      decimals="-3"
      id="ixv-13964"
      unitRef="uref_1340915823">-6210000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="cref_433015125"
      decimals="-3"
      id="ixv-13965"
      unitRef="uref_1340915823">-1345000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="cref_8656465"
      decimals="-3"
      id="ixv-13966"
      unitRef="uref_1340915823">-5660000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="cref_1613454691"
      decimals="-3"
      id="ixv-13967"
      unitRef="uref_1340915823">-2637000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="cref_778583285"
      decimals="-3"
      id="ixv-13968"
      unitRef="uref_1340915823">-8755000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="cref_433015125"
      decimals="-3"
      id="ixv-13969"
      unitRef="uref_1340915823">-2348000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="cref_8656465"
      decimals="-3"
      id="ixv-13970"
      unitRef="uref_1340915823">-12211000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1613454691"
      decimals="-3"
      id="ixv-13971"
      unitRef="uref_1340915823">-5064000</us-gaap:NetIncomeLoss>
    <us-gaap:SubsequentEventsTextBlock contextRef="cref_853412475" id="ixv-7633">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;Note &lt;span&gt;13&lt;/span&gt; &#x2014; Subsequent
Events&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company has evaluated its subsequent events
as of June 30, 2026, through the date these condensed consolidated financial statements were issued and has determined that there are
no subsequent events requiring disclosure in these condensed consolidated financial statements other than the items noted below.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Common Stock&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; As disclosed in Note &lt;span&gt;1&lt;/span&gt; &#x2014;
Organization, Description of Business, Going Concern and Significant Risks and Uncertainties, the Company effected a 1-for-25
reverse stock split of its common stock on July 7, 2026 and effected a &lt;span&gt;1&lt;/span&gt;-for-&lt;span&gt;4&lt;/span&gt; reverse stock split of its common
stock on August 17, 2026. In result, all share and per-share information presented in these condensed consolidated financial statements
has been retroactively adjusted to reflect the July and August Reverse Stock Splits. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; During July 2026, the Company issued 121,152
shares of the Company&#x2019;s common stock for settlement of $0.9
million of principal and interest on the Company&#x2019;s convertible loans payable. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Warrant Amendment&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; On August 12, 2026, the Company&#x2019;s Board
of Directors approved an amendment to the warrant conversion price related to the August Reverse Stock Split. Prior to the Company&#x2019;s
August Reverse Stock Split, the Company had 17,404,250
outstanding Warrants (excluding the Ascent Warrants) to purchase 9,282
shares of Common Stock, with each whole Warrant being exercisable under the Warrant Agreement to purchase one Warrant Share, with an exercise
price of $21,562.50
per Warrant Share. After giving effect to the August Reverse Stock Split, these 17,404,250
Warrants will be exercisable for a total of 2,320
shares of Common Stock, with each whole Warrant exercisable to purchase &lt;span&gt;1&lt;/span&gt;/&lt;span&gt;7,500&lt;/span&gt;th of a Warrant Share, and the
exercise price shall be adjusted to $86,250.00
per whole Warrant Share. After giving effect to the August Reverse Stock Split, one Warrant Share will be issuable upon the exercise of
7,500
Warrants for an aggregate exercise price of $86,250.00.
The impact of the August Reverse Stock Split on exercise price for the Ascent Warrants is discussed in &#x201c;Amendment No. &lt;span&gt;5&lt;/span&gt;
on the PIPE Subscription Agreement&#x201d; below. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;G&lt;span&gt;3&lt;/span&gt;
Acquisition Term Sheet&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;On July 2, 2026, the Company entered into a non-binding
term sheet with a privately held commercial-stage health diagnostics and toxicology testing company regarding a proposed acquisition.
The proposed transaction is subject to the completion of due diligence, negotiation and execution of definitive agreements, receipt of
required stockholder, stock exchange, regulatory and third-party approvals, completion of contemplated debt conversions, receipt of audited
financial statements of the target company, and other customary closing conditions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The term sheet contemplates consideration consisting
of shares of the Company&#x2019;s common stock equal to 19.99%
of the Company&#x2019;s then-issued and outstanding common shares and shares of non-voting convertible preferred stock, with conversion
of the preferred stock subject to stockholder approval. The proposed transaction also contemplates the exchange of certain outstanding
obligations of the Company for preferred stock and approximately $7.0
million of financing in connection with the closing. The term sheet does not obligate either party to consummate the proposed transaction,
and there can be no assurance that definitive agreements will be executed or that the proposed transaction will be completed. Because
the terms remain subject to negotiation and the transaction may not be completed, the Company is currently unable to estimate the financial
statement effects of the proposed transaction. No amounts related to the proposed transaction have been recognized in the accompanying
condensed consolidated financial statements as of June 30, 2026. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Subsequent to signing the non-binding term sheet,
the Company entered into an option agreement to acquire G&lt;span&gt;3&lt;/span&gt; on July 31, 2026, which superseded the abovementioned term sheet.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Changes in
Directors and Executive Officers&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Effective July 21, 2026, Jack Stover was appointed
Executive Chairman and Chief Executive Officer and Ben Hwang was appointed President. On July 26, 2026, Mr. Hwang resigned from the Board
while continuing to serve as President, and Liviu Goldenberg was appointed as an independent director.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-size: 9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Option Agreement
to Acquire G&lt;span&gt;3&lt;/span&gt; &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-size: 9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; On July 31, 2026, the Company entered into an
option agreement with certain stockholders of G&lt;span&gt;3&lt;/span&gt; Vision Labs Inc. (&#x201c;G&lt;span&gt;3&lt;/span&gt;&#x201d;), pursuant to which the
Company obtained the right, but not the obligation, to acquire 100%
of the outstanding equity securities of G&lt;span&gt;3&lt;/span&gt; (the &#x201c;Call Option&#x201d;). G&lt;span&gt;3&lt;/span&gt; owns all or substantially all
of the equity securities of Med Screen Laboratories Inc., Dominion Diagnostics LLC and Acutis Diagnostics Inc. If the Call Option is exercised
and the contemplated acquisition is completed, G&lt;span&gt;3&lt;/span&gt; and its subsidiaries would become direct or indirect subsidiaries of the
Company. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-size: 9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Company&#x2019;s ability to exercise the
Call Option is subject to the satisfaction of various conditions, including the Company or G&lt;span&gt;3&lt;/span&gt; consummating, or obtaining
binding commitments for, one or more financings resulting in aggregate gross proceeds of at least $30.0
million; the refinancing, repayment or other satisfaction of certain G&lt;span&gt;3&lt;/span&gt; indebtedness or receipt of applicable lender consents;
receipt of certain Company stockholder and Nasdaq approvals; continued listing of the Company&#x2019;s common stock on Nasdaq; release
of the sellers from certain obligations relating to indebtedness of the target companies; and execution of definitive acquisition documents.
The Call Option expires &lt;span&gt;90&lt;/span&gt; days after the target companies provide the Company with specified audited and reviewed financial
information. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt; 

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; As consideration for the Call Option, the Company
issued to the sellers an aggregate of 50,280
shares of common stock and 52,903.566
shares of newly designated Series A Non-Voting Convertible Preferred Stock (&#x201c;Series A Preferred Stock&#x201d;). The Call Option consideration
is not subject to a lock-up period but are subject to registration on a future Form S-&lt;span&gt;1&lt;/span&gt; which will be filed at the earliest
commercial reasonable date. Each share of Series A Preferred Stock is convertible into 1,000
shares of common stock following receipt of the required stockholder approval, subject to certain beneficial ownership limitations. If
the Company exercises the Call Option, the sellers will be entitled to receive an additional 53,918.113
shares of Series A Preferred Stock. If the conditions to exercise the Call Option are not satisfied or the Call Option is not exercised,
the sellers will retain the common stock and Series A Preferred Stock issued as consideration for the grant of the Call Option. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-size: 9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;If the acquisition closes and &lt;span&gt;18&lt;/span&gt;
months following the closing, the required stockholder approval for conversion of the Series A Preferred Stock has not been obtained and
the Company is unable or otherwise fails to deliver the common shares issuable upon conversion, each seller may elect to require the Company
to redeem its Series A Preferred Stock for cash at an amount based on the then-current fair value of the underlying common stock. The
Company is currently evaluating the appropriate accounting treatment for the Option Agreement and the related equity issuances. As of
the date these condensed consolidated financial statements were issued, the Company had not completed its evaluation or determined the
fair value of the consideration issued and, therefore, a reasonable estimate of the financial statement effect could not be made.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-size: 9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; In connection with entering into the Option
Agreement, the Company was invoiced by its financial advisor for a cash success fee of $0.6
million and 3,037.381
shares of Series A Non-Voting Convertible Preferred Stock. The Company also incurred transaction-related employee bonuses as a result
of executing the Option Agreement, with an aggregate contractual amount of $2.6
million, consisting of $0.4
million payable in cash and $2.2
million payable in equity awards. The Company also incurred legal and other professional fees as a result of executing the Option Agreement,
for which the amount is being finalized. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-size: 9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;As of the date these condensed consolidated financial
statements were issued, the Company had not completed its evaluation of the recognition, classification and measurement of the Option
Agreement consideration and related equity-denominated transaction costs and compensation. Accordingly, although certain contractual amounts
are known, the Company had not determined the total financial statement effect of the Option Agreement and related transactions. As of
the date these condensed consolidated financial statements were issued, the Call Option had not been exercised and the contemplated acquisition
had not been completed.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-size: 9pt;"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Convertible
Promissory Note &#x2013; Related Party&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-size: 9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; On July 31, 2026, the Company entered into Amendment
No. &lt;span&gt;2&lt;/span&gt; to the Note Modification and Conversion Agreement with NorthView Sponsor I, LLC. The amendment increased the beneficial
ownership limitation applicable to conversions under the note to 49.9%
of the Company&#x2019;s outstanding common stock following conversion and established the conversion price as the closing price of the
Company&#x2019;s common stock on July 31, 2026. The amendment also provides that the number of shares issuable upon conversion will equal
122%
of the principal amount being converted divided by the conversion price. All other material terms of the agreement remain in effect. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-size: 9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; On August 12, 2026, NorthView Sponsor I, LLC
converted $1.3
million of principal outstanding under the convertible Promissory Note &#x2013; Related Party into 301,991
shares of the Company&#x2019;s common stock at a conversion price of $4.28
per share. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-size: 9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Reduction
in Force&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-size: 9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Subsequent to June 30, 2026, the Company implemented
cost reduction measures designed to preserve liquidity and reduce operating expenses. These measures included a reduction in force that
reduced the Company&#x2019;s workforce from &lt;span&gt;11&lt;/span&gt; employees to &lt;span&gt;5&lt;/span&gt; employees.&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-size: 9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Amendment
No. &lt;span&gt;5&lt;/span&gt; on the PIPE Subscription Agreement with Ascent&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-size: 9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; On August 12, 2026, the Company executed the
&lt;span&gt;5&lt;/span&gt;th amendment to the Ascent Convertible Note Agreement for which the Company received an additional tranche of $0.7
million on August 13, 2026, which bears interest at 7%
per annum and matures on August 12, 2027. In connection with Amendment No. &lt;span&gt;5&lt;/span&gt;, the Company also amended the exercise price
of the Ascent Warrants to $1.07
per share. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-size: 9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Issuance
of Series A Preferred Stock upon Settlement of Liabilities&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; On August 18, 2026, the Company issued 4,271.298
shares of Series A Non-Voting Convertible Preferred Stock (&#x201c;Series A Preferred Stock&#x201d;) in settlement of approximately $4.6
million of outstanding liabilities, consisting of approximately $3.2
million owed to financial advisors and vendors, $0.8
million of accrued employee bonuses and $0.6
million of convertible notes payable. The Series A Preferred Stock is not subject to a lock-up period and is subject to registration on
a future Form S-&lt;span&gt;1&lt;/span&gt; to be filed at the earliest commercially reasonable date. Each share of Series A Preferred Stock is convertible
into 250
shares of the Company&#x2019;s common stock, after giving effect to the August Reverse Stock Split, following receipt of the required stockholder
approval and subject to certain beneficial ownership limitations. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Further, on August 19, 2026, the Company entered
into an exchange agreement with Ascent Partners Fund LLC pursuant to which the full balance of their convertible notes shall be exchanged
into shares of Series A Preferred Stock upon the exercise of the Company&#x2019;s option under the Option Agreement. Pursuant to the exchange
agreement, the existing Ascent notes are expected to be exchanged for shares of Series A Preferred Stock at a rate of 0.93458
shares of Preferred Stock for every $1,000
in aggregate principal, accrued and unpaid interest, and any other amounts owed on these existing convertible notes. The shares of Series
A Preferred Stock to be issued pursuant to the exchange agreement may be converted to Common Stock at a conversion price of $4.28
per share of Common Stock. The balance of the liabilities expected to be exchanged as of the date of the agreement and the date of the
issuance of these condensed consolidated financial statements is approximately $6.1
million in total, which is made up of approximately $5.5
million of principal and approximately $0.6
million of accrued interest.&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="cref_1291181401" id="ixv-13973">1-for-25</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="cref_1606834516"
      decimals="0"
      id="fc_1606834516"
      unitRef="uref_2062431040">121152</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:PrincipalInvestmentGainsLosses
      contextRef="cref_1774277253"
      decimals="-5"
      id="ixv-13975"
      unitRef="uref_1340915823">900000</us-gaap:PrincipalInvestmentGainsLosses>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="cref_2017145347"
      decimals="0"
      id="ixv-13976"
      unitRef="uref_2062431040">17404250</us-gaap:ClassOfWarrantOrRightOutstanding>
    <pfsa:WarrantsToPurchaseShares
      contextRef="cref_2046281447"
      decimals="0"
      id="ixv-13977"
      unitRef="uref_2062431040">9282</pfsa:WarrantsToPurchaseShares>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="cref_2017145347"
      decimals="2"
      id="ixv-13978"
      unitRef="uref_138178116">21562.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <pfsa:SharesOfReverseStockSplit
      contextRef="cref_2046281447"
      decimals="0"
      id="ixv-13979"
      unitRef="uref_2062431040">17404250</pfsa:SharesOfReverseStockSplit>
    <pfsa:SharesOfWarrantsExercisable
      contextRef="cref_2046281447"
      decimals="0"
      id="ixv-13980"
      unitRef="uref_2062431040">2320</pfsa:SharesOfWarrantsExercisable>
    <pfsa:AggregatePurchasePrice
      contextRef="cref_2017145347"
      decimals="-1"
      id="ixv-13981"
      unitRef="uref_1340915823">86250000</pfsa:AggregatePurchasePrice>
    <pfsa:ExerciseOfShares
      contextRef="cref_2046281447"
      decimals="0"
      id="ixv-13982"
      unitRef="uref_2062431040">7500</pfsa:ExerciseOfShares>
    <pfsa:AggregateExercisePrice
      contextRef="cref_2046281447"
      decimals="2"
      id="ixv-13983"
      unitRef="uref_138178116">86250</pfsa:AggregateExercisePrice>
    <pfsa:PercentageOfOutstandingCommonSharesToBeIssued
      contextRef="cref_1579910082"
      decimals="4"
      id="fc_1579910082"
      unitRef="uref_527123470">0.1999</pfsa:PercentageOfOutstandingCommonSharesToBeIssued>
    <us-gaap:PreferredStockValueOutstanding
      contextRef="cref_295563055"
      decimals="-5"
      id="ixv-13985"
      unitRef="uref_1340915823">7000000</us-gaap:PreferredStockValueOutstanding>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="cref_80705224"
      decimals="2"
      id="ixv-13986"
      unitRef="uref_527123470">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <pfsa:GrossProceeds
      contextRef="cref_1583072532"
      decimals="-5"
      id="ixv-13987"
      unitRef="uref_1340915823">30000000</pfsa:GrossProceeds>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="cref_445490913"
      decimals="0"
      id="ixv-13988"
      unitRef="uref_2062431040">50280</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="cref_1903852325"
      decimals="3"
      id="ixv-13989"
      unitRef="uref_2062431040">52903.566</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="cref_508631920"
      decimals="0"
      id="ixv-13990"
      unitRef="uref_2062431040">1000</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="cref_769800211"
      decimals="3"
      id="ixv-13991"
      unitRef="uref_2062431040">53918.113</us-gaap:ConversionOfStockSharesIssued1>
    <pfsa:TransactionCostsAndExpensesRelatedToInvestment
      contextRef="cref_769800211"
      decimals="-5"
      id="ixv-13992"
      unitRef="uref_1340915823">600000</pfsa:TransactionCostsAndExpensesRelatedToInvestment>
    <us-gaap:PreferredStockSharesIssued
      contextRef="cref_1765404405"
      decimals="3"
      id="ixv-13993"
      unitRef="uref_2062431040">3037.381</us-gaap:PreferredStockSharesIssued>
    <us-gaap:AccruedBonusesCurrentAndNoncurrent
      contextRef="cref_1760202102"
      decimals="-5"
      id="ixv-13994"
      unitRef="uref_1340915823">2600000</us-gaap:AccruedBonusesCurrentAndNoncurrent>
    <us-gaap:AccruedBonusesCurrent
      contextRef="cref_1760202102"
      decimals="-5"
      id="ixv-13995"
      unitRef="uref_1340915823">400000</us-gaap:AccruedBonusesCurrent>
    <us-gaap:ConvertibleNotesPayable
      contextRef="cref_1760202102"
      decimals="-5"
      id="ixv-13996"
      unitRef="uref_1340915823">2200000</us-gaap:ConvertibleNotesPayable>
    <pfsa:PercentageOfIssuedAndOutstanding
      contextRef="cref_1760202102"
      decimals="3"
      id="ixv-13997"
      unitRef="uref_527123470">0.499</pfsa:PercentageOfIssuedAndOutstanding>
    <pfsa:PercentageOfIssuedAndOutstanding
      contextRef="cref_988890546"
      decimals="2"
      id="ixv-13998"
      unitRef="uref_527123470">1.22</pfsa:PercentageOfIssuedAndOutstanding>
    <pfsa:PrincipalOutstanding
      contextRef="cref_2046281447"
      decimals="-5"
      id="ixv-13999"
      unitRef="uref_1340915823">1300000</pfsa:PrincipalOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="cref_200603577"
      decimals="0"
      id="ixv-14000"
      unitRef="uref_2062431040">301991</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_2017145347"
      decimals="2"
      id="ixv-14001"
      unitRef="uref_138178116">4.28</us-gaap:SharesIssuedPricePerShare>
    <pfsa:AdditionalAmount
      contextRef="cref_2046281447"
      decimals="-5"
      id="ixv-14002"
      unitRef="uref_1340915823">700000</pfsa:AdditionalAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="cref_65396335"
      decimals="2"
      id="ixv-14003"
      unitRef="uref_527123470">0.07</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="cref_65396335"
      decimals="2"
      id="ixv-14004"
      unitRef="uref_138178116">1.07</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="cref_346576114"
      decimals="3"
      id="ixv-14005"
      unitRef="uref_2062431040">4271.298</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:LiabilitiesAverageAmountOutstanding
      contextRef="cref_1406285210"
      decimals="-5"
      id="ixv-14006"
      unitRef="uref_1340915823">4600000</us-gaap:LiabilitiesAverageAmountOutstanding>
    <us-gaap:LiabilitiesAverageAmountOutstanding
      contextRef="cref_1465053354"
      decimals="-5"
      id="ixv-14007"
      unitRef="uref_1340915823">3200000</us-gaap:LiabilitiesAverageAmountOutstanding>
    <us-gaap:LiabilitiesAverageAmountOutstanding
      contextRef="cref_119935471"
      decimals="-5"
      id="ixv-14008"
      unitRef="uref_1340915823">800000</us-gaap:LiabilitiesAverageAmountOutstanding>
    <us-gaap:LiabilitiesAverageAmountOutstanding
      contextRef="cref_417250911"
      decimals="-5"
      id="ixv-14009"
      unitRef="uref_1340915823">600000</us-gaap:LiabilitiesAverageAmountOutstanding>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="cref_180299970"
      decimals="0"
      id="ixv-14010"
      unitRef="uref_2062431040">250</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="cref_1340915823"
      decimals="5"
      id="ixv-14011"
      unitRef="uref_2062431040">0.93458</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:DebtInstrumentIssuedPrincipal
      contextRef="cref_1340915823"
      decimals="-3"
      id="ixv-14012"
      unitRef="uref_1340915823">1000000</us-gaap:DebtInstrumentIssuedPrincipal>
    <us-gaap:CommonStockConvertibleConversionPriceIncrease
      contextRef="cref_1340915823"
      decimals="2"
      id="ixv-14013"
      unitRef="uref_138178116">4.28</us-gaap:CommonStockConvertibleConversionPriceIncrease>
    <us-gaap:LiabilitiesAverageAmountOutstanding
      contextRef="cref_1340915823"
      decimals="-5"
      id="ixv-14014"
      unitRef="uref_1340915823">6100000</us-gaap:LiabilitiesAverageAmountOutstanding>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="cref_754644200"
      decimals="-5"
      id="ixv-14015"
      unitRef="uref_1340915823">5500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest
      contextRef="cref_1340915823"
      decimals="-5"
      id="ixv-14016"
      unitRef="uref_1340915823">600000</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="cref_496962156" id="ixv-14017">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="cref_496962156" id="ixv-14018">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="cref_496962156" id="ixv-14019">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="cref_496962156" id="ixv-14020">false</ecd:Rule10b51ArrTrmntdFlag>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#fc_1950113667"
          xlink:label="fc_1950113667"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_354173338"
          xlink:label="fc_354173338"
          xlink:type="locator"/>
        <link:footnote id="fref_1318520185" xlink:label="fref_1318520185" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">These earnout shares exclude 129
                    shares, as adjusted for the Reverse Stock Splits, allocated to Milestone III, as Milestone III expired as of December 31, 2025. Milestone
                    III represents an operational milestone for the Company&#x2019;s consummation of a joint venture, for which management has decided not
                    to pursue the joint venture.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1950113667"
          xlink:to="fref_1318520185"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_354173338"
          xlink:to="fref_1318520185"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#fc_1685443802"
          xlink:label="fc_1685443802"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1476517352"
          xlink:label="fc_1476517352"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_61668738"
          xlink:label="fc_61668738"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1380829434"
          xlink:label="fc_1380829434"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_967183272"
          xlink:label="fc_967183272"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1135426697"
          xlink:label="fc_1135426697"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_2100081469"
          xlink:label="fc_2100081469"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_116765221"
          xlink:label="fc_116765221"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_779432120"
          xlink:label="fc_779432120"
          xlink:type="locator"/>
        <link:footnote id="fref_476326551" xlink:label="fref_476326551" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">See Note 5 for full disclosures on debt, including the convertible notes payable, convertible loans
                    payable and promissory notes.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1685443802"
          xlink:to="fref_476326551"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1476517352"
          xlink:to="fref_476326551"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_61668738"
          xlink:to="fref_476326551"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1380829434"
          xlink:to="fref_476326551"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_967183272"
          xlink:to="fref_476326551"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1135426697"
          xlink:to="fref_476326551"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_2100081469"
          xlink:to="fref_476326551"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_116765221"
          xlink:to="fref_476326551"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_779432120"
          xlink:to="fref_476326551"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#fc_2043099235"
          xlink:label="fc_2043099235"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_166583866"
          xlink:label="fc_166583866"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_9224680"
          xlink:label="fc_9224680"
          xlink:type="locator"/>
        <link:footnote id="fref_1762538919" xlink:label="fref_1762538919" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">As of June&#160;30, 2026 and December&#160;31, 2025, $41
                    thousand relating to an administrative service fee remains outstanding which originated from the net assets of the Northview balance sheet
                    that was brought over at the time of the merger at fair value and has had no change.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_2043099235"
          xlink:to="fref_1762538919"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_166583866"
          xlink:to="fref_1762538919"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_9224680"
          xlink:to="fref_1762538919"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#fc_942276356"
          xlink:label="fc_942276356"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1413374677"
          xlink:label="fc_1413374677"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_466026102"
          xlink:label="fc_466026102"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_946079108"
          xlink:label="fc_946079108"
          xlink:type="locator"/>
        <link:footnote id="fref_1675060868" xlink:label="fref_1675060868" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Other expenses includes public relations costs, insurance costs, third party professional services
                    and consulting costs and small balances of research materials and supplies.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_942276356"
          xlink:to="fref_1675060868"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1413374677"
          xlink:to="fref_1675060868"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_466026102"
          xlink:to="fref_1675060868"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_946079108"
          xlink:to="fref_1675060868"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#fc_445501554"
          xlink:label="fc_445501554"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_705606665"
          xlink:label="fc_705606665"
          xlink:type="locator"/>
        <link:footnote id="fref_1501424663" xlink:label="fref_1501424663" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes the assumed issuance of 183
                    shares of common stock for the conversion of Tasly Convertible Notes at $14,400.00
                    per share;</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_445501554"
          xlink:to="fref_1501424663"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_705606665"
          xlink:to="fref_1501424663"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#fc_1103434203"
          xlink:label="fc_1103434203"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_14449110"
          xlink:label="fc_14449110"
          xlink:type="locator"/>
        <link:footnote id="fref_159697400" xlink:label="fref_159697400" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes the assumed issuance of 751,012
                    shares of common stock at the conversion price of $10.87
                    per share for the Ascent PIPE Notes, taking 95%
                    of the lowest closing share price in the 10
                    trading days preceding June 30, 2026;</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1103434203"
          xlink:to="fref_159697400"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_14449110"
          xlink:to="fref_159697400"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#fc_219262666"
          xlink:label="fc_219262666"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1053028611"
          xlink:label="fc_1053028611"
          xlink:type="locator"/>
        <link:footnote id="fref_804314602" xlink:label="fref_804314602" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">These earnout shares exclude 129
                    shares allocated to Milestone III, as Milestone III expired as of December 31, 2025.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_219262666"
          xlink:to="fref_804314602"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1053028611"
          xlink:to="fref_804314602"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#fc_2046609879"
          xlink:label="fc_2046609879"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1559462887"
          xlink:label="fc_1559462887"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1781900980"
          xlink:label="fc_1781900980"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1963797799"
          xlink:label="fc_1963797799"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_931644489"
          xlink:label="fc_931644489"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_763554049"
          xlink:label="fc_763554049"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_248509124"
          xlink:label="fc_248509124"
          xlink:type="locator"/>
        <link:footnote id="fref_271459916" xlink:label="fref_271459916" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">See Note 8 for the key inputs used in the Black-Scholes option pricing model in calculating the fair
                    value of the Ascent Warrants during the three and six months ended June 30, 2026.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_2046609879"
          xlink:to="fref_271459916"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1559462887"
          xlink:to="fref_271459916"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1781900980"
          xlink:to="fref_271459916"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1963797799"
          xlink:to="fref_271459916"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_931644489"
          xlink:to="fref_271459916"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_763554049"
          xlink:to="fref_271459916"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_248509124"
          xlink:to="fref_271459916"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
